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Introduction 
One way that the DPMP contributes to improved Australian drug policy is through providing 
access to research evidence. We have prepared an annotated bibliography of relevant 
research in relation to prison-based drug treatment. We have endeavoured to focus on 
Australian research but also included much international work. Only research papers that 
report on programs in prison settings are included. 
 
More than 200 papers were located – the majority (approx 98) are Australian, followed by 
about 65 from the USA, and 50 from European countries. 
 
Wherever possible we provide an Abstract and a link to the reference. Access to the journal 
articles via the links will depend on your organisational subscription access. DPMP would be 
pleased to assist with retrieval of any specific papers if required.  
 
 
The bibliography is divided into a number of sections: 
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Reviews  
 
This section includes systematic reviews and meta-analysis of prison-based drug treatment. 
There have been two systematic reviews: one from US researchers Mitchell et al (as a 
Campbell Collaboration) and one by researchers at the National Drug and Alcohol Research 
Centre (Larney et al). The report published by the Australian National Council on Drugs 
(Black et al) provides a comprehensive review of Australian prison programs. These are 
central resources and have been listed first, the remainder follow alphabetically. 
 
Mitchell, O., Wilson, D. B., & MacKenzie, D. L. (2006). The Effectiveness of Incarceration-
Based Drug Treatment on Criminal Behavior: Campbell Collaboration. 
URL: http://www.campbellcollaboration.org/doc-pdf/Incarceration-
BasedDrugTxSept06final.pdf 
 
Mitchell, O., Wilson, D. B., & MacKenzie, D. L. (2007). Does incarceration-based drug 
treatment reduce recidivism? A meta-analytic synthesis of the research. Journal of 
Experimental Criminology, 3(4), 353-375.  
 
Larney, S., Mathers, B., & Dolan, K. (2007). Illicit drug treatment in prison: detoxification, 
drug-free units, therapeutic communities and opioid substitution treatment. Sydney: 
National Drug and Alcohol Research Centre. 
Abstract: The relationship between drugs, crime and subsequent imprisonment is 
acknowledged around the world. Although it is recognised that offering drug 
treatment to drug using offenders may contribute to reducing re-offending, 
treatment availability is often limited. This report summarises the published 
literature on illicit drug detoxification and treatment interventions in prisons. Where 
relevant, literature on community-based interventions is also discussed. This report 
is not intended to be used as a guide for clinical practice; rather, its aim is to draw 
attention to various approaches for the treatment of illicit drug dependence in prison 
settings. 
URL: http://www.med.unsw.edu.au/NDARCWeb.nsf/resources/TR+263-
267/$file/TR266.pdf 
 
Black, E., Wodak, A. D., & Dolan, K. A. (2004). Supply, demand and harm reduction 
strategies in Australian prisons: implementation, cost and evaluation. Canberra: 
Australian National Council on Drugs. 
Abstract: The purpose of this study was to identify supply, demand and harm 
reduction strategies within Australian prisons, their associated costs and evidence of 
their effectiveness. For each state and territory, the study identifies supply reduction 
strategies, including drug detection dogs and urinalysis; demand reduction 
strategies, which include detoxification, methadone treatment, inmate programs and 
counselling, and drug free units; harm reduction strategies, including harm reduction 
education, peer education, bloodborne viral infection testing, hepatitis B vaccination, 
condom provision, bleach / detergent provision, naloxone provision and needle and 
syringe programs; and pre and post release programs. The report finds that many of 
these strategies were poorly documented, their costs were largely unknown and their 
benefits and adverse consequences have rarely been defined. The study 
recommends, overall, that there is an urgent need to increase the quantity and 
quality of evaluation and expand the implementation of those strategies best 
supported by existing evaluations, namely demand and harm reduction strategies. 
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URL: http://www.ancd.org.au/publications/pdf/rp9_australian_prisons.pdf 
 
Andrews, D. A., Zinger, I., Hoge, R. D., Bonta, J., Gendreau, P., & Cullen, F. T. (1990). 
Does correctional treatment work? A clinically relevant and psychologically informed 
meta-analysis. Criminology(3), 369-404.  
Abstract: Careful reading of the literature on the psychology of criminal conduct and 
of prior reviews of studies of treatment effects suggests that neither criminal 
sanctioning without provision of rehabilitative service nor servicing without reference 
to clinical principles of rehabilitation will succeed in reducing recidivism. What works, 
in our view, is the delivery of appropriate correctional service, and appropriate 
service reflects three psychological principles: (1) delivery of service to higher risk 
cases, (2) targeting of criminogenic needs, and (3) use of styles and modes of 
treatment (e.g., cognitive and behavioral) that are matched with client need and 
learning styles. These principles were applied to studies of juvenile and adult 
correctional treatment, which yielded 154 phi coefficients that summarized the 
magnitude and direction of the impact of treatment of recidivism. The effect of 
appropriate correctional service (mean phi = .30) was significantly (p < .05) greater 
than that of unspecified correctional service (.13), and both were more effective than 
inappropriate service (-.06) and non-service criminal sanctioning (-.07). Service was 
effective within juvenile and adult corrections, in studies published before and after 
1980, in randomized and nonrandomized designs, and in diversionary, community, 
and residential programs (albeit, attenuated in residential settings). Clinical 
sensitivity and a psychologically informed perspective on crime may assist in the 
renewed service, research, and conceptual efforts that are strongly indicated by our 
review. 
URL:http://infotrac.galegroup.com/itw/infomark/1/1/1/purl=rc1_EAIM_0_A9429505
&dyn=5!xrn_1_0_A9429505?Z3950=1&sw_aep=unsw Electronic resource (HTML) 
HTML  
 
Campbell, N. D., Olsen, J.P., & Walden, L. (2008). The Narcotic Farm: The Rise and Fall of 
America's First Prison for Drug Addicts. London/New York, Abrams. 
 
Forensic Psychology Research Group. (2003). Substance use treatment in Victorian 
corrections : service mix and standards. Stage 1 report : literature review only. 
Adelaide: Centre for Applied Psychological Research, University of South Australia. 
Abstract: The use and abuse of licit and illicit drugs by offenders is a major concern 
for the Victorian criminal justice system. This report forms the first stage of a project 
looking at substance use treatment in the Victorian corrections system, and involved 
a review of the national and international literature on best practice in prison and 
community offender substance use programs, and on harm minimisation in prisons. 
This was approached in two ways: first, by a review of the published literature 
reporting the outcomes of correctional substance use treatment programs; and 
second, by a review of good practice in offender rehabilitation programming more 
generally. Both were used to inform the site-visits and discussions with key 
stakeholders, leading to the development of the proposed service framework. The 
literature reviewed for this report comes from a wide variety of sources. A narrative 
review of the literature was supplemented by a specific database search to yield 
program evaluations of offender programs. Four major bibliographic databases that 
include citations for criminal justice literature were searched: CINCH, PsychINFO, 
Sociological Abstracts, and the FAMILY database. These databases were selected 
because they are the key citation sources in the criminal justice field, cover both 
Australian and international literature, and include high quality Abstracts. The aim of 
the site visits was to discuss the current service mix with key stakeholders, and to 
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elicit views about possible standards and models of practice. Information about 
current service provision was gathered through focus groups and interviews, and a 
review of documentation. 
URL:http://www.justice.vic.gov.au/wps/wcm/connect/DOJ+Internet/resources/file/e
b8d9d0f6ab0160/Literature_Review_Drug_and_Alcohol_Treatment_Services.pdf 
 
Harrison, L., Cappello, R., Alaszewski, A., Appleton, S., & Cooke, G. (2003). The 
Effectiveness of Treatment for Substance Dependence with the Prison System in 
England: A Review. Canterbury, Kent: Centre for Health Services Studies. 
URL: http://www.kent.ac.uk/chss/researchcentre/docs/etdd.PDF 
 
Hough, M. (1996). Drugs misuse and the criminal justice system: A review of the literature. 
London: Central Drug Prevention Unit. 
 
McSweeney, T., Turnbull, P. J., & Hough, M. (2002). Review of criminal justice interventions 
for drug users in other countries. London: Criminal Policy Research Unit, South Bank 
University. 
Abstract: This paper examines the provision of drug treatment within the criminal 
justice system, comparing and contrasting British interventions with examples from 
America, Australia and other European countries. The discussion is restricted, as 
much as possible, to those criminal justice interventions that have been 
independently evaluated for their effectiveness. Drug treatment interventions are 
discussed at four common points of intervention: arrest; trial and sentencing by a 
court; imprisonment; and release from prison. The analysis includes consideration of 
referral and diversion schemes operating in different Australian states; findings on 
the effectiveness of drug courts and coerced treatment in reducing illicit drug use; 
and evidence on the effectiveness of different kinds of prison based drug treatment 
and post release drug treatment programs. The paper concludes that evaluations 
measuring the effectiveness of different interventions aimed at helping and treating 
drug users within the criminal justice system have shown mixed results. 
URL: http://www.nao.org.uk/publications/nao_reports/03-
04/0304366_international.pdf  
 
Mears, D. P., Winterfield, L., Hunsaker, J., Moore, G. E., & White, R. (2003). Drug 
Treatment in the Criminal Justice System: The Current State of Knowledge. 
Washington D.C.: The Urban Institute. 
URL: http://www.urban.org/publications/410618.html 
 
Neale, J., & Saville, E. (2004). Comparing community and prison-based drug treatments. 
Drugs: Education, Prevention and Policy, 11(3), 213 - 228.  
Abstract: Evaluations of drug treatment services are essential for the development 
and funding of future provision. This paper seeks to fill a gap in the existing 
literature by comparing community and prison-based drug services in terms of a 
range of factors that are important in assessing drug treatment effectiveness. Data 
were collected as part of the Drug Outcome Research in Scotland (DORIS) study. 
Over a period of approximately eight months, two structured questionnaires were 
administered to 716 drug users. At the first interview, 487 respondents (68%) were 
beginning community drug treatment and 229 (32%) were starting prison drug 
treatment. Analyses compared the two groups in terms of characteristics at 
treatment entry ; treatment services received ; and characteristics at eight-month 
follow-up. Consistent with previous research, the findings provide evidence that at 
least in the short term drug treatments work. However, the clients of community 
drug agencies experienced greater improvements than the clients of prison-based 
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services. The former received a broader range of support than their imprisoned 
counterparts and rated the assistance that they received significantly more 
positively. It is concluded that prison services in Scotland are making efforts to assist 
their drug-using inmates, but greater access to a wider range of prison drug 
treatments and efforts to improve prison client's perceptions of the help they receive 
are required. 
URL: http://www.informaworld.com/10.1080/09687630310001653598  
 
Pallone, J. N. (Ed.). (2003). Treating Substance Abusers in Correctional Contexts: New 
Understandings, New Modalities. New Brunswick: Haworth Press. 
 
Pelissier, B., Jones, N., & Cadigan, T. (2007). Drug treatment aftercare in the criminal 
justice system: A systematic review. Journal of Substance Abuse Treatment, 32(3), 
311-320.  
Abstract: Drug treatment aftercare is frequently cited as necessary for individuals 
served within the criminal justice system. The purposes of this article are to review 
how much is actually known about aftercare and to highlight issues in studying the 
role of aftercare. We begin with a review of the literature, looking at how aftercare is 
defined within the criminal justice system outcome literature and the findings on 
aftercare for offenders who received initial treatment from in-prison substance use 
treatment programs. We continue with a discussion of how substance use treatment 
provided within the federal system, drug use patterns, and responses to drug use 
create methodological difficulties in adequately assessing the effectiveness of 
aftercare services. Taking into account both the previous research on aftercare and 
the issues encountered in attempting to evaluate the federal aftercare services, we 
concluded that the claim of certainty about aftercare effectiveness is not well 
substantiated and that the precise nature of aftercare services needed is not well 
understood. We conclude with a discussion of the methodological and substantive 
issues that need to be addressed in future research. Issues identified include the 
need to address self-selection bias and to disentangle offender behavior from the 
effects of criminal justice system policies. Research is also needed to identify the 
most effective type and intensity of aftercare. 
URL: http://www.sciencedirect.com/science/article/B6T90-4MHPHK9-
5/2/82958b40d3616175ea07ba72fe84f2c5 
 
Pearson, F. S., & Lipton, D. S. (1999). A meta-analytic review of the effectiveness of 
corrections-based treatments for drug abuse. The Prison Journal, 79(4), 384-410.  
Abstract: Part of a special issue on drug treatment outcomes for correctional 
settings. A study was conducted to examine the effectiveness of corrections-based 
treatment for drug abuse. Data were drawn from the meta-analysis of evaluation 
research studies, both unpublished and published, of treatment/intervention 
programs reported from 1968 to 1996. Findings support the effectiveness of 
therapeutic community programs but do not support the effectiveness of boot camps 
and drug-focused group counseling. It is revealed that evaluations of other 
interventions were founded on too few studies to lead to strong conclusions; 
however, promising treatments that deserve further attention include use of 
methadone maintenance treatment, substance abuse education, 12-step programs, 
and cognitive behavioral therapy for offender populations. 
URL:http://vnweb.hwwilsonweb.com/hww/jumpstart.jhtml?recid=0bc05f7a67b1790e
d34b537fd18e7dacb74e646edc9de4709250fa6468e8181e4167ba4b63aa0b1c&fmt=C  
 
PriceWaterhouseCoopers (2008). Review of Prison-Based Drug Treatment Funding. London, 
PriceWaterhouseCoopers. 
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 URL: http://www.justice.gov.uk/news/announcement130608a.htm 
 
Weekes, J., Thomas, G., & Graves, G. (2004). Substance abuse in corrections: FAQs. 
Ottawa: Canadian Centre on Substance Abuse. 
URL: http://www.ccsa.ca/pdf/ccsa-011058-2004.pdf 
 
Zurhold, H., Stover, H., & Haasen, C. (2004). Female drug users in European prisons - best 
practice for relapse prevention and reintegration. Hamburg: Centre for 
Interdisciplinary Addiction Research, University of Hamburg. 
 
[no author] Drugs in prisons: national strategy review and corrections-health interface. 
(1998). Paper presented at the Australasian Conference on Drugs in Prisons, 
Brisbane. 
Abstract: This book contains the proceedings of the Australasian Conference on 
Drugs in Prisons, held in April 1998. Papers, which are separately indexed, cover 
resolutions of the Drugs in Prisons Conference held in Melbourne in 1996, the ABCI-
ACID database, the intelligence network in Queensland prisons, the New Zealand 
strategy on drugs in prisons, the South Australian drug and alcohol strategy, the 
Western Australian Ministry of Justice drug management strategy, prison drug 
initiatives in Victoria, the impact of decriminalisation of cannabis in South Australia, 
health management in corrections as it relates to drugs, the methadone experience 
in NSW prisons, drugs and HIV/AIDS prevention in Swiss prisons, and conference 
resolutions. 
URL:http://www.crimecommission.gov.au/content/publications/aidr_1999/09_Drugs
_in_prisons.pdf 
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Therapeutic communities 
 
This section covers therapeutic communities, drug-free units and intensive treatment 
programs. Some interventions include cognitive-behavioural therapies. Both program 
descriptions and evaluations are included. The distinction between ‘therapeutic community’ 
and ‘drug-free unit’ is somewhat unclear and unfortunately many of the evaluation papers 
do not provide sufficient program description to truly disentangle the TC from other 
intensive forms of prison-based treatment.  
 
This is the one of the largest section of the bibliography (44 articles) as the residential / TC 
model has been the most studied form of prison-based treatment. Much of the research in 
this section is from the USA.   
 
Breteler, M. H. M., Van Den Hurk, A. A., Schippers, G. M., & Meerkerk, G.-J. (1996). 
Enrollment in a drug-free detention program: The prediction of successful behavior 
change of drug-using inmates. Addictive Behaviors, 21(5), 665-669.  
Abstract: Factors predicting the behavior change of drug-using detainees were 
investigated in detainees in two penitentiaries in The Netherlands. Subjects attended 
either a standard program or a Drug-Free Detention Program (DFDP) and were 
assessed at the beginning of detention, at release/transfer, and at 2 years after the 
end of detention. Predictors of post-program contact with treatment agencies and 
changes in criminal recidivism, substance abuse, and psychosocial functioning were 
investigated using regression analysis. Detainees who started drug use early, without 
previous DFDP detention, and who frequently expressed self-esteem and who had 
many family problems realized meetings with drug treatment agencies more often. 
Those with a legal source of income showed decreases in addiction severity and in 
the number of days in which hard drugs were used. Comparison of the normal 
program and the DFDP showed that only for the normal wing could changes in 
substance use and psychosocial functioning be predicted. Results show the value of 
multiple-outcome criteria in criminal recidivism research and call for more studies 
investigating change processes. 
URL: http://www.sciencedirect.com/science/article/B6VC9-3VWPXWB-
9/2/104465b358c0a55cdd45c23247a04463 
  
Burdon, W. M., Prendergast, M. L., Eisen, V., & Messina, N. P. (2003). Sanctions and 
rewards in prison-based therapeutic community treatment. Federal Probation, 67(2), 
47-52.  
Abstract: Burdon et al explore the roles that sanctions and rewards play in 
promoting client motivation and involvement in prison-based therapeutic community 
(TC) substance abuse treatment programs. A proposed model for assessing 
behavioral transgressions and eliminating inconsistencies in the administering of TC 
and correctional sanctions is presented. The use of behavioral reinforcement 
approaches for promoting client participation and engagement in treatment is also 
discussed. 
URL:http://proquest.umi.com/pqdlink?did=440331561&Fmt=7&clientId=25620&RQT
=309&VName=PQD 
  
Butzin, C. A., Martin, S. S., & Inciardi, J. A. (2002). Evaluating component effects of a 
prison-based treatment continuum. Journal of Substance Abuse Treatment, 22(2), 
63-69.  
Abstract: A continuum of correctional-based therapeutic community (TC) treatment 
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programs for drug-involved offenders has been functioning for several years in 
Delaware. Previous evaluations have shown the efficacy of the full continuum for up 
to three years post-treatment, though there has been some question of the benefits 
of treatment within prison. The particular focus here is on the relative impact of the 
within-prison, transitional, and aftercare treatment components upon criminal 
recidivism and relapse to illicit drug use. The relative benefit of participation in each 
component is supported, over and above the effects of differences in demographics 
and histories of criminal behavior and illicit substance use. However, the residential 
transitional program effects are generally larger and more long lasting. Additionally, 
the two outcomes appear differentially sensitive to the degree of completion of the 
continuum.  
URL: http://www.sciencedirect.com/science/article/B6T90-45FPF3R-
2/2/2f749f81e5036666e3e90f9410c7e014  
 
Butzin, C. A., Martin, S. S., & Inciardi, J. A. (2005). Treatment during transition from prison 
to community and subsequent illicit drug use. Journal of Substance Abuse 
Treatment, 28(4), 351-358.  
Abstract: This study examined the effects of post-release transitional therapeutic 
community treatment on the drug use and employment rates of drug involved 
prisoners in the Delaware corrections system followed for up to 5 years after release. 
A comparison group received standard post-release supervision. Abstinence rates 
were 32.2% in the treatment group and 9.9% in the no-treatment group, and the 
treatment group had a higher overall proportion of time free of drug use. Time to 
relapse was a mean of 28.8 months in the treatment group versus 13.2 months in 
the no-treatment group. Relapse was defined as any use of any drug and was 
confirmed by urinalysis. Positive effects were seen even for those who did not 
complete treatment. The treatment group had a significantly higher rate of 
employment after leaving work release (54.6%) than did the no-treatment group 
(45.4%). Treatment during the transitional period between prison and community 
showed substantial and persistent benefits even for a cohort marked with extensive 
criminal history, low rates of marital bonds, and substantial unemployment. 
URL: http://www.sciencedirect.com/science/article/B6T90-4G8DVG9-
9/2/9e2d98f2636da8cf86280a0a383972da 
  
De Leon, G., Melnick, G., Thomas, G., Kressel, D., & Wexler, H. K. (2000). Motivation for 
treatment in a prison-based therapeutic community. American Journal of Drug and 
Alcohol Abuse, 26(1), 33-46.  
Abstract: Current research concludes that participation in post-prison aftercare is 
critical to the effectiveness of prison-based therapeutic community (TC) treatment. 
This conclusion makes it imperative to understand the client determinants of 
retention in prison treatment, particularly continuance in post-prison aftercare. 
Currently, however, little data exist as to client predictors of seeking and remaining 
in prison-based TCs or entering post-release aftercare. In the present study, 
significant relationships were obtained between initial motivation (i.e., 
Circumstances, Motivation, Readiness [CMR] scores), retention, aftercare, and 
outcomes in a sample of substance abusers treated in a prison-based TC program. 
Implications are discussed for theory, research, and treatment policy. 
URL: http://find.galegroup.com/itx/infomark.do?&contentSet=IAC-
Documents&type=retrieve&tabID=T002&prodId=EAIM&docId=A60794295&source=
gale&srcprod=EAIM&userGroupName=unsw&version=1.0 
  
Dietz, E. F., O'Connell, D. J., & Scarpitti, F. R. (2003). Therapeutic communities and prison 
management: An examination of the effects of operating an in-prison therapeutic 
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community on levels of institutional disorder. International Journal of Offender 
Therapy and Comparative Criminology, 47(2), 210-223.  
Abstract: There is a growing emphasis in corrections on the treatment of inmates 
with drug problems. The typical method of evaluating drug treatment programs is to 
examine how the treatment affects the inmate in terms of relapse and recidivism. 
This study examines the institutional consequences of operating a therapeutic 
community located in a medium/high-security male institution. The effect on 
management is examined from a perspective of institutional disorder. Disorders, 
from less severe inmate rule violations to more serious assaults, and rates of 
grievance filing are examined within the treatment unit and compared with rates in 
the general population. The inmate's perception of the environment, whether in 
treatment or non-treatment, is also examined. Findings indicate that in-prison 
therapeutic communities have lower levels of disorder than non-treatment housing 
units and tend to produce more positive perceptions of the living environment among 
the inmates living there. The impact of these findings for prison management is 
discussed. 
URL:http://vnweb.hwwilsonweb.com/hww/jumpstart.jhtml?recid=0bc05f7a67b1790e
d34b537fd18e7dac7d21e407260abff6227ea7fa5eeac58a8913f274da5892c3&fmt=C$
3Citation$yArticle Citation in WilsonWeb 
 
Einsberg, M., Reichers, L., & Arrigona, N. (2001). Evaluation of the Performance of the 
Texas Department of Criminal Justice Rehabilitation Tier Programs. Austin TX: 
Criminal Justice Policy Council. 
URL:http://web.archive.org/web/20030705185134/http://cjpc.state.tx.us/reports/al
phalist/RehabilitationTier.pdf 
 
Eisenberg, M., & Fabelo, T. (1996). Evaluation of the Texas Correctional Substance Abuse 
Treatment Initiative: The Impact of Policy Research. Crime Delinquency, 42(2), 296-
308.  
Abstract: An evaluation of the first Texas correctional therapeutic community 
substance abuse program indicated that recidivism was significantly reduced for 
offenders completing treatment. However, a large number of offenders did not 
complete treatment and those persons had recidivism rates comparable to those not 
participating. Rapid expansion of these programs caused problems associated with 
client selection, program consistency, and retention in treatment. Research showed 
that the operational "nuts and bolts" were not in place to effectively expand these 
programs from 5,000 beds to the originally planned 14,000 beds. Based on these 
findings, the Texas Legislature decided against expansion. 
URL: http://cad.sagepub.com/cgi/content/Abstract/42/2/296 
  
Falkin, G. P., Lipton, D. S., & Wexler, H. K. (1990). Outcome evaluation of a prison 
therapeutic community for substance abuse treatment. Criminal Justice and 
Behavior, 17(1), 71-92.  
Abstract: This study reports treatment findings for the Stay'n Out therapeutic 
community (TC), which has operated in the New York correctional system for over 12 
years. Prison-based TC treatment can produce significant reductions in recidivism 
rates for males and females. 
URL: http://info.library.unsw.edu.au/cgi-bin/local/access/ej-
access.cgi?url=http://www.csa.com/htbin/getfulltext.cgi?username=unsw&access=u
nsw513&mode=pdf&db=sagecrim-set-c&issn=0093-
8548&volume=17&issue=1&firstpage=71 
 
Farabee, D., Prendergast, M., Cartier, J., Wexler, H., Knight, K., & Anglin, M. D. (1999). 
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Barriers to implementing effective correctional drug treatment programs. The Prison 
Journal, 79(2), 150-162.  
Abstract: During the past several years, a number of aggressive federal and state 
initiatives have been undertaken to expand substance abuse treatment within 
correctional settings. These efforts have been fueled by the high rates of substance 
involvement among offenders and the growing body of research literature suggesting 
that intensive, prison-based treatment efforts can significantly reduce post prison 
substance use and recidivism. 
URL: http://info.library.unsw.edu.au/cgi-bin/local/access/ej-
access.cgi?url=http://www.csa.com/htbin/getfulltext.cgi?username=unsw&access=u
nsw513&mode=pdf&db=sagecrim-set-c&issn=0032-
8855&volume=79&issue=2&firstpage=150 
 
Griffith, J. D., Hiller, M. L., Knight, K., & Simpson, D. D. (1999). A cost-effective analysis of 
in-prison therapeutic community treatment and risk classification. The Prison 
Journal, 79(3), 352-368.  
Abstract: Policy makers need scientifically based information to help them to 
determine which correctional treatment alternatives are effective and economically 
viable. Three-year outcome data from 394 parolees (291 treated, 103 untreated 
comparison) were examined to determine the relative cost-effectiveness of prison-
based treatment and aftercare, controlling for risk of recidivism. Findings showed 
that intensive services were cost-effective only when the entire treatment continuum 
was completed, and that the largest economic impact was evident among high-risk 
cases. Therefore, assignments to correctional treatment should consider an 
offender's problem severity level, and every effort should be made to engage them 
in aftercare upon release from prison. 
URL: http://find.galegroup.com/itx/infomark.do?&contentSet=IAC-
Documents&type=retrieve&tabID=T002&prodId=EAIM&docId=A59033274&source=
gale&srcprod=EAIM&userGroupName=unsw&version=1.0 
  
Hartmann, D. J., Wolk, J. L., Johnston, J. S., & Colyer, C. J. (1997). Recidivism and 
substance abuse outcomes in a prison-based therapeutic community. Federal 
Probation, 61(4), 18-25.  
Abstract: Authors David J. Hartmann, James L. Wolk, J. Scott Johnston, and Corey 
J. Colyer focus on legal involvement, reincarceration, and substance abuse at follow-
up as outcomes for men successfully discharged from a prison-based therapeutic 
community, the Ozarks Correctional Drug Treatment Program. They compare these 
results to those of a control group of male inmates who had substance abuse 
problems but did not attend the therapeutic community. 
URL:http://infotrac.galegroup.com/itw/infomark/1/1/1/purl=rc1_EAIM_0_A2062514
8&dyn=5!xrn_1_0_A20625148?Z3950=1&sw_aep=unsw Electronic resource (HTML) 
HTML 
  
Hiller, M. L., Knight, K., & Simpson, D. D. (1999). Prison-based substance abuse treatment, 
residential aftercare, and recidivism. Addiction, 94(6), 833.  
Abstract: AIMS: This study examined the impact of residential aftercare on 
recidivism following prison-based treatment for drug-involved offenders. DESIGN: A 
matched group quasi-experimental design. Survival regression analyses were used to 
predict time until rearrest. A logistic regression model was constructed for predicting 
aftercare completion. SETTING: A 9-month in-prison therapeutic community (ITC) 
and several community-based transitional therapeutic communities (TTCs). 
PARTICIPANTS: Data were collected from 396 male inmates (293 treated, 103 
untreated). MEASUREMENTS: Background information (gender, ethnicity, age, 
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education level, criminal history and risk for recidivism) was Abstracted from the 
state criminal justice databases and a structured interview led by clinical staff. 
During treatment process measures were based on inmate self-ratings of their 
counselors, program and peers. A post-treatment interview conducted by field 
research staff assessed satisfaction with transitional aftercare. Post-release 
recidivism was based on state-maintained computerized criminal history records. 
FINDINGS: ITC treatment, especially when followed by residential aftercare, was 
effective for reducing post-release recidivism rates. Lower satisfaction with 
transitional aftercare treatment was associated with not completing the residential 
phase of community-based aftercare. CONCLUSIONS: Corrections-based treatment 
policy should emphasize a continuum of care model (from institution to community) 
with high quality programs and services. 
URL:http://proquest.umi.com/pqdlink?did=42663687&Fmt=7&clientId=25620&RQT
=309&VName=PQD 
  
Hiller, M. L., Knight, K., & Simpson, D. D. (2006). Recidivism following mandated residential 
substance abuse treatment for felony probationers. Prison Journal, 86(2), 230-242.  
Abstract: The findings from a modified therapeutic community (TC) serving drug-
abusing probationers in a large metropolitan area is presented. The findings show 
that treatment dropouts were more likely to be rearrested for a serious felony within 
2 years of leaving the TC program than were treatment graduates and probationers 
from an untreated comparison group. 
URL: http://find.galegroup.com/itx/infomark.do?&contentSet=IAC-
Documents&type=retrieve&tabID=T002&prodId=EAIM&docId=A147596988&source
=gale&srcprod=EAIM&userGroupName=unsw&version=1.0 
  
Hooper, R. M., Lockwood, D., & Inciardi, J. A. (1993). Treatment techniques in corrections-
based therapeutic communities. Prison Journal, 73(3-4), 290-307.  
Abstract: Corrections-based therapeutic communities (TC) such as the Delaware 
system use various treatment methods to rehabilitate drug abusers. The TC is 
separated from the prison population and has a clinic staff of those who have been 
substance abusers in the past, and who were treated in TCs. Treatment methods 
such as cognitive therapy, behavioral therapy, emotional therapy and psychodrama 
along with My House and Bee-Bee techniques help the individuals to lead a drug-free 
life. 
URL: http://find.galegroup.com/itx/infomark.do?&contentSet=IAC-
Documents&type=retrieve&tabID=T002&prodId=EAIM&docId=A14867669&source=
gale&srcprod=EAIM&userGroupName=unsw&version=1.0 
  
Hughey, R., & Klemke, L. W. (1996). Evaluation of a jail-based substance abuse treatment 
program. Federal Probation, 60, 40-44.  
Abstract: Authors Ray Hughey and Lloyd W. Klemke report on an evaluation of the 
Inmate Recovery Program, a substance abuse treatment program in the Linn County 
(Oregon) Jail. The evaluation revealed that inmates who graduate from this program 
have more favorable recidivism statistics. Also, the program is relatively inexpensive 
and saves taxpayers considerable post-program expenses. . 
URL:http://vnweb.hwwilsonweb.com/hww/jumpstart.jhtml?recid=0bc05f7a67b1790e
d34b537fd18e7dacb74e646edc9de47014d2590b329208d001b21919dc25428a&fmt=
C 
  
Inciardi, J. A., Martin, S. S., Butzin, C. A., Hooper, R. M., & Harrison, L. D. (1997). An 
effective model of prison-based treatment for drug-involved offenders. Journal of 
Drug Issues, 27(2), 261-278.  
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Abstract: A multistage therapeutic community treatment system has been instituted 
in the Delaware correctional system, and its effectiveness has captured the attention 
of the National institutes of Health, the Department of Justice, members of Congress, 
and the White House. Treatment occurs in a three-stage system, with each phase 
corresponding to the client's changing correctional status-incarceration, work 
release, and parole. In this paper, 18 month follow-up data are analyzed for those 
who received treatment in: (1) a prison-based therapeutic community only, (2) a 
work release therapeutic community-followed by aftercare, and (3) the prison-based 
therapeutic community followed by the work release therapeutic community and 
aftercare. These groups are compared with a no-treatment group. Those receiving 
treatment in the two-stage (work release and aftercare) and three-stage (prison, 
work release, and aftercare) models had significantly lower rates of drug relapse and 
criminal recidivism even when adjusted for other risk factors. The results support the 
effectiveness of a multistage therapeutic community, model for drug-involved 
offenders, and the importance of a work release transitional therapeutic community 
as a component of this model. 
URL:http://proquest.umi.com/pqdlink?did=13045368&Fmt=6&clientId=25620&RQT
=309&VName=PQD 
 
Incorvaia, D., & Kirby, N. (1997). A formative evaluation of a drug-free unit in a correctional 
services setting. International Journal of Offender Therapy and Comparative 
Criminology, 41(3), 231-249.  
Abstract: The effectiveness of a drug-free unit in reducing the use of drugs by adult 
offenders in Cadell Training Centre, South Australia, is evaluated. Frequency of pre-
prison and prison drug use was measured using questionnaires. Urinalysis records of 
all offenders were also examined. The drug-free unit was found to have a significant 
effect in reducing the use of drugs by offenders residing therein. Problems associated 
with urinalysis procedures and different drug use patterns of offenders are also 
discussed. 
URL: http://info.library.unsw.edu.au/cgi-bin/local/access/ej-
access.cgi?url=http://www.csa.com/htbin/getfulltext.cgi?username=unsw&access=u
nsw513&mode=pdf&db=sagecrim-set-c&issn=0306-
624X&volume=41&issue=3&firstpage=231 
 
Klebe, K. J., & O'Keefe, M. (2004). Outcome Evaluation of the Crossroads to Freedom House 
and Peer 1 Therapeutic Communities. Colorado Springs: University of Colorado. 
Abstract: The present study aims to further evaluate these previous findings by 
investigating the effectiveness of two Colorado RSAT TC programs for offenders. The 
first is a prison based program, the second a community TC program. Together these 
programs provide a continuum of care for high risk substance abusing felons. The 
current project will allow for an analysis of outcomes for felons with varying amounts 
of treatment as well as further examining factors that may affect outcomes. The 
effectiveness of these TC programs will be examined using two methodologies. The 
first study is a large sample analysis of quantitative data comparing the groups on 
several recidivism variables, including rearrest data, return to prison, and length of 
time until offense. The second study uses a case study methodology to further 
explore how the programs may have impacted the participants’ outcomes as well as 
the supports and barriers that influence outcomes. Overall, the results of these two 
studies indicated that long-term intensive residential TC treatment providing a 
continuity of care as inmates transitioned from prison to the community can produce 
strong reductions in recidivism over a two-year period. Contrary to previous 
research, this study did not show any participant characteristics to be strong 
predictors of recidivism, at least when using quantitative data. In contrast, the case 
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studies indicated that internal motivation rather than external motivation seems to 
be an indicator of positive outcomes. The case study results demonstrated that 
programs offer benefits to participants; however, they also suggest that 
strengthening treatment in developing social support may help to reduce recidivism. 
URL: http://www.ncjrs.org/pdffiles1/nij/grants/208126.pdf 
 
Knight, K., Simpson, D. D., & Hiller, M. L. (1999). Three-year reincarceration outcomes for 
in-prison therapeutic community treatment in Texas. The Prison Journal, 79(3), 337-
351.  
Abstract: Longer term in-prison therapeutic community (ITC) outcome studies are 
needed, along with more attention on who benefits most from these programs. This 
study examined reincarceration records for 394 nonviolent offenders during the 3 
years following prison. Those who completed both ITC and aftercare were the least 
likely to be reincarcerated (25%), compared to 64% of the aftercare dropouts and 
42% of the untreated comparison groups. Furthermore, high-severity aftercare 
completers were reincarcerated only half as often as those in the aftercare dropout 
and comparison groups (26% vs. 66% and 52%). The findings support the 
effectiveness of intensive treatment when it is integrated with aftercare, and the 
benefits are most apparent for offenders with more serious crime and drug-related 
problems. 
URL: http://find.galegroup.com/itx/infomark.do?&contentSet=IAC-
Documents&type=retrieve&tabID=T002&prodId=EAIM&docId=A59018303&source=
gale&srcprod=EAIM&userGroupName=unsw&version=1.0  
 
Linhorst, D. M., Knight, K., Johnston, J. S., & Trickey, M. (2001). Situational influences on 
the implementation of a prison-based therapeutic community. Prison Journal, 81(4), 
436-454.  
Abstract: Issues concerning the manner in which criminal offenders can be treated 
for substance abuse are examined. Topics include the establishment of therapeutic 
communities, the counterproductive effect of enforcing a smoking ban, and the 
disruptive effect of changing treatment providers. 
URL: http://find.galegroup.com/itx/infomark.do?&contentSet=IAC-
Documents&type=retrieve&tabID=T002&prodId=EAIM&docId=A82266706&source=
gale&srcprod=EAIM&userGroupName=unsw&version=1.0  
 
Malinowski, A. (2003). 'What works' with substance users in prison? Journal of Substance 
Use, 8(4), 223 - 233.  
Abstract: A theoretical model for a prison-based rehabilitation programme is 
described. It was developed from a theory manual, written for a prison-centred 
programme in Oxfordshire run by the Ley Community, a concept-based therapeutic 
community. It draws on two theoretical models that are historically separate and 
distinct, reviews their key theoretical components and explores integrative links. 
Concept-based therapeutic communities, their origins, aims, values and methods are 
discussed. Cognitive behavioural group work approaches are explored and the 
features crucial to their effectiveness are identified. Two types of prison-based drug 
treatment programmes, based on therapeutic community and cognitive behavioural 
approaches are described and discussed. This includes consideration of research 
findings into their effectiveness and identifies features that are considered crucial to 
a programme's success. It is suggested that the adoption of a transtheoretical model 
would enable an integration of concepts and components that underpin both 
cognitive behavioural and structured therapeutic community approaches, and may 
provide a pragmatic solution to any inherent theoretical tensions. 
URL: http://www.informaworld.com/10.1080/14659890310001636107  
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Messina, N., Burdon, W., Hagopian, G., & Prendergast, M. (2006). Predictors of prison-
based treatment outcomes: a comparison of men and women participants (Clinical 
report). American Journal of Drug and Alcohol Abuse, 32(1), 7(22). 
 Abstract: The purpose of this study was to examine differences between men and 
women entering prison-based therapeutic community (TC) treatment and to explore 
the relationship of those differences to posttreatment outcomes (i.e., aftercare 
participation and reincarceration rates). Extensive treatment-intake interview data 
for 4,386 women and 4,164 men from 16 prison-based TCs in California were 
compared using chi-square analyses and t-tests. Logistic regression analyses were 
then conducted separately for men and women to identify gender-specific factors 
associated with post-treatment outcomes. Prison intake data and treatment 
participation data come from a 5-year process and outcome evaluation of the 
California Department of Corrections' (CDC) Prison Treatment Expansion Initiative. 
The return-to-custody data came from the CDC's Offender Based Information 
System. Bivariate results showed that women were at a substantial disadvantage 
compared with their male counterparts with regard to histories of employment, 
substance abuse, psychological functioning, and sexual and physical abuse prior to 
incarceration. In contrast, men had more serious criminal justice involvement than 
women prior to incarceration. After controlling for these and other factors related to 
outcomes, regression findings showed that there were both similarities and 
differences with regard to gender-specific predictors of posttreatment outcomes. 
Time in treatment and motivation for treatment were similar predictors of aftercare 
participation for men and women. Psychological impairment was the strongest 
predictor of recidivism for both men and women. Substantial differences in 
background characteristics and the limited number of predictors related to 
posttreatment outcomes for women suggests the plausibility of gender-specific paths 
in the recovery process.  
URL: http://find.galegroup.com/itx/infomark.do?&contentSet=IAC-
Documents&type=retrieve&tabID=T002&prodId=EAIM&docId=A144605250&source=
gale&srcprod=EAIM&userGroupName=unsw&version=1.0 
 
Messina, N., Burdon, W. & Prendergast, M. (2006). Prison-based treatment for drug-
dependent women offenders: Treatment versus no treatment. Journal of 
Psychoactive Drugs, 3, 333-343. 
Abstract: This outcome study compared six- and 12-month return-to-custody data 
for 171 treatment participants and 145 nontreated general population inmates at the 
Central California Women's Facility (implementing a traditional TC program). Findings 
showed that there were no differences between the TC treatment group and the no 
treatment comparison group with regard to six- and 12-month return-to-custody 
rates (six-month: 16% vs. 16% and 12-month: 36% vs. 27%). The only significant 
difference in six-month return-to-custody rates was found between treatment-only 
participants (21%) and the treatment plus aftercare participants (6%). Treatment 
participants who participated in community-based aftercare were significantly less 
likely to be returned to custody compared with those who did not participate in 
aftercare. Multivariate analysis was also used to control for the large difference in 
psychological impairment between the two groups and other background factors 
related to reincarceration, while assessing the effect of treatment group status on 
return-to-custody. Findings indicated that treatment/no-treatment status was not 
significantly related to a six- or 12-month return-to-custody. However, success on 
parole was associated with participation in community-based aftercare. The lack of a 
prison-based treatment effect could be an indication that drug-dependent women 
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offenders need gender-responsive treatment that is designed specifically for their 
complex needs. 
URL: http://orwh.od.nih.gov/about/acrwh_news/NIDA_Messina.pdf 
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URL: http://www.ncjrs.org/pdffiles1/nij/grants/196670.pdf 
 
Mosher, C., & Phillips, D. (2006). The dynamics of a prison-based therapeutic community 
for women offenders: retention, completion and outcomes. Prison Journal, 86(1), 6-
31.  
Abstract: Part of a special issue on gender across correctional systems. A study was 
conducted to examine the day-to-day operation of a drug prevention, prison-based 
therapeutic community for female offenders. Data were obtained from observations 
and interviews with participants and principals in the New Horizons program 
administered by the Washington State Department of Corrections. Findings revealed 
that over 44 percent of program members successfully completed the program. 
Furthermore, it was found that exposure to the program resulted in lower levels of 
recidivism and that completion of the program further reduced recidivism, although 
the positive effects of program participation abated as the months passed following 
release. 
URL: http://info.library.unsw.edu.au/cgi-bin/local/access/ej-
access.cgi?url=http://www.csa.com/htbin/getfulltext.cgi?username=unsw&access=u
nsw513&mode=pdf&db=sagecrim-set-c&issn=0032-
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URL: http://www.ncjrs.gov/pdffiles1/nij/grants/181649.pdf 
 
Nielsen, A. L., Scarpitti, F. R., & Inciardi, J. A. (1996). Integrating the therapeutic 
community and work release for drug-involved offenders : The CREST program. 
Journal of Substance Abuse Treatment, 13(4), 349-358.  
Abstract: As the nation's first therapeutic community (TC) and work release center 
for drug involved offenders, CREST combines the basic elements of both modalities 
into an effective agent for behavioral change. This article explores the ways in which 
these elements are integrated and applied, and the outcome of such treatment as 
determined by subsequent substance abuse and criminal activity. Clients entering 
the program from prison progress through several phases of counseling, group 
interaction, confrontation, and education before they enter the work release phase, 
where they gain realistic experience and can implement what they learned in the TC 
concerning living drug free. Follow-up data collected at 6 and 18 months after entry 
into the program indicate that CREST clients have significantly lower relapse and 
recidivism rates than a comparable comparison group. CREST has similar effects on 
relapse and recidivism across sexes, racial/ethnic groups, and different age 
categories, although length of time in treatment and whether clients graduated do 
impact outcome variables. 
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release. American Journal of Drug and Alcohol Abuse, 27(2), 315-337.  
Abstract: Objective: The effectiveness of federal prison-based residential drug and 
alcohol treatment programs was evaluated using event history procedures that 
addressed the problem of selection bias and included a wide range of control 
variables. Methods: The sample comprised 760 treatment subjects and 809 
comparison subjects. Treatment subjects were from 20 different prisons of medium, 
low, and minimum security levels. Comparison subjects were drawn from over 30 
prisons. Results: The results indicated that individuals who entered and completed 
in-prison residential treatment were less likely to experience the critical post-release 
outcomes of new arrests and substance use during the first 6 months following 
release. Conclusions: Without controlling for selection bias, the effects of treatment 
would most likely have been attenuated. The results have greater generalizability 
than other studies of prison-based treatment. This study occurred within a multisite 
context of 20 programs serving both male and female inmates and operating within 
different security levels and different geographic regions. . 
URL: http://find.galegroup.com/itx/infomark.do?&contentSet=IAC-
Documents&type=retrieve&tabID=T002&prodId=EAIM&docId=A112083060&source
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Prendergast, M. L., Hall, E. A., Wexler, H. K., Melnick, G., & Yan, C. (2004). Amity prison-
based therapeutic community: 5-year outcomes. The Prison Journal, 84(1), 36-60.  
Abstract: The outcomes of the prison-based treatment program over a 5-year 
observation period are highlighted. The main findings were based on a conservative 
intent-to-treat approach, on measures of recidivism as The Amity treatment group 
had significantly lowered rates of reincarceration. 
URL: http://find.galegroup.com/itx/infomark.do?&contentSet=IAC-
Documents&type=retrieve&tabID=T002&prodId=EAIM&docId=A124681932&source
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Schippers, G. M., van den Hurk, A. A., Breteler, M. H., & Meerkerk, G. J. (1998). 
Effectiveness of a drug-free detention treatment program in a Dutch prison. 
Substance Use & Misuse, 33(4), 1027-1046.  
Abstract: Several Dutch penitentiaries, which have relatively severe drug-use 
related problems, experimented with drug-free detention treatment programs (DVA). 
These programs aim at controlling drug use by offering a therapeutic atmosphere 
and serve as linkage to detention post-treatment. In a Rotterdam jail (335 cells), ca. 
10% were the DVA. Information was gathered from 86 male inmates who 
volunteered to enter the program, and 42 from other wings. After 1 year the drug-
free detention group more actively searched and accepted treatment. No differences 
were found in drug use, recidivism, or physical, social, and psychological problems. 
 
Sealock, M. D., Gottfredson, D. C., & Gallagher, C. A. (1997). Drug treatment for juvenile 
offenders: some good and bad news. Journal of Research in Crime and Delinquency, 
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34(2), 210-237.  
Abstract: Approximately 700 substance-abusing youthful offenders were assigned 
to either a two-month residential substance abuse treatment program group or a 
comparison group. Upon completion of the program, the residential treatment group 
youths were placed in either the treatment or comparison group for a four-month 
community aftercare phase. Youths who participated in the residential portion of the 
program reported significantly decreased drug use and delinquency and increased 
cognitive decision-making skills and demonstrated a longer period of time from entry 
into the study until rearrest than control youths. Results for the aftercare segment of 
the program show that the positive gains made while in the residential program were 
not bolstered through aftercare. Aftercare youths reported more delinquent behavior 
and demonstrated more participation in drug-related crime than control subjects. 
After-care youths did, however, exhibit less participation in crimes of an 
interpersonal nature. 
URL: http://find.galegroup.com/itx/infomark.do?&contentSet=IAC-
Documents&type=retrieve&tabID=T002&prodId=EAIM&docId=A19465419&source=
gale&srcprod=EAIM&userGroupName=unsw&version=1.0  
 
Siegal, H. A., Wang, J., Carlson, R. G., Falck, R. S., Rahman, A. M., & Fine, R. L. (1999). 
Ohio’s prison-based therapeutic community treatment programs for substance 
abusers: Preliminary analysis of re-arrest data. Journal of Offender Rehabilitation, 
28(3/4), 33-48.  
Abstract: This study evaluates the Ohio Department of Alcohol and Drug Addiction 
Services’ prison-based therapeutic communities (TCs) for inmates with histories of 
drug abuse. The study compares arrests/charges following release from prison 
among 487 inmates with TC experience and 242 inmates without TC treatment. 
Outcome measures were based on arrest and charge statistics. The results of 
survival analysis and Cox hazards model analysis indicate that length of time in the 
TC is crucial to a positive outcome. Controlling for age, gender, ethnicity, and 
education, inmates who spent at least 180 days in a TC were significantly less likely 
than those with less time in treatment or no TC exposure to be re-arrested/charged 
with violent or drug-related crimes one year after release. 
URL: http://www.haworthpress.com/store/E-
Text/View_EText.asp?sid=XHM4UJSG89UU9LTS1BCUJLLT9SGEF1C7&a=3&s=J076&v
=28&i=3%2F4&fn=J076v28n03_03 
 
Sullivan, Dagger, McKendrick, K., Sacks, S., & Banks, S. (2007). Modified therapeutic 
community treatment for offenders with MICA disorders: substance use outcomes. 
The American Journal of Drug and Alcohol Abuse, 33(6), 823 - 832.  
Abstract: Correctional systems nationwide have increasingly turned to therapeutic 
community (TC) programs for the treatment of addiction in prisons. TC treatment, 
with modifications, has shown considerable promise in treating offenders who have 
co-occurring mental and substance use disorders, a group that has a mounting 
prevalence in prison populations. This article reports data from a study that 
randomly assigned male inmates with mental illness and chemical abuse (MICA) 
disorders (n&nbsp;=&nbsp;139) to either a Modified TC (MTC) or a comparison 
group. Analyses revealed that the MTC group had significantly greater declines in 
alcohol and drug use at 12-months post-prison release. Additional analysis related 
positive substance use outcomes to reduced contact with the justice system and self-
reported criminal activity. Implications for treatment and policy are discussed. 
URL: http://www.informaworld.com/10.1080/00952990701653800  
 
Taxman, F. S., & Bouffard, J. A. (2002). Assessing therapeutic integrity in modified 
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therapeutic communities for drug-involved offenders. The Prison Journal, 82(2), 189-
212.  
Abstract: The authors examine the use of a social observation and interview 
method for evaluating the therapeutic integrity of drug treatment programs known 
as therapeutic communities. 
URL: http://find.galegroup.com/itx/infomark.do?&contentSet=IAC-
Documents&type=retrieve&tabID=T002&prodId=EAIM&docId=A102922868&source
=gale&srcprod=EAIM&userGroupName=unsw&version=1.0  
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reduces recidivism in nonviolent offenders: A longitudinal study of Monroe County, 
New York's, Jail Treatment Drug and Alcohol Program. International Journal of 
Offender Therapy and Comparative Criminology, 48(6), 721-728.  
Abstract: Substance abuse treatment has become the new fashion for reducing 
recidivism among inmates. But the question is, does this work? Various studies have 
been done tracking the same cohort of inmates over time to assess the validity of 
treatment. This study assesses one treatment program's success over 5 years to 
determine if drug and alcohol treatment reduces recidivism among nonviolent, short-
term (sentence of less than a year) inmates. Monroe County's drug treatment 
program demonstrates that for 1 year after receiving the treatment, three different 
cohorts of nonviolent, short-term inmates (1995, 1998, and 2000) were found to be 
substantially less likely to be recidivists than control group inmates. . 
URL:http://vnweb.hwwilsonweb.com/hww/jumpstart.jhtml?recid=0bc05f7a67b1790e
d34b537fd18e7dac7d21e407260abff6d1dd7f469aeac6b2709b945f164f5a54&fmt=C  
 
Vaughn, M. S., Furjen, D., & Lou-Jou, L. (2003). Evaluating a prison-based drug treatment 
program in Taiwan. Journal of Drug Issues, 33(2), 357-383.  
Abstract: Using data collected from prerelease and 12-month follow-up interviews 
with drug-using offenders, this article evaluates the efficacy of the first prison-based 
drug treatment program in Taiwan. A quasi-experimental design matching drug-
abusing offenders into treatment and non-treatment groups was adopted. Program 
outcomes were measured in five domains: criminal recidivism, post-release drug use 
patterns, improved family and social relationships, problems adjusting to community 
life, and mental health after release. Logistic and OLS regression were employed to 
identify possible correlates of program outcomes. The results generally failed to 
confirm positive outcomes generated by the compulsory drug treatment program. 
Program participants reported higher rates of recidivism and post-release illicit drug 
use than non-program participants. Program participants also reported more 
problems adjusting to community life after release. Post-release living arrangements, 
friends or family members abusing illicit drugs, and problems adjusting to 
community life after release were also found to be significant correlates of recidivism 
and post-treatment drug use. Post-release employment status and mental health 
status were significantly related to post-treatment drug use, but not to recidivism. 
Since multiple factors lead to drug addiction, the article concludes that the structure 
and implementation of Taiwan's prison-based drug treatment program needs reform 
to effect positive behavioral change on drug-abusing offenders. . 
URL:http://proquest.umi.com/pqdlink?did=380003081&Fmt=7&clientId=25620&RQT
=309&VName=PQD  
 
Walters, G. D., Heffron, M., Whitaker, D., & Dial, S. (1992). The CHOICE program: A 
comprehensive residential treatment program for drug-involved federal offenders. 
International Journal of Offender Therapy & Comparative Criminology, 36(1), 21-29.  
Abstract: This article describes the CHOICE program, a comprehensive residential 
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drug treatment program for offenders who have been seriously involved with drugs 
in the past. This ten-month program is comprised of seven principal elements or 
components-Intake/Evaluation/Follow-Up, Drug Education, Skills Development, 
Lifestyle Modification, Wellness, Responsibility, and Individualized Counseling/Case 
Supervision-each of which is discussed in the body of this paper. The individual 
strengths, weaknesses, and future research agenda of this residential program for 
drug-involved offenders are discussed in the conclusion of this preliminary report. 
URL: http://ijo.sagepub.com/cgi/content/Abstract/36/1/21  
 
Welsh, W. N. (2007). A multisite evaluation of prison-based therapeutic community drug 
treatment. Criminal Justice and Behavior, 34(11), 1481-1498.  
Abstract: A quasi-experimental study examined multiple post-release outcomes up 
to 2 years for inmates who participated in therapeutic community (TC) drug 
treatment programs (n = 217) or comparison groups (n = 491) at five state prisons. 
Statistical controls included level of need for treatment, current and prior criminal 
history, and post-release employment. Prison TC was effective even without 
mandatory community aftercare, although main effects and interactions varied 
somewhat across different outcome measures and sites. TC significantly reduced 
rearrest and reincarceration rates but not drug relapse rates. Post-release 
employment predicted drug relapse and reincarceration, and employment interacted 
with age to predict rearrest. Two sites had higher drug relapse rates than the other 
three. Implications for research and policy are discussed. 
URL: http://cjb.sagepub.com/cgi/content/Abstract/34/11/1481  
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treatment on inmate misconduct: A repeated measures analysis. Criminal Justice and 
Behavior, 34(5), 600-615. 
 Abstract: A small body of research supports the "treatment hypothesis" that 
participation in prison treatment programs reduces inmate misconduct, although 
methodological weaknesses have limited generalizable conclusions. Using general 
linear modeling repeated measures techniques, this study examined pre- and 
posttreatment misconduct for 1,073 inmates who participated in therapeutic 
community (TC) drug treatment (n = 294) or a comparison group (n = 779) at five 
state prisons. Predictors included age, length of sentence, drug dependency, and 
prior and current criminal history. The hypothesis that TC treatment alone would 
significantly reduce misconduct over time was not supported. Instead, changes in 
misconduct over time interacted with individual characteristics and time served 
posttreatment. The article discusses implications of these results for treatment 
policies and future research. 
 
 
Welsh, W. N., & McGrain, P.N. (2008). Predictors of therapeutic engagement in prison-based 
drug treatment. Drug and Alcohol Dependence, 96(3), 271-280. 
Abstract: Few studies to date have examined predictors of therapeutic engagement 
(TE) or other indicators of responsiveness to prison drug treatment. Subjects were 
347 inmates participating in a 12-month modified therapeutic community (TC) drug 
treatment program at a specialized treatment prison for convicted, drug-involved 
offenders. Data were obtained through correctional databases and the administration 
of the TCU Drug Screen II, the Resident Evaluation of Self and Treatment (REST), 
and the Counselor Rating of Client (CRC) form. Three main hypotheses were 
supported: (1) baseline motivation predicted therapeutic engagement net of other 
inmate characteristics; (2) critical dimensions of the treatment experience (e.g., peer 
support, counselor rapport) also predicted therapeutic engagement; and (3) dynamic 
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predictors and programmatic characteristics became more important over time. 
Implications for research, theory and policy are discussed. 
 URL: http://www.sciencedirect.com/science/article/B6T63-4SJ952S-
1/2/e6ad3f2749f300a4063994748f92dac0 
 
Wexler, H. K., Melnick, G., Lowe, L., & Peters, J. (1999). Three-year reincarceration 
outcomes for amity in-prison therapeutic community and aftercare in California. The 
Prison Journal, 79(3), 321-336.  
Abstract: The study assessed 36-month recidivism outcomes for a prison 
therapeutic community (TC) program with aftercare using an intent-to-treat design 
with random assignment, Outcomes-for 478 felons at 36 months replicated findings 
of an earlier report on 12 - and 24-month outcomes, showing the best outcomes for 
those who completed both in-prison and aftercare TC programs. 
URL: http://info.library.unsw.edu.au/cgi-bin/local/access/ej-
access.cgi?url=http://www.csa.com/htbin/getfulltext.cgi?username=unsw&access=u
nsw513&mode=pdf&db=sagecrim-set-c&issn=0032-
8855&volume=79&issue=3&firstpage=321 
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This section covers research on pharmacotherapies in prisons, including methadone, 
buprenorphine, LAAM and naltrexone. Evaluations of programs as well as descriptions of 
implementation are included. There is less literature on pharmacotherapies than TCs but 
much more of it is Australian. Opioid agonist research (methadone and LAAM) is listed first 
(alphabetically), followed by antagonists (naltrexone). 
 
Alberti, S., & Cowie, M. (2001). Evaluation of the Methadone Maintenance Program in South 
Australian Prisons. Melbourne: Turning Point Alcohol and Drug Centre. 
 
Brecht, M.-L., Anglin, M. D., & Wang, J.-C. (1993). Treatment effectiveness for legally 
coerced versus voluntary methadone maintenance clients. American Journal of Drug 
and Alcohol Abuse, 19(1), 89-107.  
Abstract: Analyses examined whether addicts reporting themselves coerced into 
drug abuse treatment by actions of the criminal justice system differed from 
voluntary admissions in their response to treatment, and whether such 
responsiveness varied across gender or ethnicity. Six hundred eighteen methadone 
maintenance clients admitted to programs in six southern California counties were 
categorized into high, moderate, and low legal coercion levels. Multivariate analysis 
of variance procedures for repeated measures (before, during, and after initial 
treatment episode) were used to test relevant hypotheses. Dependent variables 
included criminal justice system contact, criminal activities, drug and alcohol 
involvement, and measures of social functioning. Few differences within any 
measured domain were found among the three groups. All groups were similar in 
showing substantial improvement in levels of narcotics use, criminal activities, and 
most other behaviors during treatment with some regression in these behaviors 
post-treatment. Results support legal coercion as a valid motivation for treatment 
entry; those coerced into treatment respond in ways similar to voluntary admissions 
regardless of gender or ethnicity. 
 URL: http://find.galegroup.com/itx/infomark.do?&contentSet=IAC-
Documents&type=retrieve&tabID=T002&prodId=EAIM&docId=A13497388&source=g
ale&srcprod=EAIM&userGroupName=unsw&version=1.0 
 
Bruce, R. D., & Schleifer, R.A. (2008). Ethical and human rights imperatives to ensure 
medication-assisted treatment for opioid dependence in prisons and pre-trial 
detention. International Journal of Drug Policy, 19(1), 17-24.  
Abstract: Opioid dependence is a complex medical condition affecting 
neurocognitive and physical functioning. Forced or abrupt opioid withdrawal may 
cause profound physical and psychological suffering, including nausea, vomiting, 
diarrhoea, extreme agitation and/or anxiety. Opioid-dependent individuals are 
especially vulnerable at the time of arrest or initial detention, when they may, as a 
result of their chemical dependency, be coerced into providing incriminating 
testimony, or be driven to engage in risky behaviour (such as sharing needles in 
detention) in order to avoid painful withdrawal symptoms. Upon incarceration, many 
opioid-dependent prisoners are forced to undergo abrupt opioid withdrawal (both 
from legally prescribed agonist therapy such as methadone as well as illicit opioids). 
Physical and psychological symptoms attendant to withdrawal may impair capacity to 
make informed legal decisions, and cause prisoners to risk HIV and other blood-
borne diseases by sharing injection equipment. Although prisons must provide at 
least the standard of care to prisoners that is available in the general population, 
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medication-assisted treatment, endorsed by international health and drug agencies 
as an integral part of HIV prevention and care strategies for opioid-dependent drug 
users, is unavailable to most prisoners. Medication-assisted treatment is a well-
studied and validated pharmacological therapy for the medical condition known as 
opioid dependence. The failure to ensure prisoner access to this medical therapy 
threatens fundamental human rights protections against cruel, inhuman or degrading 
treatment and rights to health and to life. It also poses serious ethical problems for 
health care providers, violating basic principles of beneficence and non-malfeasance 
(i.e., do good/do no harm). Governments must take immediate action to ensure 
access to opioid substitution to prisoners to ensure fulfilment of ethical and human 
rights obligations.  
 
Cropsey, K. L., Villalobos, G. C., & Clair, C. L. S. (2005). Pharmacotherapy treatment in 
substance-dependent correctional populations: A review. Substance Use & Misuse, 
40(13), 1983 - 1999.  
Abstract: The number of drug or alcohol dependent inmates has increased 
dramatically in recent years. About half of all inmates meet DSM-IV criteria for 
dependence at the time of their arrest and require substance use treatment or 
detoxification. Few inmates receive treatment while in prison, increasing the 
likelihood that they will continue to use substances in prison and after release. While 
pharmacotherapy interventions have been shown to be effective with substance 
users in the community, few studies have investigated these treatments with a 
prison population. Further research is needed to better understand the feasibility and 
efficacy of providing pharmacotherapies for substance dependence disorders within 
this population. 
URL: http://www.informaworld.com/10.1080/10826080500294866 
  
Dolan, K., & Wodak, A. (1996). An international review of methadone provision in prisons. 
Addiction Research, 4(1), 85-97.  
Abstract: In many developed and an increasing number of developing countries, 
illicit drug use has created major health, social and legal problems. Production of 
illicit drugs is expanding globally, consumption is spreading to new populations 
(Stimson, 1992) and consequences of illicit drug use are becoming more serious. 
Therefore, measures which offer promise of ameliorating the adverse consequences 
of illicit drug use and especially those which are under-utilised deserve careful 
consideration. In this paper, the rationale, current international implementation and 
evidence of the effectiveness of methadone provision to inmates is reviewed. 
URL: http://www.informaworld.com/smpp/content~content=a784814302~db=all 
 
Dolan, K. A., Hall, W. D., & Wodak, A. D. (1998). Methadone maintenance treatment 
reduces heroin injection in New South Wales prisons. Drug and Alcohol Review, 
17(2), 153-158.  
Abstract: The purpose of this study was to examine whether methadone 
maintenance treatment reduces injecting risk behaviour (and therefore transmission 
of blood-borne viral infections) among prisoners in New South Wales (NSW), using 
comparison of retrospective reports of drug use in prisons for people who received 
standard drug treatment, time-limited methadone treatment and methadone 
maintenance treatment. The setting for the study was the NSW prison system. One 
hundred and eighty-five injecting drug users who had been recently released from 
NSW prisons were recruited in 1993. Self-reported drug use and injecting risk 
behaviour were compared in inmates who received standard drug treatment 
(counselling), time-limited methadone treatment and methadone maintenance 
treatment. HIV status was determined by serology. Intervention comprised high and 
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low dose methadone treatment and counselling. The groups were similar in terms of 
most basic demographic characteristics but subjects who had been maintained on 
methadone reported a significantly lower prevalence of heroin injection, syringe 
sharing and scored lower on an HIV Risk-taking Behavioural Scale than subjects who 
received standard drug treatment and time-limited methadone treatment. This study 
suggests that methadone treatment is associated with reduced injecting risk 
behaviour in prison with adequate (greater than 60 mg) dose and duration in 
treatment. These treatment conditions are known to increase effectiveness in 
community-based methadone programmes. Prospective studies are required to 
evaluate the effectiveness of methadone programmes in the prevention of HIV and 
other blood-borne viral infections among IDU prisoners. 
URL: http://info.library.unsw.edu.au/cgi-bin/local/access/ej-
access.cgi?url=http://www.informaworld.com/openurl?genre=journal&issn=0959-
5236&volume=17&issue=2&spage=153 
 
Dolan, K. A., Hall, W. D., & Wodak, A. D. (1998). The provision of methadone within prison 
settings. In J. Ward, R. P. Mattick & W. Hall (Eds.), Methadone maintenance 
treatment and other opioid replacement therapies. Amsterdam: Harwood Academic 
Publishers. 
Abstract: The rationale, implementation and likely benefits of providing methadone 
programs to prisoners are examined. The arguments against prison methadone 
programs are considered and the limited published research into prison based 
methadone programs is reviewed. 
 
Dolan, K. A., Shearer, J., MacDonald, M., Mattick, R. P., Hall, W., & Wodak, A. D. (2003). A 
randomised controlled trial of methadone maintenance treatment versus wait list 
control in an Australian prison system. Drug and Alcohol Dependence, 72(1), 59-65.  
Abstract: Objectives: The aim was to determine whether methadone maintenance 
treatment reduced heroin use, syringe sharing and HIV or hepatitis C incidence 
among prisoners. Methods: All eligible prisoners seeking drug treatment were 
randomised to methadone or a waitlist control group from 1997 to 1998 and followed 
up after 4 months. Heroin use was measured by hair analysis and self report; drugs 
used and injected and syringe sharing were measured by self report. Hepatitis C and 
HIV incidence was measured by serology. Results: Of 593 eligible prisoners, 382 
(64%) were randomised to MMT (n=191) or control (n=191). 129 treated and 124 
control subjects were followed up at 5 months. Heroin use was significantly lower 
among treated than control subjects at follow up. Treated subjects reported lower 
levels of drug injection and syringe sharing at follow up. There was no difference in 
HIV or hepatitis C incidence. Conclusions: Consideration should be given to the 
introduction of prison methadone programs particular where community based 
programs exist. 
URL: http://www.sciencedirect.com/science/article/B6T63-494SB7R-
1/2/e467b8872c412a83d9bda6e88d9088db 
  
Dolan, K. A., Shearer, J., White, B., Zhou, J., Kaldor, J., & Wodak, A. D. (2005). Four-year 
follow-up of imprisoned male heroin users and methadone treatment: mortality, re-
incarceration and hepatitis C infection. Addiction, 100(6), 820-828.  
Abstract: Aims: To examine the long-term impact of methadone maintenance 
treatment (MMT) on mortality, re-incarceration and hepatitis C seroconversion in 
imprisoned male heroin users. Design, setting and participants: The study cohort 
comprised 382 imprisoned male heroin users who had participated in a randomized 
controlled trial of prison-based MMT in 1997/98. Subjects were followed-up between 
1998 and 2002 either in the general community or in prison. Measurements All-
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cause mortality, re-incarceration, hepatitis C and HIV serostatus and MMT retention. 
Findings There were no deaths recorded while subjects were enrolled in MMT. 
Seventeen subjects died while out of MMT, representing an untreated mortality rate 
of 2.0 per 100 person-years (95% CI, 1.2-3.2). Re-incarceration risk was lowest 
during MMT episodes of 8 months or longer (adjusted hazard ratio 0.3 (95% CI, 0.2-
0.5; P < 0.001), although MMT periods 2 months or less were associated with 
greatest risk of re-incarceration (P < 0.001). Increased risk of hepatitis C 
seroconversion was significantly associated with prison sentences of less than 2 
months [adjusted hazard ratio 20 (95% CI, 5-76; < P = 0.001)] and MMT episodes 
less than 5 months [adjusted hazard ratio 4.2 (95% CI, 1.4-12.6; P = 0.01)]. 
Subjects were at greatest risk of MMT dropout during short prison sentences of 1 
month or less (adjusted hazard ratio 10.4 (95% CI, 7.0-15.7; P < 0.001). HIV 
incidence was 0.3 per 100 person-years (95% CI, 0.03-0.99). Conclusions Retention 
in MMT was associated with reduced mortality, re-incarceration rates and hepatitis C 
infection. Prison-based MMT programmes are integral to the continuity of treatment 
needed to ensure optimal outcomes for individual and public health. 
URL: http://www.blackwell-synergy.com/doi/abs/10.1111/j.1360-
0443.2005.01050.x 
  
Gordon, M.S., Kinlock, T.W., Schwartz, R.P., & O’Grady, K.E. (2008). A randomized clinical 
trial of methadone maintenance for prisoners: findings at 6 months post-release. 
Addiction, 103(8), 1333-1342. 
Abstract: Aims: This study examined the effectiveness of methadone maintenance 
initiated prior to or just after release from prison at 6 months post-release. Design: A 
three-group randomized controlled trial was conducted between September 2003 and 
June 2005. Setting: A Baltimore pre-release prison. Participants: Two hundred and 
eleven adult pre-release inmates who were heroin-dependent during the year prior to 
incarceration. Intervention: Participants were assigned randomly to the following: 
counseling only: counseling in prison, with passive referral to treatment upon release 
(n = 70); counseling + transfer: counseling in prison with transfer to methadone 
maintenance treatment upon release (n = 70); and counseling + methadone: 
methadone maintenance and counseling in prison, continued in a community-based 
methadone maintenance program upon release (n = 71). Measurements: Addiction 
Severity Index at study entry and follow-up. Additional assessments at 6 months 
post-release were treatment record review; urine drug testing for opioids, cocaine 
and other illicit drugs. Findings: Counseling + methadone participants were 
significantly more likely than both counseling only and counseling + transfer 
participants to be retained in drug abuse treatment (P = 0.0001) and significantly 
less likely to have an opioid-positive urine specimen compared to counseling only 
(P = 0.002). Furthermore, counseling + methadone participants reported 
significantly fewer days of involvement in self-reported heroin use and criminal 
activity than counseling only participants. Conclusions: Methadone maintenance, 
initiated prior to or immediately after release from prison, increases treatment entry 
and reduces heroin use at 6 months post-release compared to counseling only. This 
intervention may be able to fill an urgent treatment need for prisoners with heroin 
addiction histories. 
URL: http://dx.doi.org/10.1111/j.1360-0443.2008.002238.x 
 
Haig, T. (2003). Randomized controlled trial proves effectiveness of methadone 
maintenance treatment in prison. HIV/AIDS Policy & Law Review, 8(3), 48.  
Abstract: A study on methadone maintenance treatment (MMT) undertaken by the 
Correctional Service of Canada in 2001 demonstrated that MMT has a positive impact 
on release outcome and on institutional behaviour. Now, a new study undertaken in 
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an Australian prison system has demonstrated that MMT also reduces drug use and 
injection in prisons. The implications of this study are far reaching. They suggest that 
in all jurisdictions where community-based programs operate, prison-based 
methadone programs should be introduced or expanded. 
 
Hall, W., Ward, J., & Mattick, R. (1993). Methadone maintenance treatment in prisons: The 
New South Wales Experience. Drug and Alcohol Review, 12(2), 193 - 203.  
Abstract: This paper uses the New South Wales experience with methadone 
maintenance treatment in prison to address the question: should methadone 
maintenance treatment be provided in Australian prisons for opioid-dependent 
prisoners? First, it outlines three rationales for providing drug dependence treatment 
in prisons: as a way of giving prisoners access to community-based forms of drug 
treatment in the prison setting; as a measure to reduce recidivism in opioid-
dependent prisoners; and as a measure to prevent the transmission of HIV and other 
infectious diseases within prisons, and to the sexual partners of prisoners on their 
release. Secondly, it reviews the kind of research evidence that supports the 
effectiveness of community-based methadone maintenance treatment in Australia. 
Thirdly, the effectiveness of the New South Wales Prison Methadone Programme, one 
of the few prison-based methadone programmes in the world, is evaluated in the 
light of the available research evidence. 
URL: http://www.informaworld.com/10.1080/09595239300185631 
  
Heimer, R., Catania, H., Newman, R. G., Zambrano, J., Brunet, A., & Ortiz, A. M. (2006). 
Methadone maintenance in prison: Evaluation of a pilot program in Puerto Rico. Drug 
and Alcohol Dependence, 83(2), 122-129.  
Abstract: Objectives: To describe and evaluate a pilot methadone maintenance 
program for heroin-dependent inmates of Las Malvinas men's prison in San Juan, 
Puerto Rico. Methods: Data from self-report of inmates' drug use before and during 
incarceration, attitudes about drug treatment in general and methadone 
maintenance in particular, and expectations about behaviors upon release from 
prison and from testing inmates' urine were analyzed comparing program patients (n 
= 20) and inmates selected at random from the prison population (n = 40). 
Qualitative data obtained by interviewing program staff, the correctional officers and 
superintendent, and commonwealth officials responsible for establishing and 
operating the program were analyzed to identify attitudes about methadone and 
program effectiveness. Results: Heroin use among prisoners not in treatment was 
common; 58% reported any use while incarcerated and 38% reported use in past 30 
days. All patients in the treatment program had used heroin in prison in the 30 days 
prior to enrolling in treatment. While in treatment, the percentage of patients not 
using heroin was reduced, according to both self-report and urine testing, to one in 
18 (94% reduction) and one in 20 (95% reduction), respectively. Participation in 
treatment was associated with an increased acceptance of methadone maintenance. 
Prison personnel and commonwealth officials were supportive of the program. 
Conclusions: The program appears to be a success, and prison officials have begun 
an expansion from the current ceiling of 24 inmates to treat 300 or more inmates. 
URL: http://www.sciencedirect.com/science/article/B6T63-4HR75M2-
1/2/11e50e1e10e1234101e44fc42c936cba 
  
Hume, S., & Gorta, A. (1998). The effects of the NSW Prison Methadone Program on 
Criminal Recidivism, and Retention in Methadone Treatment. New South Wales, 
Australia: NSW Department of Corrective Services. 
URL:http://www.dcs.nsw.gov.au/information/research_and_statistics/research_publi
cation/rp019.pdf 
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Johnson, S. L., Ven, J. V. d., & Grant, B. A. (2001). Institutional Methadone Maintenance 
Treatment: Impact on Release Outcome and Institutional Behaviour. Ottawa: 
Addictions Research Centre, Correctional Services Canada. 
URL: http://www.csc-scc.gc.ca/text/rsrch/reports/r119/r119_e.pdf 
 
Kerr, T., & Jurgens, R. (2004). Methadone Maintenance Therapy in Prisons: Reviewing the 
Evidence. Ottawa: Canadian HIV/AIDS Legal Network. 
URL: http://www.aidslaw.ca/publications/interfaces/downloadFile.php?ref=163 
 
Kinlock, T. W., Gordon, M.S., Schwartz, R.P., & O’Grady, K.E. (2008). A study of methadone 
maintenance for male prisoners: 3-month postrelease outcomes. Criminal Justice and 
Behavior, 35(1). 
Abstract: This study examined benefits of methadone maintenance among 
prerelease prison inmates. Incarcerated males with preincarceration heroin 
dependence (n = 197) were randomly assigned to (a) group educational counseling 
(counseling only); (b) counseling, with opportunity to begin methadone maintenance 
on release (counseling + transfer); or (c) counseling and methadone maintenance in 
prison, with opportunity to continue methadone maintenance on release (counseling 
+ methadone). At 90-day follow-up, counseling + methadone participants were 
significantly more likely than counseling-only and counseling + transfer participants 
to attend drug treatment (p = .0001) and less likely to be reincarcerated (p = .019). 
Counseling + methadone and counseling + transfer participants were significantly 
less likely (all ps < .05) to report heroin use, cocaine use, and criminal involvement 
than counseling-only participants. Follow-up is needed to determine whether these 
findings hold over a longer period. 
URL:http://infotrac.galegroup.com/itw/infomark/1/1/1/purl=rc1_EAIM_0_A1731010
02&dyn=5!xrn_1_0_A173101002?Z3950=1&sw_aep=unsw 
 
Kinlock, T. W., Battjes, R. J., & Schwartz, R. P. (2005). A novel opioid maintenance program 
for prisoners: report of post-release outcomes. American Journal of Drug and Alcohol 
Abuse, 31(3), 433-455.  
Abstract: Because prisoners with preincarceration heroin dependence typically 
relapse following release, a pilot study examined a novel opioid agonist maintenance 
program whereby consenting males initiated levo-alpha-acetylmethadol (LAAM) 
treatment shortly before release from prison with opportunity to continue 
maintenance in the community. Treated prisoners (experimental group) were 
compared with controls who received community treatment referral information only 
and prisoners who withdrew from treatment prior to medication regarding treatment 
participation and community adjustment during nine months post-release. Nineteen 
of 20 (95%) prisoners who initiated maintenance in prison entered community 
treatment, compared with 3 of 31 (10%) controls, and 1 of 13 (8%) who withdrew. 
Moreover, 53% of experimental participants remained in community treatment at 
least six months, while no other participants did so. Differences in heroin use and 
criminal involvement between experimental participants and each of the other two 
groups, while not consistently statistically significant, uniformly favored the 
experimental group. Despite study limitations, robust findings regarding treatment 
attendance suggest that this intervention is highly promising. . 
 URL: http://find.galegroup.com/itx/infomark.do?&contentSet=IAC-
Documents&type=retrieve&tabID=T002&prodId=EAIM&docId=A135661025&source
=gale&srcprod=EAIM&userGroupName=unsw&version=1.0 
 
Magura, S., Rosenblum, A., & Lewis, C. (1993). The effectiveness of in-jail methadone 
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maintenance. Journal of Drug Issues, 23(1), 75-99.  
URL:http://vnweb.hwwilsonweb.com/hww/jumpstart.jhtml?recid=0bc05f7a67b1790e
d34b537fd18e7dacb74e646edc9de470e544a9c6512093cf3da6246caae07e97&fmt=C 
  
McLeod, F. (1991). Methadone, AIDS and jails. Paper presented at the Corrections Health : 
First National Conference. 
Abstract: This paper provides a narrative account of the development of the 
Methadone Program in New South Wales prisons and addresses particular problems 
found related to specifics of the prison population. McLeod discusses the drug itself, 
unwanted side effects, treatment models, the benefits of the program, and its costs. 
(Based on paper presented at the Australian Institute of Criminology Conference on 
'HIV/AIDS and Prisons', November 1990). 
 
Mistral, W., Wilkinson, S., Mastache, C., Midgley, S., & Law, F. (2008). Efficacy of 
naltrexone treatment with combined crack and opiate users: A descriptive study of a 
new treatment service in Bristol, UK. Drugs - Education Prevention and Policy, 15(1), 
107-120. 
Abstract: Naltrexone has been shown to be clinically effective in treating opioid 
dependence, although there are reports that it may be unsafe in treatment of 
unselected cases. Although there are no generally accepted pharmacological 
treatments for crack cocaine addiction alone, there is evidence that naltrexone can 
be useful in cases of concurrent cocaine and heroin use. In 2005 Bristol Specialist 
Drug Service initiated a naltrexone treatment programme targeted at pre-release 
offenders using both crack cocaine and heroin. Of 172 referrals, only 51 (30%) were 
inducted into treatment, and only 16% of these were retained at 3 months, and 4% 
at 9 months. There was evidence to support induction in prison, as 90% of those 
who were inducted there continued treatment on release. An integrated approach 
between criminal justice and community services is of primary importance in getting 
users into treatment. Interviews highlighted that the environment outside of prison 
can trigger relapse, and that community clinics need to separate clients on an 
abstinence programme from those who continue to use. Of clients interviewed, 52% 
reported that they use heroin to mitigate severe come down from crack, and it is 
suggested that naltrexone may be of use for these specialized combined users.  
URL: http://www.informaworld.com/smpp/content~content=a790039405~db=all 
 
Shearer, J., Wodak, A., & Dolan, K. (2004). The Prison Opiate Dependence Treatment Trial. 
Sydney: National Drug and Alcohol Research Centre. 
Abstract: (NA). This paper describes the results of a NSW trial of naltrexone, 
methadone and buprenorphine in prison. 
URL:http://ndarc.med.unsw.edu.au/NDARCWeb.nsf/resources/TR_3/$file/TR.199.pdf 
 
Stallwitz, A., & Stover, H. (2007). The impact of substitution treatment in prisons: A 
literature review. International Journal of Drug Policy, 18(6), 464-474.  
Abstract: Substitution treatment (ST) has established itself as a generally 
recognised type of treatment for opioid dependence worldwide. Although the number 
of countries providing ST in prison has slowly started to grow over the last years, its 
application in the custody setting remains controversial. ST in prison is mainly 
employed in form of detoxification. Maintenance treatment is provided in only a 
limited number of international prisons. This literature review is centred around the 
question: "What is known about the effectiveness of prison based ST?" Furthermore, 
it investigates how this knowledge can be applied to improve treatment scope and 
quality. Effectiveness, as defined by the examined studies, refers to short- and long-
term reduction of drug use and relapse, reduction in drug use related risk 
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behaviours, reduction in criminal conduct and recidivism, facilitating the 
manageability of drug using prisoners and improving their physical stabilisation. In 
this context, substitute dosage, treatment duration, patient retention rates, 
complementary psycho-social care and the effects of disrupting maintenance 
treatment when entering the institution are scrutinised. Results show that prison-
based ST and especially prison-based methadone maintenance treatment (PMMT) 
can reduce drug use and injection in penal institutions. Moreover, PMMT provision 
can reduce injecting risk behaviours as well as drugs charges and re-admission rates. 
However, for PMMT to retain patients in treatment and reduce illegal drug use and 
criminal behaviour a sufficiently high dose of methadone (e.g., >60 mg) and the 
treatment duration lasting the entire period of imprisonment appear crucial. On the 
basis of the analysed results the authors recommend the provision of PMMT for 
individuals with long-standing opioid dependence and suggest major expansions of 
prison based ST in many countries. 
URL: http://www.sciencedirect.com/science/article/B6VJX-4MRNCN2-
3/2/0f2d5242afc46bf60cd049990f724e46 
  
Stover, H., Casselman, J., & Hennebel, L. (2006). Substitution treatment in European 
prisons. A study of policies and practices in 18 European countries. International 
Journal of Prisoner Health, 2(1), 3 - 12.  
Abstract: The objective of this study was to examine practices and policies in place 
for the provision of substitution treatment in prison in 18 European countries. 
Methodology. Across the 15 European member states (prior to 1 May 2004) and 
Czech Republic, Poland and Slovenia, interviews with ministerial representatives, 
professionals (i.e. service providers and security officials) working in prisons, and a 
total of 33 focus groups with a total of 132 male and 52 female prisoners were 
conducted. Results. Although constraints of access to substitution treatment for 
specific target groups only (e.g. HIV-positive opiate users) have largely vanished, 
substitution treatment is now offered to a broad cross-section of prisoners. The 
provision of this treatment still lags behind the standards of substitution treatment in 
the community (regarding access and continuity). In most countries, this form of 
therapy is most likely to be discontinued when entering prison. A treatment gap 
persists between prisoners requiring substitution maintenance treatment and those 
receiving it. Heterogeneous and inconsistent regulations and treatment modalities 
appear throughout Europe, sometimes within the same country or region. The 
concrete provision practice of substitution treatment in prison varies from one 
country to the other, from one prison to the other, within a medical team, and even 
from one doctor to another. Although psychosocial care was seen as a valuable 
additional and necessary part of the treatment to support the medical part of the 
substitution treatment in prison, it was found that such support was rarely provided. 
Compared to previous research, this study illustrates that the scope of substitution 
treatment has extended considerably across Europe. Across the board, a consensus 
surrounding the need to continue substitution treatment that had already been 
started in the community was apparent. 
URL: http://www.informaworld.com/10.1080/17449200600743396 
  
Warren, E., & Viney, R. (2004). An Economic Evaluation of the Prison Methadone Program in 
New South Wales. Sydney: Centre for Health Economics Research and Evaluation. 
URL: http://www.chere.uts.edu.au/pdf/rep22.pdf 
 
Warren, E., Viney, R., Shearer, J., Shanahan, M., Wodak, A., & Dolan, K. (2006). Value for 
money in drug treatment: economic evaluation of prison methadone. Drug and 
Alcohol Dependence, 84(2), 160-166.  
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Abstract: Background: Although methadone maintenance treatment in community 
settings is known to reduce heroin use, HIV infection and mortality among injecting 
drug users (IDU), little is known about prison methadone programs. One reason for 
this is the complexity of undertaking evaluations in the prison setting. This paper 
estimates the cost-effectiveness of the New South Wales (NSW) prison methadone 
program. Methods: Information from the NSW prison methadone program was used 
to construct a model of the costs of the program. The information was combined with 
data from a randomised controlled trial of provision of prison methadone in NSW. 
The total program cost was estimated from the perspective of the treatment 
provider/funder. The cost per heroin free day, compared with no prison methadone, 
was estimated. Assumptions regarding resource use were tested through sensitivity 
analysis. Results: The annual cost of providing prison methadone in NSW was 
estimated to be AUD$2.9 million (or $3,234 per inmate per year). The incremental 
cost effectiveness ratio is AUD $38 per additional heroin free day. Conclusions: From 
a treatment perspective, prison methadone is no more costly than community 
methadone, and provides benefits in terms of reduced heroin use in prisons, with 
associated reduction in morbidity and mortality. 
URL: http://www.sciencedirect.com/science/article/B6T63-4J90W1H-
4/2/e9cb000883932b094af13565939cecef 
  
 
Naltrexone 
 
Cornish, J. W., Metzger, D., Woody, G. E., Wilson, D., McLellan, A. T., Vandergrift, B., et al. 
(1997). Naltrexone pharmacotherapy for opioid dependent federal probationers. 
Journal of Substance Abuse Treatment, 14(6), 529-534.  
Abstract: Federal probationers or parolees with a history of opioid addiction were 
referred by themselves or their probation/parole officer for a naltrexone treatment 
study. Participation was voluntary and subjects could drop out of the study at any 
time without adverse consequences. Following orientation and informed consent, 51 
volunteers were randomly assigned in a 2:1 ratio to a 6-month program of probation 
plus naltrexone and brief drug counseling, or probation plus counseling alone. 
Naltrexone subjects received medication and counseling twice a week, controls 
received counseling at similar intervals. All therapy and medication were 
administered in an office located adjacent to the federal probation department. Fifty-
two percent of subjects in the naltrexone group continued for 6 months and 33% 
remained in the control group. Opioid use was significantly lower in the naltrexone 
group. The overall mean percent of opioid positive urine tests among the naltrexone 
subjects was 8%, versus 30% for control subjects (p < .05). Fifty-six percent of the 
controls and 26% of the naltrexone group (p <.05) had their probation status 
revoked within the 6-month study period and returned to prison. Treatment with 
naltrexone and brief drug counseling can be integrated into the Federal 
Probation/Parole system with favorable results on both opioid use and re-arrest rate. 
 URL: http://www.sciencedirect.com/science/article/B6T90-3S131FS-
K/2/eede81e585001a7d8f1d4abbb86db255  
 
Mistral, W., Wilkinson, S., Mastache, C., Midgley, S., & Law, F. (2008). Efficacy of 
naltrexone treatment with combined crack and opiate users: A descriptive study of a 
new treatment service in Bristol, UK. Drugs: education, prevention and policy, 15(1), 
107 - 119.  
Abstract: Naltrexone has been shown to be clinically effective in treating opioid 
dependence, although there are reports that it may be unsafe in treatment of 
unselected cases. Although there are no generally accepted pharmacological 
 29
Pharmacotherapies 
 30
treatments for crack cocaine addiction alone, there is evidence that naltrexone can 
be useful in cases of concurrent cocaine and heroin use. In 2005 Bristol Specialist 
Drug Service initiated a naltrexone treatment programme targeted at pre-release 
offenders using both crack cocaine and heroin. Of 172 referrals, only 51 (30%) were 
inducted into treatment, and only 16% of these were retained at 3 months, and 4% 
at 9 months. There was evidence to support induction in prison, as 90% of those 
who were inducted there continued treatment on release. An integrated approach 
between criminal justice and community services is of primary importance in getting 
users into treatment. Interviews highlighted that the environment outside of prison 
can trigger relapse, and that community clinics need to separate clients on an 
abstinence programme from those who continue to use. Of clients interviewed, 52% 
reported that they use heroin to mitigate severe come down from crack, and it is 
suggested that naltrexone may be of use for these specialized combined users. 
URL: http://www.informaworld.com/10.1080/09687630601109098 
 
Shearer, J., Wodak, A. D., & Dolan, K. A. (2007). Evaluation of a prison-based naltrexone 
program. International Journal of Prisoner Health, 3(3), 214.  
Abstract: The study evaluated the introduction of naltrexone in an Australian prison 
system for imprisoned male heroin users. Treatment outcomes were analysed for 
two sub-samples taken from an unsuccessful randomised controlled trial. The first 
sample comprised 68 participants who were randomly allocated to naltrexone 
treatment. The second sample comprised 47 participants who commenced opioid 
pharmacotherapy during the study period. Thirteen per cent of subjects started 
naltrexone, with only 7% retained in treatment at six months. Six-month retention 
was significantly lower in naltrexone compared to methadone (p = 0.0007). Poor 
patient acceptability and retention did not support oral naltrexone maintenance in 
this treatment group. 
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This section covers Needle Syringe Programs in prisons. The five articles here explicitly 
address NSP in prison. In the “Risk Behaviours” listing, there are many papers that note 
NSP as an important risk reduction strategy but do not explicitly address the evidence for 
NSP. 
 
Dixon, D., Dolan, K. A., Hall, W. D., Maher, L., Rutter, S., & Wodak, A. D. (1995). Is syringe 
exchange feasible in a prison setting? An exploratory study of the issues. Sydney: 
National Drug and Alcohol Research Centre. 
Abstract: The issues raised by Prison Syringe Exchange programs are considered 
with a view to assessing possible benefits, possible adverse consequences and the 
feasibility of implementing Prison Syringe Exchange. The feasibility was examined by 
documenting issues raised by key stakeholders in the New South Wales prison 
system. Groups were asked to discuss problems in a correctional context associated 
with syringe use, effectiveness of and problems associated with HIV and hepatitis 
prevention measures, and possible benefits and costs of establishing and evaluating 
a pilot syringe exchange program in prisons. 
URL:http://notes.med.unsw.edu.au/NDARCWeb.nsf/resources/TR_27/$file/TR.025.p
df 
 
Dolan, K., Rutter, S., & Wodak, A. D. (2003). Prison-based syringe exchange programmes: 
a review of international research and development. Addiction, 98(2), 153-158.  
Abstract: Journal publications and conference presentations on prison-based syringe 
exchange (PSE) programmes were identified by a comprehensive search of electronic 
databases. Experts involved with development and evaluation of current PSE 
programmes or policy were contacted for reports, documents and unpublished 
material. Spanish information on PSE was translated for this review. We identified 14 
papers specifically on PSE programmes in Switzerland (six papers), Germany (four) 
and Spain (four). The first PSE programme started in 1992 in Switzerland. As of 
December 2000, seven PSEs were operating in Switzerland, seven in Germany and 
five in Spain. There have been six evaluations of prison syringe exchange 
programmes and all have been favourable. Reports of drug use decreased or 
remained stable over time. Reports of syringe sharing declined dramatically. No new 
cases of HIV, hepatitis B or hepatitis C transmission were reported. The evaluations 
found no reports of serious unintended negative events, such as initiation of injection 
or of the use of needles as weapons. Staff attitudes were generally positive but 
response rates to these surveys varied. Overall, this review indicated that prison 
syringe exchange programmes are feasible and do provide benefit in the reduction of 
risk behaviour and the transmission of blood-borne infection without any unintended 
negative consequences. 
URL: http://info.library.unsw.edu.au/cgi-bin/local/access/ej-
access.cgi?url=http://www.blackwell-
synergy.com/openurl?volume=98&date=2003&spage=153&issn=0965-
2140&issue=2&genre=article 
 
Lines, R., Jurgens, R., Betteridge, G., & Stover, H. (2005). Taking action to reduce injecting 
drug-related harms in prisons: The evidence of effectiveness of prison needle 
exchange in six countries. International Journal of Prisoner Health, 1(1), 49 - 64.  
Abstract: This article examines the issue of prison needle-exchange programmes 
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(PNEP) based upon the international experience and evidence in six countries. A 
review of existing literature was undertaken together with original research 
comprising site visits to prison needle-exchange programmes in four countries 
operating such initiatives in October 2002. During the course of the research, prison 
needle-exchange programmes were initiated in two other countries, Kyrgyzstan and 
Belarus. Site visits were not possible in respect of these two countries, and data was 
gathered via conversations with staff and funding organisations involved and by the 
examination of documentary evidence. The paper presents an overview of the PNEP 
initiated and a commentary on the outcomes. Based upon the evidence emerging 
from the investigation, the paper concludes that while prison syringe-exchange 
programmes have been implemented in diverse environments and under differing 
circumstances, the results of the programmes have been remarkably consistent. 
Improved prisoner health and reduction of needle sharing have been achieved. Fears 
of violence, increased drug consumption, and other negative consequences have not 
materialised. Based on the evidence and experience, it can be concluded 
unequivocally that prison needle-exchange programmes effectively address the 
health-related harms associated with needle sharing in prisons and do not undermine 
institutional safety or security. 
URL: http://www.informaworld.com/10.1080/17449200500157085  
 
Selvanera, G. (1996). The case for needle and syringe exchange in the prison system. 
HIV/AIDS Legal Link, 7(4), 6-7.  
Abstract: The Australian prison system's refusal to allow prisoners access to 
methods of minimising HIV and Hepatitis C positive transmission is raising concerns 
that the prison system is becoming a source of infection for prisoners and the rest of 
the community. This article presents data on the prevalence of HIV infection in 
Australian prisons, before providing examples of needle and syringe exchanges which 
have been established in prisons overseas and the results of these programs. 
 
Stover, H., & Nelles, J. (2003). Ten years of experience with needle and syringe exchange 
programmes in European prisons. International Journal of Drug Policy, 14(5-6), 437-
444.  
Abstract: Results of needle and syringe exchange programmes (SEPs) in prisons 
based on 10 years experience in Switzerland, Germany, Spain and Moldova are 
presented. SEPs have been introduced in 46 European prisons, predominantly as 
pilot projects. Forty-three of these projects were still operating at the time of writing. 
In 11 prisons, SEPs were evaluated to assess feasibility and efficacy. Results did not 
support fears that commonly arise in the start-up of implementation of SEPs. Syringe 
distribution was not followed by an increase in drug use or injection drug use. 
Syringes were not misused, and disposal of used syringes was uncomplicated. 
Sharing of syringes among drug users reduced. Based on these experiences, it can 
be concluded that in these settings harm reduction measures, including syringe 
exchange, were not only feasible but efficient. Despite these positive results, syringe 
exchange in prison is far from general acceptance. However, a governmental decree 
released in Spain in 2001 that all prisons in the country are required to provide drug 
users with sterile injection equipment may lead to a breakthrough of this harm 
reduction measure in the future. The discrepancy concerning the success of SEPs in 
prisons on the one hand and its low acceptance on the other hand is striking. 
Suggestions for the installation of SEPs in prison are given to assist a more objective 
discussion. 
URL: http://www.sciencedirect.com/science/article/B6VJX-49W370K-
C/2/74b526e2bd99ed3df62eb264e35d9418  
Throughcare 
 
Throughcare / aftercare  
 
This section covers research that specifically addresses issues of throughcare and post-
prison continuity of treatment. Some of the papers in the other sections (TC, 
pharmacotherapies) also include reference to throughcare, so this list is only those that 
specifically evaluated or discussed throughcare issues.  
 
Burrows, J., Clarke, A., Davidson, T., Tarling, R., & Webb, S. (2000). The Nature and 
Effectiveness of Drugs Throughcare for Released Prisoners. London: Home Office 
Research, Development and Statistics Directorate. 
Abstract: This summary report provides the results of a study examining the nature 
of drugs throughcare for severely drug dependent prisoners who were eligible for 
prison treatment. Drugs throughcare relates to the treatment and support offered to 
prisoners making the transition from prison to the community. The research gauges 
the impact of these interventions on offenders’ drug taking and offending behaviour, 
as well as what constitutes good practice in this area. Half of the prisoners surveyed 
were offered help to obtain treatment on release. However, only 11% had a fixed 
appointment with a drug agency; most were given more indirect help. Effective 
throughcare is reliant on multi-agency co-operation. However the survey identified 
structural problems restricting provision, with responsibility not falling to any single 
agency. Unless treatment is maintained in the community, offenders are likely to 
relapse, returning to crime and to prison. Some four months after their release, 86% 
reported that they had used some form of drug. About half were using heroin every 
day, which represents a decline of about 20 percentage points on the proportion 
using heroin before going into prison. 
URL: http://www.homeoffice.gov.uk/rds/pdfs/r109.pdf 
 
Farrell, M., & Marsden, J. (2008). Acute risk of drug-related death among newly released 
prisoners in England and Wales. Addiction, 103(2), 251-256. 
Abstract: To investigate drug-related deaths among newly released prisoners in 
England and Wales. Database linkage study. National sample of 48,771 male and 
female sentenced prisoners released during 1998-2000 with all recorded deaths 
included to November 2003. There were 442 recorded deaths, of which 261 (59%) 
were drug-related. In the year following index release, the drug-related mortality 
rate was 5.2 per 1000 among men and 5.9 per 1000 among women. All-cause 
mortality in the first and second weeks following release for men was 37 and 26 
deaths per 1000 per annum, respectively (95% of which were drug-related). There 
were 47 and 38 deaths per 1000 per annum, respectively, among women, all of 
which were drug-related. In the first year after prison release, there were 342 male 
deaths (45.8 were expected in the general population) and there were 100 female 
deaths (8.3 expected in the general population). Drug-related deaths were attributed 
mainly to substance use disorders and drug overdose. Coronial records cited the 
involvement of opioids in 95% of deaths, benzodiazepines in 20%, cocaine in 14% 
and tricyclic antidepressants in 10%. Drug-related deaths among men were more 
likely to involve heroin and deaths among women were more likely to involve 
benzodiazepines, cocaine and tricyclic antidepressants. Newly released male and 
female prisoners are at acute risk of drug-related death. Appropriate prevention 
measures include overdose awareness education, opioid maintenance 
pharmacotherapy, planned referral to community-based treatment services and a 
community overdose-response using opioid antagonists. 
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Melnick, G., De Leon, G., Thomas, G., Kressel, D., & Wexler, H. K. (2001). Treatment 
process in prison therapeutic communities: motivation, participation, and outcome. 
American Journal of Drug and Alcohol Abuse, 27(4), 633-651.  
Abstract: Although the largest effects of prison-based therapeutic community (TC) 
programs are associated with entry into aftercare, only a minority of prisoners 
volunteer for these aftercare programs. The study addresses the gap in our 
knowledge concerning these low rates of voluntary entry. A theoretical formulation of 
the TC process involving the effect of the interaction of clients' motivation and 
participation in the activities of the TC on entry into aftercare was tested on a sample 
of 110 volunteers in a prison-based TC for whom there were client and staff ratings 
of 3-month participation and 12-month follow-up data on relapse and recidivism. 
Path analyses support a model in which the interaction of motivation and 3-month 
participation ratings have a direct effect on the selection of aftercare, and aftercare 
has a direct effect on relapse and recidivism. The use of a combination of enhanced 
motivation and early program participation as a means of increasing the utilization 
and effectiveness of aftercare is discussed. 
 URL: http://find.galegroup.com/itx/infomark.do?&contentSet=IAC-
Documents&type=retrieve&tabID=T002&prodId=EAIM&docId=A80771913&source=
gale&srcprod=EAIM&userGroupName=unsw&version=1.0 
 
Pelissier, B., Jones, N., & Cadigan, T. (2007). Drug treatment aftercare in the criminal 
justice system: A systematic review. Journal of Substance Abuse Treatment, 32(3), 
311-320.  
Abstract: Drug treatment aftercare is frequently cited as necessary for individuals 
served within the criminal justice system. The purposes of this article are to review 
how much is actually known about aftercare and to highlight issues in studying the 
role of aftercare. We begin with a review of the literature, looking at how aftercare is 
defined within the criminal justice system outcome literature and the findings on 
aftercare for offenders who received initial treatment from in-prison substance use 
treatment programs. We continue with a discussion of how substance use treatment 
provided within the federal system, drug use patterns, and responses to drug use 
create methodological difficulties in adequately assessing the effectiveness of 
aftercare services. Taking into account both the previous research on aftercare and 
the issues encountered in attempting to evaluate the federal aftercare services, we 
concluded that the claim of certainty about aftercare effectiveness is not well 
substantiated and that the precise nature of aftercare services needed is not well 
understood. We conclude with a discussion of the methodological and substantive 
issues that need to be addressed in future research. Issues identified include the 
need to address self-selection bias and to disentangle offender behavior from the 
effects of criminal justice system policies. Research is also needed to identify the 
most effective type and intensity of aftercare. 
URL: http://www.sciencedirect.com/science/article/B6T90-4MHPHK9-
5/2/82958b40d3616175ea07ba72fe84f2c5  
 
Prendergast, M. L., Wellisch, J., & Wong, M. M. (1996). Residential treatment for women 
parolees following prison-based drug treatment: treatment experiences, needs and 
services, outcomes. The Prison Journal, 76(3), 253-275.  
Abstract: There have been few studies on the experiences of drug-using women 
prisoners out on parole and the reasons behind the success or failure of drug 
treatment programs for these women. To remedy this problem, the community 
residential phase of the prison-based 'Forever Free Substance Abuse Program' at the 
California Institute of Women is evaluated. Results indicate that women who apply 
for residential treatment when they have been discharged from prison are more 
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likely to have lower drug use rates and successful parole discharge levels than those 
who did not get any residential treatment. 
URL: http://find.galegroup.com/itx/infomark.do?&contentSet=IAC-
Documents&type=retrieve&tabID=T002&prodId=EAIM&docId=A18920361&source=
gale&srcprod=EAIM&userGroupName=unsw&version=1.0  
 
Ramsay, M. (Ed.). (2003). Prisoners' drug use and treatment: seven research studies (Vol. 
Study 267). London: Home Office Research, Development and Statistics Directorate. 
URL: http://www.homeoffice.gov.uk/rds/pdfs2/hors267.pdf 
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This section covers various treatments other than TC and pharmacotherapies, such as 
detoxification, cognitive-behavioural treatment, counselling, education, peer based 
programs, alcohol treatment and one paper on amphetamine type stimulant treatment in 
prison.  
 
Crundall, I., & Deacon, K. (1997). A prison-based alcohol use education program: 
evaluation of a pilot study. Substance Use & Misuse, 32(6), 767-777.  
Abstract: Northern Territory prisoners were followed up after release to determine 
the effect of an alcohol education course on their alcohol consumption, drinking 
group, disruptive behavior, criminal activity, family relationships, how they use their 
time, general health, ability to cope and take responsibility. Measures were obtained 
both from prisoners and key informants, and two groups of prisoners were 
compared: those who completed the course and others who had not done the 
course. A high level of correspondence was found between measures from key 
informants and prisoners. The prisoners attending the course showed significant 
improvements on all dimensions when compared to the control subjects. 
 
Daley, M., Love, C. T., Shepherd, D. S., Petersen, C. B., White, K. L., & Hall, F. B. (2004). 
Cost effectiveness of Connecticut's in-prison substance abuse treatment. Journal of 
Offender Rehabilitation, 39(3), 69-92.  
Abstract: Over the past two decades, the criminal justice population in the US has 
grown by over 200%, most of this due to an increase in drug-involved offenders. 
Although there is good evidence that prison-based substance abuse treatment 
programs can be effective in reducing rearrest, few cost-effectiveness studies have 
been conducted. Using data from the Connecticut Department of Correction and the 
Connecticut Department of Mental Health and Addiction Services (DMHAS), we 
compared the cost-effectiveness of four tiers (levels) of substance abuse treatment 
programs for a sample of 831 offenders who were released during FY1996-FY1997. 
Effectiveness, measured by reductions in the likelihood of rearrest within six months, 
one year and 18 months post-release, was compared for inmates who had received 
treatment while incarcerated (n = 358) and those who had not (n = 473). At all 
intervals, offenders who attended any of the higher tier programs (two, three and 
four) had significantly lower rates of rearrest when compared to offenders who 
attended Tier One only or who had attended no tier programs, even after controlling 
for background characteristics that may have differentiated the two groups. The 
benefits to the State of Connecticut correctional system alone, measured in terms of 
the costs of avoided re-incarcerations, were from 1.8 to 5.7 times the cost of 
implementing the programs, ranging from $20,098 (Tier Four) to $37,605 (Tier 
Two). Since society receives a favorable return on its investment in prison-based 
treatment programs, we should find ways to ensure that more drug-involved inmates 
receive treatment.  
URL: http://find.galegroup.com/itx/retrieve.do?contentSet=IAC-
Documents&resultListType=RESULT_LIST&qrySerId=Locale%28en%2C%2C%29%3
AFQE%3D%28JN%2CNone%2C36%29%22Journal+of+Offender+Rehabilitation%22
%3AAnd%3ALQE%3D%28DA%2CNone%2C8%2920041001%24&sgHitCountType=N
one&inPS=true&sort=DateDescend&searchType=PublicationSearchForm&tabID=T00
2&prodId=EAIM&searchId=R2&currentPosition=4&userGroupName=unsw&docId=A1
26120005&docType=IAC 
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Decorte, T. (2007). Problems, needs and service provision related to stimulant use in 
European prisons. International Journal of Prisoner Health, 3(1), 29 - 42.  
Abstract: The objective of this study was to examine practices and policies in place 
for the provision of targeted prevention and treatment of cocaine and Amphetamine 
Type Stimulant (ATS) users in prison in nine European countries. Methodology: 
Across nine European member states (Belgium, the Netherlands, Czech Republic, 
Lithuania, Slovenia, Sweden, Malta, Ireland and Portugal), interviews were 
conducted with ministerial representatives professionals (i.e. service providers and 
security officials) working in prisons and a total of 16 focus groups with a total of 125 
prisoners. Results: The use of stimulants in prison is associated with aggression and 
violence, financial problems, and psychological and physical problems in prisoners 
(depression, anxiety and psychological craving). Both security and healthcare staff in 
prison often feel ill-equipped to deal with stimulant-related problems, leading to a 
lack of equivalence of care for stimulant users in prison, therefore the variety and 
quality of drug services outside is not reflected sufficiently inside prison. There is a 
need for more specific product information and harm reduction material on 
stimulants, for clear guidelines for the management of acute stimulant intoxication 
and stimulant withdrawal, for structural adjustments to improve potential diagnosis 
of personality and psychiatric disorders, for more non-pharmacological treatment 
strategies and more opportunities for prisoners to engage in purposeful activities. 
URL: http://www.informaworld.com/10.1080/17449200601149122  
 
Devilly, G., Sorbello, L., Eccleston, L., & Ward, T. (2005). Prison-based peer-education 
schemes. Aggression and Violent Behavior, 10, 219-240.  
Abstract: Historically, peer programs have been utilized in school and community 
settings to address a range of health issues such as HIV / AIDS, drug and alcohol 
abuse, and youth violence. However, in terms of offender rehabilitation, the change 
process has generally rested upon professional staff, with little formal consideration 
of the powerful positive influence that offenders can have on fellow offenders. This 
paper, therefore, suggests that prison-based, peer-led programs have something to 
offer to correctional organizations. First, the paper explores the theoretical 
underpinnings of peer programs, followed by a general overview of the scarce 
empirical research on correctional peer programs in the areas of HIV/AIDS and 
health education, drug and alcohol abuse, sexual assault/offending, prison 
orientation, and suicide/violence prevention. The discussion then focuses on the 
difficulties of implementing such programs, as well as their overall appeal for fellow 
offenders, peers, and the organization itself. The paper concludes that while 
preliminary reports of offender-peer programs are positive, controlled research is 
lacking. To aid in the development of such programs, and promote further research, 
the paper provides an outline to effectively implement and evaluate peer programs. 
It is further concluded that such innovations are important to the future of offender 
rehabilitation policies and practices (Author Abstract). 
URL: http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VH7-4BNMJ09-
1&_user=37161&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C0000042
18&_version=1&_urlVersion=0&_userid=37161&md5=f69a404edb4b0c9bd49c73b4d
f98b1f0 
 
Dolan, K., & Rouen, D. (2003). Evaluation of an educational comic on harm reduction for 
prison inmates in New South Wales. International Journal of Forensic Psychology, 
1(1), 138-141.  
Abstract: The aim of this study was to educate inmates about harm reduction 
measures as a first step towards the reduction of hepatitis C transmission in prison. 
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An educational comic was developed and covered a range of relevant topics. A 
survey was included in the comic to assess inmates' knowledge. There was a very 
high level of knowledge among inmates who took part in the survey, but the 
response rate was very low. It appears that comics are a useful medium for the 
education of inmates about harm reduction measures, but education alone is 
insufficient. Inmates need to be provided with the means for prevention. 
URL: http://ijfp.psyc.uow.edu.au/IJFPArticlesIssue1/Dolan.pdf 
 
Dowden, C., & Blanchette, K. (2002). An evaluation of the effectiveness of substance abuse 
programming for female offenders. International Journal of Offender Therapy and 
Comparative Criminology, 46(2), 220-229.  
Abstract: Although a recent meta-analysis reported that substance abuse treatment 
was associated with moderate reductions in recidivism for female offenders, very few 
of the tests of treatment (k = 4) focused on adults. The purpose of this study was to 
contribute to this relatively sparse area of scientific inquiry by exploring the 
effectiveness of substance abuse programming in reducing recidivism for a sample of 
98 federally sentenced female offenders in Canada. Results revealed a significant 
reduction in general recidivism for treated substance abusers. Moreover, the data 
indicated that violent reoffending was also reduced for the treated group, although 
the difference did not reach statistical significance. 
URL: http://info.library.unsw.edu.au/cgi-bin/local/access/ej-
access.cgi?url=http://www.csa.com/htbin/getfulltext.cgi?username=unsw&access=u
nsw513&mode=pdf&db=sagecrim-set-c&issn=0306-
624X&volume=46&issue=2&firstpage=220 
 
Dugan, J. R., & Everett, R. S. (1998). An experimental test of chemical dependency therapy 
for jail inmates. International Journal of Offender Therapy and Comparative 
Criminology, 42(4), 360-368.  
Abstract: A treatment group and a non-treatment (control) group were comprised 
of 145 jail inmates who were screened for chemical dependency and who were 
assigned randomly to the two groups. Treatment involved 72 hours of group therapy 
based on Glasser's (1985) "Reality Therapy." Post release criminal behaviour was 
evaluated for a period of 2 years after treatment. The analysis of recidivism using 
the National Crime Information Center Interstate Identification Index-III indicated no 
significant differences in recidivism between treatment and non-treatment groups. 
Characteristics of successful chemical dependency treatment are discussed. . 
URL: http://info.library.unsw.edu.au/cgi-bin/local/access/ej-
access.cgi?url=http://www.csa.com/htbin/getfulltext.cgi?username=unsw&access=u
nsw513&mode=pdf&db=sagecrim-set-c&issn=0306-
624X&volume=42&issue=4&firstpage=360 
 
Duke, K. (2005). Déjà vu? Opportunities and obstacles in developing alcohol policy in 
English prisons. Drugs: education, prevention and policy, 12(5), 417-430.  
Abstract: Under the new Alcohol Harm Reduction Strategy for England published by 
the Prime Minister's Strategy Unit in 2004, there has been an increasing focus on 
crime and public order issues and alcohol-related harm experienced by 'vulnerable' & 
'at risk' groups. Prisoners have been identified as a vulnerable group who have high 
rates of dependence on alcohol and problems with alcohol-related offending. In late 
2004, the Prison Service launched its first alcohol strategy. Based on an analysis of 
key policy documents, official enquiries and research, this paper explores how the 
'problem' of alcohol can be defined within the prison setting and the issues it raises 
for both the individual prisoner and the institution. It examines the lack of policy and 
strategic direction prior to the publication of the new prison alcohol strategy and the 
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possible reasons for the complacency around alcohol in prisons in contrast to illicit 
drugs. The paper critically assesses the new strategy in relation to the testing and 
treatment initiatives proposed and the lack of research and resources underpinning 
them. There is a real risk that the strategy will fail unless adequate resources are 
forthcoming to expand treatment provision. Given the neglect and complacency 
around alcohol, policy champions or policy entrepreneurs are needed to lobby for 
funding and keep the prison alcohol issue on the policy agenda. 
URL: http://www.informaworld.com/10.1080/09687630500281873 
 
Elkadi, S., Dick, S., & Dain, S. (2006). The psychological impact of prison based drug and 
alcohol programs on young offenders. Paper presented at the 5th International 
Conference on Drugs and Young People. from 
http://www.adf.org.au/article.asp?ContentID=Presentations Abstract: Young 
offenders are a significant group within the Victorian Prisons system. This conference 
paper outlines a study undertaken by Caraniche Pty Ltd for Corrections Victoria, to 
examine the psychological impact of prison based, moderate intensity drug 
treatment programs on young offenders in comparison to older offenders. In 
addition, the implications of the findings were discussed in relation to program 
content and program delivery, including future directions for prison based treatment. 
All male and female offenders assessed by Corrections Victoria as being of medium 
to high risk of alcohol and other drugs abuse are referred to Carniche. This review 
focuses on those young offenders identified as medium to high risk of reoffending 
who also completed the 40 hour closed drug treatment program (i.e. 724 young 
people). The results suggest that young offenders constitute a group with unique and 
complex needs within the prison population, and that treatment requires a system-
wide approach, including education, employment and case management, with early 
intervention critical. 
URL: http://www.adf.org.au/article.asp?ContentID=Presentations 
  
Gaes, G. G., & et al. (1999). Adult correctional treatment. In M. Tonry & J. Petersilia (Eds.), 
Prisons, Crime and Justice: A Review of Research. Chicago: University of Chicago 
Press. 
 
Henderson, D. J. (1998). Drug abuse and incarcerated women: a research review. Journal 
of Substance Abuse Treatment, 15(6), 579-587.  
Abstract: Drug abuse is the primary reason women enter prison and is the primary 
health problem of women in prison. There has been little research conducted 
specifically with this population; information must be drawn from studies with 
nonincarcerated addicted women and incarcerated addicted men. The purpose of this 
paper is to review what is known about the treatment and aftercare needs of this 
group (including relapse and recidivism prevention) and to propose an agenda for 
future research. 
URL: http://www.sciencedirect.com/science/article/B6T90-3V8CHXJ-
C/2/6bf0090854ca7aa16379d5f84886c25d  
 
Howells, C., Allen, S., Gupta, J., Stillwell, G., Marsden, J., & Farrell, M. (2002). Prison based 
detoxification for opioid dependence: a randomised double blind controlled trial of 
lofexidine and methadone. Drug and Alcohol Dependence, 67(2), 169-176.  
Abstract: This paper reports results from the first controlled trial of opioid 
withdrawal treatment in the UK using lofexidine in a prison setting. Seventy-four 
opioid dependent male inmates at a Southern England prison were randomised to 
receive either methadone (the standard prison treatment) or lofexidine using a 
randomised double-blind design. No significant statistical difference between the 
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treatment groups was found in relation to the primary variable of severity of 
withdrawal symptoms (effect SIZE=0.12). No discernible difference was found in the 
sitting blood pressure or heart rate of the two groups during the trial. These results 
provide support for the use of lofexidine for the management of opioid detoxification 
in the prison setting. 
URL: http://www.sciencedirect.com/science/article/B6T63-45J947V-
1/2/e444363926cbad1fbbe27fd16b8a6907 
 
Jeanmonod, R., Harding, T., & Staub, C. (1991). Treatment of opiate withdrawal on entry to 
prison. British Journal of Addiction, 86(4), 457-463.  
Abstract: Forty-nine opiate-dependent persons entering remand prison were treated 
with methadone over 5-10 days in decreasing doses according to standard practice 
of the prison medical service. The prisoners were mainly young, unmarried men with 
an average of 5 years regular opiate use and an average of four previous 
imprisonments; 45% were known to be HIV infected, although routine testing was 
not carried out. Ten were on methadone maintenance prior to imprisonment. Urine 
analysis on entry detected an average of three psychoactive substances, principally 
opiates, benzodiazepines and cannabis. Prescribed starting doses of methadone were 
not correlated to independently assessed withdrawal severity. Starting doses were 
related to prisoners' requests and to their age. Withdrawal severity decreased after 4 
days treatment but symptom relief was incomplete. Treating withdrawal symptoms 
on entry to prison poses unsolved ethical and practical problems. 
 
Koski-Jannes, A. (1997). Prevention and treatment of alcohol-related violence through 
prison programs: a Finnish perspective. Contemporary Drug Problems, 24(4), 765-
785.  
Abstract: Reviewing the connection between drinking and violent crimes in Finland, 
the paper describes the features of effective programs for offenders in order to stop 
the cycle of intoxication and violence, and suggests ways this knowledge can be used 
to improve interventions with prisoners. This paper reviews the connection between 
drinking and violent crimes in Finland and discusses ways of intervening in this 
connection through correctional programs. It summarizes features of effective 
programs and presents examples of substance-abuse programs for violent offenders, 
with some suggestions on how to improve their efficacy. 
URL: http://find.galegroup.com/itx/infomark.do?&contentSet=IAC-
Documents&type=retrieve&tabID=T002&prodId=EAIM&docId=A20932545&source=g
ale&srcprod=EAIM&userGroupName=unsw&version=1.0 
 
Moller, L. F., van den Bergh, B.J., Karymbaeva, S., Esenamanova, A., & Muratalieva, R. 
(2008). Drug use in prisons in Kyrgyzstan: a study about the effect of health 
promotion among prisoners. International Journal of Prisoner Health, 4(3), 124 - 
133. 
Abstract: In Kyrgyzstan the prevalence of injecting drug behaviour is among the 
highest found throughout the world. Health promotion training, improved health care 
and needle/syringe exchange (NSE) programmes have been shown to decrease risk 
behaviour among injecting drug users. In Kyrgyzstan, an intervention study with 
training of prison staff and prisoners was performed in one prison. Before and after 
the training, a random selection of the prisoners answered a questionnaire about 
drug use, risk behaviour and health care. The survey was carried out in both the 
intervention prison and in a reference prison. The number of drug users, the use of 
drugs and risk behaviour were improved significantly within half a year and, 
especially, the injection and use of drugs decreased in the intervention group. The 
study clearly shows that increased focus, improved healthcare and training of 
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prisoners and staff on drug use and harm reduction can reduce both use of drugs 
and risk behaviour. 
URL: http://www.informaworld.com/10.1080/17449200802264654 
 
Pelissier, B. M. M., Camp, S. D., Gaes, G. G., Saylor, W. G., & Rhodes, W. (2003). Gender 
differences in outcomes from prison-based residential treatment. Journal of 
Substance Abuse Treatment, 24(2), 149-160.  
Abstract: This study examines gender similarities and differences in background 
characteristics, the effectiveness of treatment, and the predictors of post-release 
outcomes among incarcerated drug-using offenders. The sample of 1,842 male and 
473 female treatment and comparison subjects came from a multi-site evaluation of 
prison-based substance abuse treatment programs. Three-year follow-up data for 
recidivism and post-release drug use were analyzed using survival analysis methods. 
Despite the greater number of life problems among women than men, women had 
lower three-year recidivism rates and rates of post-release drug use than did men. 
For both men and women, treated subjects had longer survival times than those who 
were not treated. There were both similarities and differences with respect to gender 
and the other predictors of the two post-release outcomes. Differences in 
background characteristics and in factors related to post-release outcomes for men 
and women suggest the plausibility of gender-specific paths in the recovery process. 
URL: http://www.sciencedirect.com/science/article/B6T90-48J3RHX-
8/2/337fd5c651d778b67c510e9dcaed7168 
 
Peters, R. H., Kearns, W. D., Murrin, M. R., Dolente, A. S., & et al. (1993). Examining the 
effectiveness of in-jail substance abuse treatment. Journal of Offender Rehabilitation, 
19(3-4), 1-39.  
Abstract: Evaluated 6-week jail substance abuse treatment program. Compared to 
no-treatment controls (n=422), program participants (n=535) remained significantly 
longer in community until rearrest, experienced fewer arrests, and served less jail 
time during the first year following their release. Participants made significant 
improvements in coping abilities, knowledge acquisition, and self-confidence. 
 
Pedic, F. (1990). Drug use in prisons: data collection procedures: a review and 
recommendations. Sydney: National Drug and Alcohol Research Centre. 
Abstract: Potential sources of data that might be of interest to the National Drug 
Abuse Data System with regard to drug use in prisons are reviewed. Information 
which is presently collected in the various jurisdictions is listed and the feasibility of 
further and more detailed collection is then examined. Recommendations are made 
regarding future prison data collection. 
 
Prendergast, M. L., Hall, E. A., & Wexler, H. K. (2003). Multiple measures of outcome in 
assessing a prison-based drug treatment program. Journal of Offender 
Rehabilitation, 37(3/4), 65.  
Abstract: Evaluations of prison-based drug treatment programs typically focus on 
one or two dichotomous outcome variables related to recidivism. In contrast, this 
paper uses multiple measures of outcomes related to crime and drug use to examine 
the impact of prison treatment. Crime variables included self-report data of time to 
first illegal activity, arrest type, and number of months incarcerated. Days to first 
reincarceration and type of reincarceration are based on official records. Drug use 
variables included self-report data of the time to first use and drug testing results. 
Prisoners randomly assigned to treatment performed significantly better than 
controls on: days to first illegal activity, days to first incarceration, days to first use, 
type of reincarceration, and mean number of months incarcerated. No differences 
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were found in type of first arrest or in drug test results. Subjects who completed 
both prison-based and community-based treatment performed significantly better 
than subjects who received lesser amounts of treatment on every measure. Survival 
analysis suggested that subjects were most vulnerable to recidivism in the 60 days 
after release. Although the overall results from the analyses presented support the 
effectiveness of prison-based treatment, conclusions about the effectiveness of a 
treatment program may vary depending on which outcomes are selected. The results 
of this study argue for including more than fewer outcomes in assessing the impact 
of prison-based substance abuse treatment. 
 
Rosen, P. J., Hiller, M. L., Webster, J. M., Staton, M., & Leukefeld, C. (2004). Treatment 
motivation and therapeutic engagement in prison-based substance use treatment. 
Journal of Psychoactive Drugs, 36(3), 387-396.  
Abstract: Studies of community-based substance use treatment show that 
motivation for treatment is critical for clients becoming therapeutically engaged. 
Little research, however, has been conducted on therapeutic engagement in 
corrections-based substance use treatment. The current study examines the 
association between internal treatment motivation and therapeutic engagement for a 
sample of 220 mate substance-using offenders enrolled in a corrections-based 
treatment program. Findings showed that problem recognition and desire for help 
were associated with cognitive indicators of therapeutic engagement, specifically 
confidence in and commitment to treatment. Increased focus on internal motivation 
for treatment may lead to more effective treatment for substance-using offenders. 
Pretreatment motivational interventions therefore are recommended for substance-
using offenders with low internal motivation for treatment. 
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This section covers drug testing and other supply reduction papers. Two papers on 
screening for drug problems are included at the end of the section. 
 
Bird, A. G., Gore, S. M., Hutchinson, S. J., Lewis, S. C., Cameron, S., & Burns, S. (1997). 
Harm reduction measures and injecting inside prison versus mandatory drugs 
testing: results of a cross sectional anonymous questionnaire survey. British Medical 
Journal, 315(7099), 21-24.  
Abstract: Objectives: (a) To determine both the frequency of injecting inside prison 
and use of sterilising tablets to clean needles in the previous four weeks; (b) to 
assess the efficiency of random mandatory drugs testing at detecting prisoners who 
inject heroin inside prison; (c) to determine the percentage of prisoners who had 
been offered vaccination against hepatitis B. Design: Cross sectional willing 
anonymous salivary HIV surveillance linked to a self completion risk factor 
questionnaire. Setting: Lowmoss prison, Glasgow, and Aberdeen prison on 11 and 30 
October 1996. Subjects: 293 (94%) of all 312 inmates at Lowmoss and 146 (93%) 
of all 157 at Aberdeen, resulting in 286 and 143 valid questionnaires. Main outcome 
measures: Frequency of injecting inside prison in the previous four weeks by injector 
inmates who had been in prison for at least four weeks. Results: 116 (41%) 
Lowmoss and 53 (37%) Aberdeen prisoners had a history of injecting drug use but 
only 4% of inmates (17/395; 95% confidence interval 2% to 6%) had ever been 
offered vaccination against hepatitis B. 42 Lowmoss prisoners (estimated 207 
injections and 258 uses of sterilising tablets) and 31 Aberdeen prisoners (229 
injections, 221 uses) had injected inside prison in the previous four weeks. The 
prisons together held 112 injector inmates who had been in prison for more than 
four weeks, of whom 57 (51%; 42% to 60%) had injected in prison in the past four 
weeks; their estimated mean number of injections was 6.0 (SD 5.7). Prisoners 
injecting heroin six times in four weeks will test positive in random mandatory drugs 
testing on at most 18 days out of 28. Conclusions: Sterilising tablets and hepatitis B 
vaccination should be offered to all prisoners. Random mandatory drugs testing 
seriously underestimates injector inmates' harm reduction needs. Key messages Half 
of injector inmates of two Scottish prisons who had been in prison for more than four 
weeks had injected in the previous four weeks--an average of six times Injector 
inmates used sterilising tablets to clean injecting equipment as often as they injected 
Only 4% of inmates had ever been offered vaccination against hepatitis B 
Vaccination against hepatitis B and sterilising tablets are prisoners' rights Random 
mandatory drugs testing is likely to detect only one third to two thirds of heroin 
injectors in prison and so seriously underestimates injector inmates' drug reduction 
needs. 
URL: http://www.bmj.com/cgi/content/Abstract/315/7099/21 
  
Dean, J. (2005). The future of mandatory drug testing in Scottish prisons: A review of 
policy. International Journal of Prisoner Health, 1(2), 163 - 170.  
Abstract: This article reviews the procedures for the management of drug misuse in 
Scottish prisons 10 years after the introduction of the legislative framework 
permitting the introduction of mandatory drug testing (MDT). In April 2005 the 
Scottish Prison Service announced its decision to discontinue mandatory random 
drug tests (MRDTs) in Scottish prisons. This decision was not without controversy 
and was met by criticisms in the media that the prison service had given up on the 
fight against controlling substance abuse among inmates within Scottish prisons. 
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This research examines the reality of the problem and some of the issues that have 
arisen over the past 10 years. The current usage of mandatory drug testing and 
some possible future implications of its usage are researched through the realistic 
but forward-looking approach currently utilised at Edinburgh prison. 
URL: http://www.informaworld.com/10.1080/17449200600553134 
  
Edgar, K., & O'Donnell, I. (1998). Mandatory Drug Testing in Prisons: The relationship 
between MDT and the level and nature of drug misuse. London: Home Office. 
Abstract: This report is based on a study of mandatory drug testing (MDT) in five 
Prison Service establishments. One hundred and forty eight prisoners who had been 
tested recently (three - quarters on a random basis) we re interviewed about their 
experiences of drug misuse and the extent to which this had changed as a result of 
MDT. One hundred and forty six members of staff were asked about the impact of 
MDT on their response to prisoners' drug misuse and more generally about their 
views on the effectiveness of the policy. 
URL: http://www.homeoffice.gov.uk/rds/pdfs/hors189.pdf 
 
Fraser, A. D., & Zamecnik, J. (2002). Substance abuse monitoring by the correctional 
service of Canada. Therapeutic Drug Monitoring, 24(1), 187-191.  
Abstract: The Correctional Service of Canada implemented a urine drug-testing 
program over a decade ago. Offenders residing in federal correctional institutions 
and living in the community on conditional release were subject to urine drug 
testing. The objective of this study is to describe this testing program and the extent 
of drug use by conditional release offenders in 2000. Urine specimens were tested 
for drugs of abuse and prescription drugs including amphetamines, cannabinoids, 
cocaine metabolite, opiates, phencyclidine, benzodiazepines, methyl phenidate, 
meperidine, pentazocine and fluoxetine by immunoassay screening followed by GC-
MS confirmation. Ethyl alcohol was analyzed when specifically requested. Alternative 
screening and confirmation methods with lower cut-off values were used whenever 
urine specimens were dilute (creatinine <20 mg/dL and specific gravity &LE;1.003). 
Total number of urine specimens analyzed in 2000 was 38,431 (6.7% were dilute). 
The positive rate for one or more drugs was 27.2% in 2000 in conditional release 
offenders. In the community setting 28,076 normally concentrated (nondiluted) 
specimens were tested (9.6% were positive for cannabinoids and 3.3% positive for 
cocaine metabolite), In the 1,270 dilute specimens collected from conditional release 
offenders in 2000, 12.8%, were positive for cannabinoids and 10.6% were positive 
for cocaine metabolite. The authors conclude that forensic urine drug testing 
provides an objective measure of drug use when assessing offenders living in the 
community on conditional release from correctional institutions in Canada. 
URL: http://info.library.unsw.edu.au/cgi-bin/local/access/ej-
access.cgi?url=http://gateway.ovid.com/ovidweb.cgi?T=JS&checkipval=yes&PAGE=f
ulltext&D=ovft&MODE=ovid&NEWS=N&SEARCH=0163-
4356.is+and+24.vo+and+1.ip+and+187.pg 
 
Gore, S. M., & Bird, A. G. (1996). Cost implications of random mandatory drugs tests in 
prisons. Lancet, 348, 1124-1127.  
Abstract: Background Compulsory urine testing of prisoners for drugs, a control 
initiative, was introduced in eight prisons in England and Wales early in 1995. 
Despite no evidence of effectiveness, testing was extended to all prisons in England 
and Wales by March 1996. We consider the cost of testing. We combined the costs of 
refusals, confirmatory tests, punishment of confirmed positives for cannabis or for 
class A drugs to estimate the average costs of random compulsory drugs testing. 
These costs were then compared to: i) the healthcare budget for a prison; and ii) the 
 44
Drug Testing 
cost of putting in place a credible prisons' drugs reduction programme. We then used 
Scottish data on incarceration and regional prevalence of injecting drug users to 
estimate the extent of the injecting drug use problem that prisons face. Findings 
Costs per 28 days of the random mandatory drugs testing control initiative in an 
establishment for 500 inmates where refusal rate is a) 10[percent] or b) nil; and 35 
[percent] of urine samples test positive, one tenth of them for class A drugs were 
estimated at between a) £ UK22,800 and b) £ UK16,000 per 28 days {a) $US35,100 
and b) $US24,600}. This cost was equivalent to twice the cost of running a credible 
drugs reduction and rehabilitation programme, and around half the total healthcare 
expenditure for a prison of 500 which averaged £ UK41,114 per 28 days 
{$US64,860}. Major cost-generating events were the punishment of refusals--over 
one third of cost a)--and testing positive for cannabis--over 50[percent] of cost a). 
In Scotland, around 5[percent] of injecting drug users (IDUs) are incarcerated at any 
time: 5[percent] of Lothian's drugs care, treatment and prevention costs and 
2.5[percent] of its HIV/AIDS prevention budget in 1993-94 amounted to £ 
UK101,300 per annum--or £ UK7770 per 28 days ($US11,970)--and about 
35[percent] of monthly MDT costs. We suggest that 5[percent] of current resources 
for drugs prevention and treatment and for IDU-targeted HIV/AIDS prevention 
should be directed towards the prisons because in the prisons, where 5[percent] of 
the clients are at any time, injectors have less access to harm reduction measures 
than on the outside. 
URL:http://vnweb.hwwilsonweb.com/hww/jumpstart.jhtml?recid=0bc05f7a67b1790e
d34b537fd18e7dacb74e646edc9de470424f1ef635b41228bf438a5811ff5077&fmt=C  
 
MacPherson, P. (2001). Random urinalysis program: policy, practice, and research results. 
Forum on Corrections Research, 13(3), 54-57.  
Abstract: Urinalysis is a method of detecting recent drug use by looking for 
evidence of drugs (metabolites) in urine. In Canadian federal penitentiaries, 
offenders can be asked to provide a urine sample when there is reasonable grounds 
to suspect use; as a condition of participation in a program or activity involving 
community contact, as part of participation in a substance abuse treatment program, 
or if they have been chosen to participate in the random testing program. The 
purpose of this paper is to describe some of the results from the random component 
of urinalysis testing conducted by Correctional Service Canada (CSC). 
URL: http://198.103.98.138/text/pblct/forum/e133/v13n3a17e.pdf 
 
McDonald, M. (1997). Mandatory Drug Testing in Prisons. Birmingham: Centre for Research 
into Quality, The University of Central England in Birmingham. 
URL: http://www0.bcu.ac.uk/crq/publications/mdt.pdf 
 
Mundy, J. (1996). Crackdown on drug use in jails. Connexions, 16, 24. 
Abstract: A computer-based information system for visitors, screening prisoners' 
outgoing phone calls, limiting the number of prisoners' visits and closing toilets in 
prison visiting areas are among measures introduced in South Australian prisons in 
an attempt to reduce drug use. In Victoria, similar detection measures and random 
drug sampling have resulted in a drop in positive drug tests from 35 to 8 percent. 
The Victorian Corrections Commissioner notes 'our measures have been called 
draconian but we are saving lives. Overdosing in Victorian prisons is now almost nil.' 
 
Perry, R. W. K., & Marty, P. (2000). Drug testing in Canadian jails: To what end? Canadian 
Journal of Public Health, 91(1), 26-28.  
Abstract: Since 1995, Corrections Services Canada (CSC) has conducted 
randomized urinalysis screening of a minimum of 5% of the federal inmate 
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population on a monthly basis. Urine samples are screened for a broad range of 
psychoactive substances. The stated purpose of such screening is to reduce 
substance use in federal jails. Analysis of data provided by CSC for testing between 
1994 and 1998 reveals small but statistically significant increases in the percentage 
of all urine samples that tested positive over that time. Analysis of the results of 
screening for opiates, cocaine and THC from data provided by CSC for the same time 
period, shows steady rates of opiate and cocaine detection at maximum and medium 
levels of security, decreases in opiate and cocaine detection in minimum security, 
and statistically significant increases in THC detection at all levels of security. The 
implications of these findings are discussed. 
URL:http://proquest.umi.com/pqdweb?did=52626681&Fmt=7&clientId=25620&RQT
=309&VName=PQD  
  
Shearer, J., White, B., Gilmour, S., Wodak, A. D., & Dolan, K. A. (2006). Hair analysis 
underestimates heroin use in prisoners. Drug and Alcohol Review, 25(5), 425 - 431.  
Abstract: The value of hair analysis in measuring treatment outcome was examined 
in a randomised controlled trial (RCT) of an Australian state prison-based methadone 
programme between 1997 and 1998 (n = 382 male prisoners). Hair samples were 
analysed for morphine using immunoassay techniques. Agreement between hair 
analysis and self-report was tested using kappa, McNemar's test of symmetry and 
Pearson's correlation coefficient r. Hair analysis based on immunoassay was 
inadequate as the primary outcome measure for the RCT but had value in 
supplementing self-reported heroin use. There was a modest correlation (r = 0.31, p 
< 0.001) between self-reported frequency of heroin use and morphine 
concentrations in hair. Sectional hair analysis, a reflection of duration of drug use, 
was uninformative and generally impractical due to the length of hair sections 
needed.  
URL: http://www.informaworld.com/10.1080/09595230600868512 
  
Singleton, N., Pendry, E., Simpson, T., Goddard, E., Farrell, M., Marsden, J., et al. (2005). 
The impact of mandatory drug testing in prisons. UK: Home Office Online Report 
03/05. 
URL: http://www.homeoffice.gov.uk/rds/pdfs05/rdsolr0305.pdf 
 
Woodham, R. G. (1995). Briefing paper on drug trafficking into NSW correctional centres. 
Sydney: NSW Department of Corrective Services. 
Abstract: Woodham discusses drug trafficking in and out of correctional centres in 
New South Wales. Issues discussed include drug trafficking methods, corrupt staff, 
civilian workers, deliveries and stores, vehicles, inmate mail, hoarding and trading of 
medication, drug and alcohol manufacture, Task Force Sted, drug detection dog unit, 
urinalysis, searching, visitor restriction and drug rehabilitation programs. 
 
Kevin, M. (1997). The Alcohol and Other Drug Screen with inmate receptions in New South 
Wales: a pilot initiative. Sydney: NSW Department of Corrective Services. 
Abstract: The results of a pilot project aimed at identifying inmates with alcohol or 
other drug related problems on reception into prison are reviewed. By this means, 
current drug users, especially those with a high dependency problem, can be 
channeled into appropriate drug treatment programs, with the ultimate aim of 
greater rehabilitation and less recidivism post-release. 
 
Peters, R. H., Greenbaum, P. E., Steinberg, M. L., Carter, C. R., Ortiz, M. M., Fry, B. C., et 
al. (2000). Effectiveness of screening instruments in detecting substance use 
disorders among prisoners. Journal of Substance Abuse Treatment, 18(4), 349-358.  
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Abstract: This study examined the effectiveness of several screening instruments in 
detecting substance use disorders among prison inmates. A sample of 400 male 
inmates were administered eight different substance abuse screening instruments 
and the Structured Clinical Interview for DSM-IV (SCID-IV), Version 2.0, Substance 
Abuse Disorders module. The latter was used as a diagnostic criterion measure to 
determine the presence of substance use disorders. Based on positive predictive 
value, sensitivity, and overall accuracy, the Texas Christian University Drug Screen, 
the Simple Screening Instrument, and a combined instrument--Alcohol Dependence 
Scale/Addiction Severity Index-Drug Use section were found to be the most effective 
in identifying substance abuse and dependence disorders. 
URL: http://www.sciencedirect.com/science/article/B6T90-407GJ5J-
6/2/7288ef79021358f14d25a5c38521c105 
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Awofeso, N. (2003). Implementing Smoking Cessation Programmes in Prison Settings. 
Addiction Research and Theory, 11, 119-130.  
Abstract: In spite of abundant evidence as to the adverse health problems of 
tobacco use over the past half century, progress towards tobacco control in prisons 
have been minimal. Lack of political will, boredom, stress, imprisonment-related 
deprivation, sub-optimal demographic characteristics of prisoners, and the 
unavailability of formal funding mechanisms for smoking cessation support - 
including nicotine replacement therapy - are common reasons for this minimal 
progress. The author suggests that another important obstacle is a limited adoption 
of smoking cessation interventions that are specifically tailored for use in prison 
cohorts. Since 2000, the author developed and implemented smoking cessation 
programmes, using a Social Marketing framework, in eight Australian prisons as part 
of a tobacco control project. Based on his experience, the author discusses issues to 
consider in implementing such programmes in other prisons. Prison-based smoking 
cessation programmes remain a neglected but important health intervention. 
Adaptation of Social Marketing techniques may facilitate the feasibility and 
effectiveness of such programmes. 
URL:http://www.ingentaconnect.com/content/tandf/gart/2003/00000011/00000002/
art00005  
 
Belcher, J. M., Butler, T., Richmond, R. L., Wodak, A. D., & Wilhelm, K. (2006). Smoking 
and its correlates in an Australian prisoner population. Drug and Alcohol Review, 
25(4), 343 - 348.  
Abstract: Despite evidence of high rates of smoking among prisoners, there has 
been limited research that describes smoking patterns and risk factors associated 
with smoking in this group. This study describes inmate smokers and identifies 
factors associated with smoking in prison, using a survey comprising a cross-
sectional random sample of inmates stratified by sex, age and Aboriginality. A total 
of 914 adult inmates (747 men, 167 women) were recruited from 29 New South 
Wales (Australia) correctional centres. Information on the prevalence of smoking, 
smoking history, smoking behaviours and other risk factors were collected. Of the 
participants, 79% were current smokers (78% men, 83% women). Younger inmates 
were more likely than older inmates to smoke (86% vs. 64%). Most individuals 
smoked between 11 and 20 cigarettes a day and a median of 50 grams per week. In 
the previous year, over half (52%) of current smokers had attempted to quit or 
reduce the amount they smoked. At the time of the survey, 58% of smokers had 
plans to quit; 21% within 3 months. Independent predictors of current smoking in 
the multivariate analysis were past use of cannabis and a history of illicit drug use. 
The prevalence of smoking in prison is extraordinarily high and exceeds that of the 
general community. Despite this, the majority of prisoners report plans to quit. 
Readily available smoking cessation advice, support and treatment are needed to 
assist those wanting to quit in this stressful environment. As the prevalence of 
smoking within the general community declines, assisting cessation in groups 
containing a disproportionate number of smokers will become increasingly important. 
Despite high levels of tobacco dependence, many prisoners intend to quit and health 
planners and custodial authorities need to encourage and support inmates who do 
attempt to quit. 
URL: http://www.informaworld.com/10.1080/09595230600741198  
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Colclough, J. A. (2003). Smoking cessation dilemmas in prison. British Medical Journal, 
327(7405), p. 29.  
URL: http://find.galegroup.com/itx/infomark.do?&contentSet=IAC-
Documents&type=retrieve&tabID=T002&prodId=EAIM&docId=A105852012&source
=gale&srcprod=EAIM&userGroupName=unsw&version=1.0  
 
Richmond, R. L., Butler, T., Belcher, J. M., Wodak, A., Wilhelm, K. A., & Baxter, E. (2006). 
Promoting smoking cessation among prisoners: feasibility of a multi-component 
intervention. Australian and New Zealand Journal of Public Health, 30(5), 474-479.  
Abstract: Objective: To conduct a pilot study to determine the feasibility and 
effectiveness of a multi-component smoking cessation intervention among prison 
inmates. 
Conclusions: Prison inmates are able to quit or reduce tobacco consumption while in 
prison but any smoking cessation intervention in this setting needs to address 
prison-specific issues such as boredom, stress, transfers to other prisons, court 
appearances, and isolation from family and friends. 
Implications: The prevalence of smoking within Australian prisons is alarmingly high. 
Further work into how to encourage prisoners to quit smoking is required. 
URL:http://infotrac.galegroup.com/itw/infomark/1/1/1/purl=rc1_EAIM_0_A1535171
55&dyn=5!xrn_1_0_A153517155?Z3950=1&sw_aep=unsw Electronic resource 
(HTML) HTML 
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This section covers attitudes of prison staff and prisoners towards drug use and treatment.  
 
Airey, N., & Marriot, J. (2002). Measuring therapeutic attitudes in the prison environment: 
development of the Prison Attitude to Drugs scale. Addiction, 98(2), 179.  
Abstract: To develop and test the validity of a scale measuring therapeutic attitudes 
among prison staff working with drug misusers. A cross-sectional postal 
questionnaire study using 27 statements with a five-point Likert scale was used. Four 
prisons in the south-west of England were administered the questionnaire. A total of 
252 prison staff (response rate 70%), including 67 for test-retest (response rate 
57%).The study resulted in a three-dimensional, nine-item scale: the Prison Attitude 
to Drugs scale (PAD). The three subscales measure confidence in skills (four items), 
personal rewards (three items) and job satisfaction (two items). Test-retest 
correlations for the questions were above 0.7, with each factor having an internal 
coherence (coefficient alpha) of greater than 0.7.The PAD is a reliable tool that can 
be used in the prison environment. 
 
Carlin, T. (2005). An exploration of prisoners' and prison staff's perceptions of the 
methadone maintenance programme in Mountjoy Male Prison, Dublin, Republic of 
Ireland. Drugs: Education, Prevention and Policy, 12(5), 405 - 416.  
Abstract: This study, which was based in Ireland's main committal prison, used 
semi-structured interviews and a focus group to explore the perceptions of staff and 
prisoners towards methadone maintenance within the prison setting. Although the 
research subjects identified advantages and disadvantages associated with 
methadone prescribing within the prison, they were generally positive in their 
assessment of Mountjoy's methadone programme. Prisoners perceived it as leading 
to an improvement in their relationships with their families, while staff viewed it as 
facilitating a more stable and safer working environment. However, although 
prisoners' use of heroin had reportedly declined since the advent of the methadone 
maintenance programme in the prison, their use of other drugs had not. There were 
negative views expressed by both groups about the manner in which methadone is 
dispensed within the prison, and also because methadone was viewed as being as 
addictive as heroin. Regarding perceptions of the purpose of methadone 
maintenance, there was a spectrum of interpretations among the interviewees. Five 
purposes were identified. These were: (1) to ensure continuity of harm-reduction 
policies from the community; (2) to reduce the supply of heroin in the prison; (3) to 
prevent needle sharing and the spread of blood-borne infections; (4) to treat heroin 
addiction; and (5) to control prisoners and maintain order and discipline within the 
prison. Apropos the latter, there was a widely held perception within the total sample 
that this latent function of methadone maintenance could be seen as of greater 
importance than the more conventional harm-reduction functions that were also 
identified. 
URL: http://www.informaworld.com/10.1080/09687630500249599 
  
Gjersing, L. R., Butler, T., Caplehorn, J. R. M., Belcher, J. M., & Matthews, R. (2007). 
Attitudes and beliefs towards methadone maintenance treatment among Australian 
prison health staff. Drug and Alcohol Review, 26(5), 501 - 508.  
Abstract: Introduction and Aims. Justice Health NSW has one of the most extensive 
prison-based methadone programmes in the world. We examine prison health staff 
attitudes towards methadone treatment and compare these with community 
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methadone staff. Design and Methods. A cross-sectional survey of 202 staff 
employed by Justice Health New South Wales was undertaken in 2003. Results. The 
mean scores on the various sub-scales were: abstinence-orientation (AO) 2.9 (95% 
CI 2.8 - 3.0); disapproval of drug use (DDU) 3.3 (95% CI 3.2 - 3.4); knowledge 
(Know) 2.7 (95% CI 2.4 - 2.9); and toxicity 4.6 (95% CI 4.2 - 5.0). Both the AO and 
DDU score were correlated negatively with the Know score (r = -0.37 and r = -0.13, 
respectively). Prison health staff had higher AO (2.9 vs. 2.6, p < 0.001) and DDU 
(3.3 vs. 2.6, p < 0.001) scores, and lower Know (2.7 vs. 7.0, p < 0.001) scores than 
methadone staff working in the Australian community. They were more 
knowledgeable than US community methadone staff about the toxicity of methadone 
(4.6 vs. 0.0, p < 0.001). Discussion and Conclusions. This is the first survey to 
examine prison health staff attitudes to methadone treatment. Correctional health 
staff tend to be more abstinence-orientated, more likely to disapprove of drug use, 
and less knowledgeable about the risks and benefits of methadone than Australian 
community methadone staff. The findings have important implications for training 
health staff working in the prison environment with regard to client retention on 
methadone treatment. 
URL: http://www.informaworld.com/10.1080/09595230701499118 
  
Wilson, G. B., Galloway, J., Shewan, D., Marshall, L., Vojt, G., & Marley, C. (2007). 
'Phewww, bingoed!': Motivations and variations of methods for using heroin in 
Scottish prisons. Addiction Research & Theory, 15(2), 205 - 224.  
Abstract: While prison is recognised as a setting for infectious disease transmission 
among drug users, little is known about psychological and situational factors 
influencing high-risk behaviours, knowledge vital to prison-based interventions. 
Qualitative interview and focus group data were collected from staff and prisoners in 
six Scottish prisons. A general view was that prison heroin use had increased, but 
injecting and sharing remained a covert and minority behaviour. "Anti-injecting 
culture" among staff and most prisoners emerged as an important factor, though not 
linked by prisoners to an "anti-drug culture". Of individual and social risk factors 
identified, only the desire to inject in prison for maximum effect was unique to prison 
injectors and sharers. This decision-based behaviour requires further theory-
focussed research. Given these findings, introducing needle exchanges into Scottish 
prisons could undermine their low drug injection rates. Enabling injecting, albeit 
within a public health framework, conflicts with the major prison objective of 
rehabilitation. 
URL: http://www.informaworld.com/10.1080/16066350601160639 
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Program descriptions (Australian) 
 
This section covers papers that provide Australian program descriptions – they do not 
include evaluations nor specify necessarily the types of treatment provided. Rather they are 
generic program descriptions. 
 
Abru, E. (1999). Drugs behind bars. New South Wales Police News, 79, 18-19. 
Abstract: Drug use in prisons not only hurts prisoners, but can also be dangerous 
for prison officers who may become potential victims of drug users. Corrective 
Services have introduced a package of new anti drug measures which include zero 
tolerance. Abru outlines some of these measures, including the searching of visitors, 
monitoring contact visits, and random testing of prisoners by urinalysis. 
 
Allen, D. (1994). Social justice issues and drug and alcohol services : implications for 
correctional programmes. Paper presented at the Health for all? Social justice issues 
in the alcohol and other drug field: proceedings from the seventh National Drug and 
Alcohol Research Centre Annual Symposium. 
Abstract: The opportunities for inmates to experience social justice in relation to 
alcohol and other drug issues in prison are discussed in this paper. Since a large 
proportion of inmates in New South Wales prisons have drug and alcohol problems, 
the Drug and Alcohol Services provide a treatment and education program to 
inmates in these prisons. The program seeks to provide inmates with support and 
skills to minimise the harm associated with their alcohol and other drug use both in 
jail and on release. 
URL:http://www.med.unsw.edu.au/NDARCWeb.nsf/resources/Mono_3/$file/Mono.21
.pdf 
 
Anderton, C. (2004). Justice Drug Plan : 15 months on... what have we achieved? APCCA 
Newsletter, 19, 5-6. 
Abstract: This article describes the implementation of key therapeutic elements of 
the Western Australian Department of Justice's Justice Drug Plan. At 15 September 
2004, 230 prisoners were receiving pharmacotherapies, mainly methadone, provided 
by the Prisoner Addiction Services Team. Seventeen additional treatment programs 
have been introduced for high risk offenders, and these have catered for an 
additional 166 drug offenders, with a total of 259 offenders completing the programs 
in 2003-2004. Two Drug Free Units (DFUs) have also been opened at Bandyup 
Women's Prison and Albany Regional Prison, and there have been 71 placements so 
far in the Bandyup DFU and 32 placements in the Albany DFU. 
URL: http://www.apcca.org/Pubs/News/19/newsletter_19_2004-12.pdf 
 
Cameron, M. (2001). Women prisoners and correctional programs. Canberra: Australian 
Institute of Criminology. 
Abstract: This paper discusses trends in the incarceration of women and 
intervention programs available to women in prison. Currently there is considerable 
interest in the design and delivery of interventions for prisoners with drug abuse 
problems. However, although women are often unemployed and tend to be poorly 
educated at the time of their incarceration, little attention is paid to employment and 
education programs. Cameron examines drug intervention programs and 
employment and education programs for women, and finds that they are often 
delivered without consideration of their effectiveness. 
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URL: http://www.aic.gov.au/publications/tandi/ti194.pdf 
 
Carroll, M. (1998). Turning the Tide : the perspective of CORE : the Public Correctional 
Enterprise. Paper presented at the Drugs in prisons : national strategy review and 
corrections-health interface : proceedings of the Australasian Conference. 
Abstract: This paper looks at the 'Turning the Tide' drugs in prisons initiative 
operating in the Victorian prison system. The initiative has been extensively 
implemented at the Bendigo Community Treatment Prison, where the treatment 
regime is significantly improving inmate behaviour and attitudes towards drugs. 
CORE (Public Correctional Enterprise) recommends that more attention now be 
focused on young offenders who are serving short sentences, are disinclined to 
change, are not in treatment for long enough to make a difference, and are not 
deterred from using drugs in prison by the usual disciplinary methods. 
 
Guy, D., & Irlam, P. (1999). Drug rehabilitation within prisons : stemming the flow or 
bandaiding? (the Cadell Training Centre Model). Paper presented at the Australasian 
Conference on Drugs Strategy. 
Abstract: The Drug Therapeutic Unit at Cadell Training Centre is a drug free unit 
within a low security prison where prisoners are contracted to remain drug free. The 
underlying principles of the Unit are: to create an environment where each person 
can improve their sense of self worth; to improve their behaviour towards others 
while in the Unit; and to reduce the number and severity of future crimes. This paper 
presents a profile of prisoner clients and program characteristics. 
 
Hamilton, P. (1991). Prison based treatment programs. Paper presented at the Corrections 
Health : First National Conference. 
Abstract: Since 1986 the Corrections Health Service has provided a number of 
alcohol and drug programs for the Office of Corrections in Victoria. Hamilton's paper 
focuses on one aspect of this - the delivery of programs within the prison system, 
particularly programs in the 'K' Division, a maximum security environment. The 
programs are designed to challenge the prisoner's approach to life and to their 
attitudes and lifestyle within a community atmosphere. Hamilton includes data which 
proves that the program does have an effect on prisoners, both while on the 
program and on their release. 
 
Henry-Edwards, S., Grant, L., Community Restorative Centre, & New South Wales. Dept. of 
Corrective Services. (2005). Drugs in prisons : policy and practice. Of Substance, 3, 
24-25.  
Abstract: In these articles, two organisations working in the correctional sector 
present their point of view on the issue of drugs in prisons. The Community 
Restorative Centre (NSW) describes the difficulties involved in addressing drug 
problems in prison, based on discussions with twelve ex inmates. The New South 
Wales Department of Corrective Services describes initiatives for reducing the risk of 
HIV and hepatitis C infection among prisoners, especially those serving very short 
sentences, and indicates that the Department is reviewing the alcohol and other drug 
treatment programs available to prisoners with a view to providing integrated 
treatment pathways. 
 
Hunter, W. (1998). A perspective of the health-corrections interface. Paper presented at the 
Drugs in prisons : national strategy review and corrections-health interface. 
Abstract: The intersection of corrections policies on drug use and inmate health care 
is investigated. This paper considers the need for appropriate health care and drug 
treatment for substance-abusing inmates, training of custodial staff in health issues, 
 53
Program descriptions (Aus) 
the role of the Prison Medical Service, harm minimisation strategies, drug testing, 
management of communicable diseases, and appropriate research. 
  
Kevin, M. (1995). Research driven drug treatment strategies for prisoners : the NSW 
experience. Paper presented at the National Drug and Alcohol Research Centre 
Annual Symposium. 
Abstract: The Drug and Alcohol Services has been conducting drug and alcohol 
dedicated research of prisoners drug use for a number of years. This paper presents 
research findings which have been addressed in service planning and delivery for 
men, women, Aborigines and recidivists. Some prison context factors which impact 
on the provision of treatment are examined. The paper outlines a number of 
priorities, strategies and program content which are being adopted by the Drug and 
Alcohol Services. 
 
Kevin, M. (2005). Offenders with drug and alcohol dependencies. In S. O'Toole & S. Eyland 
(Eds.), Corrections Criminology (pp. 145-150). Leichhardt, NSW: Hawkins Press. 
Abstract: On arrival to prison in New South Wales, half of all prisoners reportedly 
experience drug withdrawal syndrome and on any given day more than one in ten 
prisoners receive some form of drug substitution therapy for their drug problem. 
After discussing the links between drug abuse and offending, this chapter describes 
the findings from a biennial data collection which is conducted in NSW on a sample of 
about to be released prisoners on a range of drug related measures. The findings 
show that drug use prevalence rates and frequency levels decline with imprisonment, 
that most prisoners who share injecting equipment clean the equipment with water 
and bleach, and that a sizeable proportion of drug users in the prison system seek 
treatment. The chapter also describes drug treatment services in NSW prisons, and 
discusses the challenges of prison drug strategy. 
 
Legislative Assembly, WA (1997). Taking the profit out of drug trafficking: an agenda for 
legal and administrative reforms in Western Australia to protect the community from 
illicit drugs: interim report  
Abstract: An analysis of problems that need to be addressed by drug and alcohol 
treatment programs which target offenders serving community based orders by use 
of legal and social forms of coercion is provided. The chapter also seeks to 
emphasise the magnitude of difficulties faced by prison administrators in adequately 
assessing and managing prisoners with histories of drug abuse. 
 
Marngoneet: Victoria's first Programs Prison (2006). Justice Review, 3, 1. 
Abstract: This brief article describes the opening of Victoria's Marngoneet 
Correctional Centre, which has a strong focus on rehabilitation. Therapeutic 
programs for sex offenders, violent offenders and offenders with substance abuse 
offence behaviour will all be located within this centre. 
 
New South Wales Auditor General. (2006). Performance audit : prisoner rehabilitation : 
Department of Corrective Services Sydney: Audit Office of New South Wales. 
Abstract: Currently New South Wales has over 9,000 people in prison and this 
figure is growing. Prisons help us to feel safe my removing offenders from our 
streets. Prisons also provide an opportunity for offenders to rehabilitate themselves. 
This not only gives them the chance to lead a life free of crime once released, it can 
have major benefits for the community in reducing crime and its associated costs. 
But rehabilitating prisoners is not easy. Many come from some of the most 
disadvantaged and underprivileged sectors of our society. Many have complex needs 
arising from antisocial thinking, drug use, poor work skills and limited education. The 
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Department of Corrective Services aims to address these factors while offenders are 
in prison. However crime is more than a corrective services issue. Many of the 
factors that influence offending are outside the department's immediate control. 
Government and community agencies must work closely together to tackle these 
complex social issues. This report highlights some of the challenges faced by those 
working to rehabilitate prisoners. . 
URL:http://www.audit.nsw.gov.au/publications/reports/performance/2006/prisoner/
prisoner_rehabilitation.pdf  
 
New South Wales Legislative Council Standing Committee on Law and Justice. (2000). 
Recidivism and programs within prison. Crime prevention through social support : 
second report.  
Abstract: This chapter discusses how effective programs administered in NSW 
prisons are at preventing recidivism. It concludes that some programs reduce 
recidivism risks for some types of offenders. Due to increasing prisoner populations, 
combined with restricted program budgets, places for prisoners within programs are 
limited. It is recommended that drug and alcohol programs, mental health programs 
and educational and vocational programs be increased to keep up with increases in 
the prison population. 
 
Weller, P. (1998). Drugs, clients and performance indicators. Paper presented at the Drugs 
in prisons : national strategy review and corrections-health interface. 
Abstract: Economically rational arguments for funding prison drug treatment 
programs are explored, from the point of view of justifying the need to adequately 
fund such services rather than cutting funding in this area. The clients of prisons are 
not the prisoners but the general public, and thus they deserve to receive 
rehabilitated offenders back into the community, rather than individuals who are 
likely to reoffend, and continue to cost the community rather than contribute 
positively to it. 
 
White, V. (1998). The South Australian drug and alcohol strategy. Paper presented at the 
Drugs in prisons: national strategy review and corrections-health interface : 
proceedings of the Australasian Conference. 
Abstract: This paper looks at the drug and alcohol strategy currently operating in 
South Australian prisons. The strategy is based on: the minimisation of alcohol and 
other drug related harm; the Department for Correctional Services' duty of care to 
offenders and staff; integrated service provision; reflection of community standards 
in attitudes to drug use; differential response based on potential harm of the specific 
drug; and undertaking programs and tasks which reduce the perceived need for 
drugs. 
 
White, V. (1999). Eliminating elimination: South Australian Department for Correctional 
Services embraces harm minimisation. Paper presented at the Australasian 
Conference on Drugs Strategy. 
Abstract: Despite the prohibition of drugs in prison, some prisoners arrange an illicit 
supply of drugs. The responsibility of the prison is to prevent that supply, and to stop 
the use of the alcohol and other drugs that still manage to get into the prison. White 
describes the Drug and Alcohol Strategy Project which is a collaboration between the 
Drug and Alcohol Council and the Department for Correctional Services. 
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This section covers papers that describe generic prison-based treatment programs outside 
Australia.  
 
European Monitoring Centre for Drugs and Drug Addiction. (2003). Treating drug users in 
prison - a critical area for health promotion and crime reduction policy. 
URL: http://www.emcdda.europa.eu/attachements.cfm/att_538_EN_pb_07_en.pdf 
 
Farabee, D., & et al. (1999). Barriers to implementing effective correctional drug treatment 
programs. The Prison Journal, 79(2), 150-162.  
Abstract: This paper identifies six common barriers to developing effective 
correctional treatment programs in USA. 
 
Huriwai, T. (2002). Innovative alcohol and drug-user treatment of inmates in New Zealand 
prisons. Substance Use & Misuse, 37(8), 1035 - 1045.  
Abstract: The Kowhai Alcohol and Drug Treatment Unit at Rolleston Prison offers an 
innovative treatment approach for New Zealand inmates. The development of the 
program has involved local staff from Public Prisons, Psychological Services, and the 
Community Probation Service (CPS). This presentation outlines the author's 
impression of this bold innovation. The primary aim of the program is to reduce 
recidivism. This is achieved by assisting inmates to recognize the thoughts, 
emotions, and behaviours that are present in the period preceding and/or during the 
commission of criminal activity - particularly those that are precipitated and/or 
maintained by alcohol and drug use. This insight, coupled with the learning of 
specific coping skills and intensive lifestyle and reintegration planning, leads 
naturally to the follow-up phase that is conducted in the community. The functional 
relationship between offending and substance use is far more explicitly addressed in 
this new program compared with past programs that focused more on substance 
use. 
URL: http://www.informaworld.com/10.1081/JA-120004164  
 
Kothari, G., Marsden, J., & Strang, J. (2002). Opportunities and obstacles for effective 
treatment of drug misusers in the criminal justice system in England and Wales. The 
British Journal of Criminology, 42(2), 412-432.  
URL: http://info.library.unsw.edu.au/cgi-bin/local/access/ej-
access.cgi?url=http://www.oxfordjournals.org/content?genre=article&issn=0007-
0955&volume=42&issue=2&atitle=Opportunities%20and%20obstacles%20for%20ef
fective%20treatment%20of%20drug%20misusers%20in%20the%20criminal%20jus
tice%20system%20in%20England%20and%20Wales&aulast=Gemma&spage=412&s
id=metalib:PQ_TEMPLATE&pid=content:fulltext 
 
Leukefeld, C. G., & Tims, F. R. (1993). Drug abuse treatment in prisons and jails. Journal of 
Substance Abuse Treatment, 10(1), 77-84.  
Abstract: Acknowledging the fact that the criminal justice system is currently awash 
with drug abusers and that prison drug abuse treatment has had a varied history in 
the United States, this article explores possible directions for the future of drug 
abuse treatment in prisons and jails. The current status of drug abuse treatment is 
reviewed, and selected treatment approaches are highlighted. In addition, evaluation 
issues are presented, and special issues are reviewed including case management, 
community follow-up, and methodological considerations. Finally, recommendations 
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are suggested for treatment, research, evaluation, demonstrations, management 
information, community linkage, training, and technical assistance. 
URL: http://www.sciencedirect.com/science/article/B6T90-460XJSH-
88/2/4dc98675ba731ce6c51834399f96ccca  
 
Miovsky, M., & Gajdosikova, H. (2005). The prison system in the Czech Republic: analysis of 
the current state of illicit drug use and prevention and treatment measures. 
International Journal of Drug Policy, 16(4), 262-266.  
Abstract: After 1989, rapid ideological and political change led the Czech Republic 
toward a more rational drug policy. The nature of substance use and prevention and 
treatment services in the Czech prison system, however, has not yet been 
comprehensively described and this paper reviews the available evidence. Limitations 
to evaluation and monitoring of service delivery in Czech prisons are highlighted and 
recommendations to improve responses to drug use are discussed. Changes in 
substance use in the Czech Republic in the 1990s, especially opiate use, are reflected 
in Czech prisons, which now more closely resemble the substance use situation in 
Western European prisons. 
URL: http://www.sciencedirect.com/science/article/B6VJX-4GWBDTG-
3/2/1521370535c0a67e8794bd8226f179f6 
  
Pereira, M. (1999). Drugs : there has to be a better way : part one. Inside Out, 39, 6-7. 
Abstract: In 1998 Gino Vumbaca visited various agencies throughout Switzerland, 
Holland, England, Wales and Canada, consulting with practitioners, researchers, 
policy makers and service providers in the areas of public health, drug use and 
corrections. This article presents the findings from his time in Switzerland. It 
examines the prison system, community drug use, and heroin prescription programs. 
 
Porporino, F. J., Robinson, D., Millson, B., & Weekes, J. R. (2002). An outcome evaluation of 
prison-based treatment programming for substance abusers. Substance Use & 
Misuse, 37(8), 1047 - 1077.  
Abstract: This paper briefly documents the results of a broad-based implementation 
of substance user treatment programs within the Federal correctional system in 
Canada. 
URL: http://www.informaworld.com/10.1081/JA-120004165 
  
Taxman, F. S., Perdoni, M. L., & Harrison, L. D. (2007). Drug treatment services for adult 
offenders: The state of the state. Journal of Substance Abuse Treatment, 32(3), 239-
254.  
Abstract: We conducted a national survey of prisons, jails, and community 
correctional agencies to estimate the prevalence of entry into and accessibility of 
correctional programs and drug treatment services for adult offenders. Substance 
abuse education and awareness is the most prevalent form of service provided, 
being offered in 74% of prisons, 61% of jails, and 53% of community correctional 
agencies; at the same time, remedial education is the most frequently available 
correctional program in prisons (89%) and jails (59.5%), whereas sex offender 
therapy (57.2%) and intensive supervision (41.9%) dominate in community 
correctional programs. Most substance abuse services provided to offenders are 
offered through correctional programs such as intensive supervision, day reporting, 
vocational education, and work release, among others. Although agencies report a 
high frequency of providing substance abuse services, the prevalence rates are 
misleading because less than a quarter of the offenders in prisons and jails and less 
than 10% of those in community correctional agencies have daily access to these 
services through correctional agencies; in addition, these are predominantly drug 
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treatment services that offer few clinical services. Given that drug-involved offenders 
are likely to have dependence rates that are four times greater than those among 
the general public, the drug treatment services and correctional programs available 
to offenders do not appear to be appropriate for the needs of this population. The 
National Criminal Justice Treatment Practices survey provides a better understanding 
of the distribution of services and programs across prisons, jails, and community 
correctional agencies and allows researchers and policymakers to understand some 
of the gaps in services and programs that may negatively affect recidivism reduction 
efforts. 
URL: http://www.sciencedirect.com/science/article/B6T90-4N74J20-
7/2/348ba091cea3f16de528592ce5e19510  
 
Tompkins, C. N. E., Neale, J., Sheard, L., & Wright, N. M. J. (2007). Experiences of prison 
among injecting drug users in England: A qualitative study. International Journal of 
Prisoner Health, 3(3), 189 - 203.  
Abstract: Imprisonment is common among drug users. However, historically 
healthcare for injecting drug users in prison in England and Wales has not been 
equivalent to that offered in community settings. Fifty-one injecting drug users who 
had a history of imprisonment were interviewed. Interviews focused on the 
experiences of drug-related care and treatment in prison. The interviews were 
analysed using the Framework method. Accounts of prison drug treatment 
experiences provided valuable insights into drug treatment in the English prison. The 
participants’ accounts provided a historical perspective, many of which reflected the 
different practices of different prisons and prison staff and the changes in policy and 
practice that have occurred in prison healthcare over recent decades. Positive and 
negative experiences of healthcare and drug treatment in prison were discussed. 
Issues that affected levels of drug use inside prisons and their receipt of care, 
support and treatment in prison included prescribing policies, illicit drug availability 
and prison staff and doctor attitudes. Whilst negative experiences of prison and drug 
treatment prevailed, users identified that recent policy and practice changes had 
positively influenced healthcare provision for drug users in prison, particularly the 
provision of opiate maintenance therapy. Drug users often saw prison as an 
opportunity to detoxify and contemplate their drug use. Further work needs to build 
on the positive experiences identified to ensure that prison drug treatment in 
England and Wales is consistent, effective and efficient in the future. 
URL: http://www.informaworld.com/10.1080/17449200701520123  
 
Trace, M. (1998). Tackling drug use in prison: a success story. International Journal of Drug 
Policy, 9(4), 277-282.  
Abstract: Downview prison, like most UK prisons, experienced a growth in drug use, 
and addiction among prisoners, throughout the 1980s. In 1992 a strategy was 
introduced with the aims of reducing the level of drug use in the prison, and of 
providing treatment to prisoners with the most severe problems to help them stay 
drug and crime free on release. The strategy, jointly managed by the Prison 
Managers and an independent treatment organisation, included the requirement that 
all prisoners sign a contact promising to avoid all drug use in prison; a system of 
incentives that reward compliance with the drug strategy; and provision of a 
treatment programme to those prisoners who admit they need help. The results now 
observed include a reduction in positive drug tests from 50% in 1983 to 8% in 1997; 
contravention of prison rules reduced by 775% over the same period, and almost 
200 graduates of the treatment programme. This article will detail these 
achievements and analyse the key elements of a successful prison drug strategy. 
URL: http://www.sciencedirect.com/science/article/B6VJX-3TYG1G1-
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Turnbull, P. J., & Webster, R. (1998). Demand reduction activities in the criminal justice 
system in the European Union. Drugs; Education, Prevention & Policy, 5(2), 177-184.  
Abstract: With increased prisoner numbers, many European Union member states 
have begun to consider the possibility of drug demand reduction interventions within 
the criminal justice system. In this paper the results of a six month study of drug 
demand reduction activity within the criminal justice system (CJS) of the member 
states of the European Union are presented. The extent of activity at the arrest stage 
varies widely between states. The two most common objectives of interventions 
aimed at drug using arrestees are to provide information and to encourage contact 
with treatment services. The extent of activity at the court stage was difficult to 
establish, however, in many countries legislation exists which extends the possibility 
of drug treatment as an alternative to a legal sanction. There is a considerable and 
increasing range of interventions focused on drug users in prison. All countries 
provide some form of demand reduction activity within this context. Many 
respondents indicated a very low level of drug demand reduction activity targeted at 
released prisoners. Despite the existence of many interventions, no member state 
has an extensive programme of demand reduction activities at every stage of the 
criminal justice system. Further, activities are rarely available throughout all 
geographical areas of a country. 
URL:http://proquest.umi.com/pqdlink?did=31924090&Fmt=7&clientId=25620&RQT
=309&VName=PQD  
 
Zurhold, H., & Haasen, C. (2005). Women in prison: Responses of European prison systems 
to problematic drug users. International Journal of Prisoner Health, 1(2), 127-141.  
Abstract: Problematic drug use in prison remains a pervasive and increasing 
concern throughout the European Union (EU) in terms of costs to the individual, 
community and the state. Drug-related problems in prison seem to be more 
prominent among female prisoners, as a high proportion of them are problematic 
drug users whose use continues in prison. Assuming that women's drug use is an 
indication of need for treatment and health care, it becomes increasingly interesting 
how the European penal institutions differ in their response to this need. For this 
reason, a survey of the prison drug services for adult female drug users has been 
carried out among the Ministries of Justice of all 25 EU member states. The main 
purpose of the survey was to gain comprehensive and systematic information on the 
prevalence of female problematic drug users in European prisons and the availability 
of treatment and healthcare services. Altogether, 27 European countries and 
autonomous regions completed the questionnaire developed for this survey. The 
results of the data analyses indicate that there is poor availability and quality of data 
relating to the extent of problematic drug use in women's prisons and, where it is 
available, it seems to underestimate the proportion of female problematic drug users 
in prisons. However, most of the European countries provide a range of different 
harm-reduction and drug treatment services to respond to the reported health and 
rehabilitation problems of female problematic drug users. At the same time, 
however, it is evident that there is a need for further action in some countries, due 
to their low provision of prison drug treatment and healthcare services for this group. 
URL: http://www.informaworld.com/10.1080/17449200600553019 
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There is an extensive literature that describes prisoners, demographic characteristics, health 
needs and so on. We have endeavoured to select papers in this section that mainly describe 
the prison population in relation to drug use histories, rates of drug use in prison, demand 
for drug treatment, barriers to drug treatment, pharmaceutical misuse and mental health 
issues.  
 
Belenko, S., & Peugh, J. (2005). Estimating drug treatment needs among state prison 
inmates. Drug and Alcohol Dependence, 77(3), 269-281.  
Abstract: Growing prison populations in the U.S. are largely due to drug-related 
crime and drug abuse. Yet, relatively few inmates receive treatment, existing 
interventions tend to be short-term or non-clinical, and better methods are needed 
to match drug-involved inmates to level of care. Using data from the 1997 Survey of 
Inmates in State Correctional Facilities, a nationally representative sample of 14,285 
inmates from 275 state prisons, we present a framework for estimating their levels 
of treatment need. The framework is drawn partly from the American Society of 
Addiction Medicine Patient Placement Criteria and other client matching protocols, 
incorporating drug use severity, drug-related behavioral consequences, and other 
social and health problems. The results indicate high levels of drug involvement, but 
considerable variation in severity/recency of use and health and social consequences. 
We estimate that one-third of male and half of female inmates need residential 
treatment, but that half of male and one-third of female inmates may need no 
treatment or short-term interventions. Treatment capacity in state prisons is quite 
inadequate relative to need, and improvements in assessment, treatment matching, 
and inmate incentives are needed to conserve scarce treatment resources and 
facilitate inmate access to different levels of care. 
URL: http://www.sciencedirect.com/science/article/B6T63-4DK5634-
1/2/948f4d681939ae965ab2e52c7c65b427  
 
Bockman, D. (1991). Medication: uses and abuses. Paper presented at the Corrections 
Health: First National Conference. 
Abstract: Bockman discusses what he considers to be normal medical care within a 
prison community, particularly emphasising appropriate drug use. He explains the 
increased prescribing of medication when prisoners enter a prison and considers 
common factors affecting new prisoners requiring medical attention. He also 
examines what level of drug use can be considered normal for the chemically 
dependent prison population. 
 
Brooke, D., Taylor, C., Gunn, J., & Maden, A. (1998). Substance misusers remanded to 
prison - a treatment opportunity? Addiction, 93(12), 1851-1856.  
Abstract: AIMS: To describe self-reported levels of substance misuse before arrest 
among remanded prisoners (unconvicted prisoners awaiting trial), to assess their 
degree of dependency on opiates and stimulants and to record their experiences of 
treatment in prison. DESIGN: Random selection of subjects from prisons chosen to 
give a geographical spread across England and Wales; self-report at semi-structured 
interview, plus examination of the prison medical record. SETTING: Thirteen male 
prisons, three Young Offenders' Institutions and three womens' prisons. 
PARTICIPANTS: Nine hundred and ninety-five consenting, unconvicted prisoners 
randomly selected from all locations within the prisons: 750 men (9.4% sample) and 
245 women (82.2% of all remanded women). MEASUREMENTS: CAGE Questionnaire, 
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Severity of Dependence Scales (SDS) for daily users of opiates and/or stimulants. 
FINDINGS: Before arrest, 145 (19.3%) men and 72 (29.4%) women had been 
dependent on street drugs; 91 (12.1%) men and 16 (6.5%) women were solely 
dependent on alcohol. Seventeen (2.3%) men and four (1.6%) women reported 
injecting drugs during this imprisonment. Mean SDS scores were 10.6 for opiate and 
7.7 for stimulant users. 244 (25%) of all subjects described withdrawal symptoms on 
reception into custody; 157 (16%) reported being prescribed some symptomatic 
relief; 235 (24%) requested treatment at interview. CONCLUSIONS: By 
extrapolation, 1905 people--23% of all unconvicted prisoners--want treatment for 
substance misuse. This apparent shortfall in provision must be addressed; the 
rapidity with which remanded prisoners return to the community dictates that prison 
and community services should be closely linked. 
URL:http://proquest.umi.com/pqdlink?did=37352266&Fmt=7&clientId=25620&RQT
=309&VName=PQD  
 
Butler, T., Levy, M. H., Dolan, K., & Kaldor, J. M. (2003). Drug use and its correlates in an 
Australian prisoner population. Addiction Research and Theory, 11, 89-101.  
Abstract: In this paper the prevalence of past and present tobacco, alcohol, and 
illicit drug use is examined in a cross sectional random sample of prisoners. A total of 
789 male and female prisoners from 27 correctional centres across New South Wales 
participated in the survey. Information was collected using face-to-face interview on 
community and prison drug use, and intoxication while offending. Current tobacco 
use was reported by 72% of the sample. Use of alcohol by females was more likely 
than males to be classified as 'safe' according to the Alcohol Use Disorders 
Identification Test (39 vs. 26%). Overall, 64% of prisoners had used illicit drugs at 
some time in the past with cannabis and heroin the most common. Forty four 
percent of prisoners had a history of injecting drug use, with injecting prevalence 
significantly higher in females than males (64 vs. 40%) with approximately half of 
both male and female injectors reporting that they had injected while in prison. 
'Harmful' or 'hazardous' use of alcohol was associated with imprisonment for violent 
crimes. Sixty two percent of property offenders had an injecting history. Correctional 
authorities need to ensure that drug treatment programs are available to prisoners 
and consideration should be given to piloting needle and syringe exchange programs 
in NSW prisons given the high levels of sharing injecting equipment in prison. 
URL:http://www.ingentaconnect.com/content/tandf/gart/2003/00000011/00000002/
art00003 
 
Butler, T., & Milner, L. (2003). The 2001 New South Wales Inmate Health Survey Matraville, 
NSW Corrections Health Service, NSW. 
Abstract: This survey follows on from the success of a wide-ranging health survey 
of the New South Wales inmate population conducted in 1996, which led to the 
introduction of health interventions and other initiatives aimed at improving 
prisoners' health. The main aim of the previous survey was to provide reliable 
epidemiological data on the health status of the prisoner population. Several new 
topics were incorporated into the 2001 survey to reflect areas of emerging concern 
such as intellectual disability, head injury, and mental health. The methodology 
design represents a cross-sectional random sample of inmates stratified by sex, age 
and Aboriginality. The sample includes approximately 10% male and 34% female 
inmates in full-time custody. In addition the individuals who had participated in the 
1996 survey and were still in custody were re-screened. This cohort of prisoners is 
unique and will enable the long-term impact of incarceration on health to be 
examined. The research clearly shows that prisoners' health is poor compared with 
the general community in all areas, in particular the high level of infectious diseases 
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which pervade this population. This report presents the overall findings of the 2001 
survey classified by sex and age, and forms a key component of the Corrections 
Health Service planning strategy for the prison health system. 
URL: http://www.justicehealth.nsw.gov.au/pubs/Inmate_Health_Survey_2001.pdf 
  
Denton, B. (1994). Prison, drugs and women: voices from below. Victoria: Report for the 
National Campaign Against Drug Abuse. 
Abstract: It has been recognised that the lives of women drug users in prison are 
different to those of drug using men. This project seeks to explore the prevalence of 
substance dependence disorders among women in prison, the factors which 
contribute to drug use and the interventions needed to provide adequate health care 
services for drug users in prison. In understanding the participation of women in the 
criminal justice system and their relationship with drugs, the study also focuses on 
the perceptions and experiences of the women drug users in prison. 
 
Eckstein, G., Levy, M. H., & Butler, T. (2007). Can health inequalities be addressed? : An 
assessment of Prisoner Health Services in New South Wales, Australia. International 
Journal of Prisoner Health, 3, 69-76.  
Abstract: The poor health of prisoners was highlighted in the results of two 
comprehensive health surveys conducted with prisoners in New South Wales. The 
capacity of a dedicated service to address the health needs of prisoners was tested 
through analysis of the health of two prisoner cohorts: a continuously serving cohort, 
and a cohort of prisoners who had been incarcerated and released during the period 
of interest, 1996-2001. It appears that mental health services best addressed the 
needs of a stable prisoner population. Short-stay prisoners do not gain any degree of 
benefit. Primary health and drug and alcohol services address the needs of prisoners 
less effectively, irrespective of their duration of stay. Women's health was very poor 
on all measures that were assessed. With the exception of mental illness, the health 
inequalities that prisoners experience are not addressed by existing prisoner health 
services. This may be due to the magnitude of the burden of ill health among 
prisoners, or due to inadequate resources - or some combination of both. While 
these results should not be taken as supportive of coercive institutionalisation (i.e. 
imprisonment) as a therapeutic option, there may be benefit in more humane and 
compassionate institutions for some of society's most vulnerable individuals. The 
results highlight the potential for prisoner health service providers in redressing 
years of health neglect and the low levels of service utilisation by this group while in 
the community. 
 
George, S., & Moreira, K. (2008). Subutex snorters: A case series. Journal of Substance 
Use, 13(2), 131-138. 
Abstract: Aim: To present an account of six heroin addicts who have snorted 
buprenorphine (Subutex) and to provide a brief insight into their reasons for and 
experiences of snorting Subutex. Design: A case series of six patients studied using a 
semi-structured questionnaire with a qualitative component. Setting and 
participants: A tier 3 NHS community drug treatment service in Birmingham. Six 
heroin dependent patients who reported having snorted Subutex. Findings: The 
practice of snorting Subutex seemed almost exclusive to prison settings. The sample 
snorted Subutex on average 4.8 times while in prison, always as a group activity and 
never overdosed on it. Reasons given for snorting Subutex included: it is safer than 
injecting, only a small amount required to get a buzz, peer influence and the relative 
ease of procuring Subutex in prisons. Patient experiences after snorting Subutex 
were: a 'buzz', similar to using heroin and some unpleasant experiences. 
Conclusions: Snorting Subutex seems particularly popular in prisons. Peer influence, 
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contextual factors and availability of Subutex in prisons all play their part in initiating 
and maintaining this habit. Most patients seem to try snorting Subutex for a 'buzz', 
and reported feelings similar to a 'gouch', but often quicker in onset and shorter 
lasting. Prescribers should note this risk of misuse, especially if Subutex is dispensed 
un-supervised.  
 
Hakanssona, A., Schlyterb, F., & Berglunda, M. (2008). Factors associated with history of 
non-fatal overdose among opioid users in the Swedish criminal justice system. Drug 
and Alcohol Dependence, 94, 48-55. 
Abstract: Background: Overdose (OD) is a common cause of death in opioid users. 
Also, many current opioid users report a history of non-fatal OD. The present study 
aimed to identify factors associated with a history of non-fatal OD. Methods: A 
sample of 7085 Swedish criminal justice clients with alcohol or drug misuse was 
assessed, using the Addiction Severity Index. Subjects reporting use of opioids 
during the 30 days prior to incarceration were included (n = 1113). Relevant 
variables of misuse pattern, heredity, psychiatric symptoms and previous criminal 
charges were analysed in a logistic regression model. Results: A history of non-fatal 
OD was reported by 55% (n = 604). The estimated contribution to the variance in 
OD history was 25% for variables describing misuse pattern, compared to 10% for 
psychiatric symptoms, 8% for heredity, and 8% for previous criminal charges. The 
final model included the following variables: history of injection drug use (OR 3.28), 
history of heroin use (OR 2.87), history of suicide attempt (OR 1.92), history of 
tranquilliser use (OR 1.91), being born in Sweden or other Nordic countries (OR 
1.74), difficulty in controlling violent behaviour (OR 1.68), and paternal alcohol 
problems (OR 1.57). Conclusions: Suicide attempts and difficulty in controlling 
violent behaviour were associated with history of non-fatal OD, independent of 
variables of misuse pattern. This may indicate a possible association with impulse 
control disturbances, and may have clinical applications. Country of birth and 
heredity of alcohol problems also had some influence. As expected, severity of 
misuse most strongly contributed to history of non-fatal OD. 
 
Hiller, M. L., Knight, K., Broome, K. M., & Simpson, D. D. (1996). Compulsory community-
based substance abuse treatment and the mentally ill criminal offender. Prison 
Journal, 76(2), 180-192.  
Abstract: An analysis of the relationship between mental health status and 18-
month follow-up rearrest data of 191 probationers remanded to 4 months of 
treatment at a corrections-operated community-based residential substance abuse 
program was conducted. The results indicate an association between 
psychopathology and personality diagnoses with rearrest after discharge from 
treatment. Diagnoses of drug dependence and dysthymia are significant risk factors 
for rearrest of probationers after treatment. 
URL: http://find.galegroup.com/itx/infomark.do?&contentSet=IAC-
Documents&type=retrieve&tabID=T002&prodId=EAIM&docId=A18580482&source=
gale&srcprod=EAIM&userGroupName=unsw&version=1.0  
 
Johnson, H. (2006). Concurrent drug and alcohol dependency and mental health problems 
among incarcerated women. Australian and New Zealand Journal of Criminology, 39, 
190-217.  
Abstract: Research suggests that the determinants and pathways of substance use 
and mental health problems differ for women and men in important ways and 
therefore women's experiences merit special attention. The 2003 Drug Use Careers 
of Offenders female study is used in this article to examine the prevalence, patterns 
and predictors of drug and alcohol dependency and mental health problems among 
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incarcerated women. Over half of the women in this study had concurrent substance 
dependencies and mental health problems in the six months prior to arrest. Factors 
associated with having mental health problems include past experiences of sexual 
and emotional abuse, prescription drug use, drug dependency, and concurrent drug 
and alcohol dependency. Drug dependency was associated with involvement in crime 
or sex work to earn a living, early exposure to drug problems in the family of origin, 
use of prescription drugs, previous adult prison, and mental health problems. Alcohol 
dependency was associated with Indigenous status and physical abuse. The results 
of this study can contribute to treatment planning for women offenders. The finding 
that repeated admissions to prison is a predictor of drug dependency suggests that 
identification and treatment of drug problems is frequently absent, ineffective or not 
suited to the particular needs of women. (Abstract.). 
URL: http://info.library.unsw.edu.au/cgi-bin/local/access/ej-
access.cgi?url=http://www.atypon-link.com/AAP/doi/pdf/10.1375/acri.39.2.190 
 
Johnson, H. (2006). Drug use by incarcerated women offenders. Drug and Alcohol Review, 
25(5), 433 - 437.  
Abstract: The Drug Use Careers of Offenders (DUCO) project, conducted by the 
Australian Institute of Criminology, aims to contribute empirical evidence about the 
interaction between drug use and criminal offending. A total of 470 women 
incarcerated in six jurisdictions in Australia were interviewed for the female 
component of the DUCO project. This study examines illegal drug use prior to arrest 
and the correlates of drug use among these incarcerated women. Regular use of 
illegal drugs in the 6 months prior to arrest was reported by 62% of offenders and 
39% reported multiple drug use. Indigenous women reported higher rates of 
cannabis use while non-Indigenous women had higher rates of heroin, 
amphetamines and benzodiazepines as well as multiple drug use. Multivariate 
analysis identified the following statistically significant predictors of regular drug use 
prior to arrest: age, marital status, not having children, early exposure to drug 
problems among family members, violent victimisation as an adult, earning an 
income primarily from crime or sex work and using amphetamines, benzodiazepines 
or morphine on prescription. Additional factors predicting multiple drug use were low 
education, non-Indigenous status, having mental health problems and having been 
in juvenile detention. These results suggest that drug treatment that fails to identify 
and respond to some of the antecedents of drug use such as mental health problems 
and the effects of violent victimisation may result in higher rates of drug use relapse 
and lower success upon release from prison. <i>[Johnson H. Drug use by 
incarcerated women offenders</i>. Drug Alcohol Rev 
<i>2006;25:433&nbsp;&ndash;&nbsp;437]</i>. 
URL: http://www.informaworld.com/10.1080/09595230600876598 
 
Kevin, M. (1994). Women in prison with drug related problems : part 1 : background 
characteristics. Sydney: NSW Department of Corrective Services. 
Abstract: This report represents the first of a two part series which examines the 
patterns of drug use of imprisoned women, their treatment needs and the 
effectiveness of the Drug and Alcohol Services in reaching those women with drug 
and alcohol problems. The findings in this booklet relate to the drug related 
background characteristics of the women interviewed. Also included are other 
background characteristics which literature in the field has identified as being 
potentially relevant when addressing the treatment needs of women with drug 
problems. 
URL:http://www.dcs.nsw.gov.au/information/research_and_statistics/research_publi
cation/rp032.pdf 
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Kevin, M. (1994). Women in prison with drug related problems : part 2 : contact with 
treatment services. Sydney: NSW Department of Corrective Services. 
Abstract: This report represents the second of a two part series which examines the 
patterns of drug use of imprisoned women, their treatment needs and the 
effectiveness of the Drug and Alcohol Service in reaching those women with drug and 
alcohol problems. It investigates whether women with drug related problems 
experience barriers to accessing treatment. It examines the prevalence of sanctioned 
prescription drug use, including methadone by women in prison and assesses the 
treatment needs of women with drug related problems in prison. 
URL:http://www.dcs.nsw.gov.au/information/research_and_statistics/research_publi
cation/rp033.pdf 
 
Kevin, M. (2003). Addressing the Use of Drugs in Prison: prevalence, nature and context. 
Sydney: NSW Department of Corrective Services. 
 
Kevin, M. (2005). Addressing prisoner drug use : prevalence, nature and context : 3rd 
collection of a biennial survey of prisoners in New South Wales. Sydney: NSW 
Department of Corrective Services. 
Abstract: Drug misuse is one of the key criminogenic factors that affects both the 
general community and the prison community. This is the third data collection in a 
biennial series designed to obtain information on the actual drug use behaviour of 
inmates both prior to and during imprisonment and the social context in which 
prison-based drug use takes place. The extent and severity of drug-related problems 
among inmate populations presents significant challenges to correctional 
administrators. Inmates presenting with drug problems are among the most difficult 
to care for and manage. The aim of the research was to obtain data on the patterns 
of drug use of inmates prior to and while serving a custodial sentence. It further 
sought to provide a safer understanding of the social context of drug use in the New 
South Wales correctional system. The sample survey consisted of 307 (265 males 
and 42 females) full-time inmates serving a sentence of at least one month who 
were shortly to be released to the community. The current findings suggest an 
encouraging trend in the rate of drug-related offending and drug-related morbidity in 
the NSW inmate population. Even though this trend is positive, the levels of drug-
related morbidity remain sufficiently high to maintain this as a priority area. The 
findings from this data collection series provide factual data to improve policy and 
strategy for this high need and high risk population. It also provides a valuable 
insight into prison life that can be used in the development of further effective 
management and rehabilitation programs. (Preface, Executive summary, 
Introduction, edited.). 
URL:http://www.dcs.nsw.gov.au/information/research_and_statistics/research_publi
cation/rp047.pdf  
 
Kjelsberg, E., & Hartvig, P. (2005). Too much or too little? Prescription drug use in a 
nationwide prison population. International Journal of Prisoner Health, 1(1), 75 - 87.  
Abstract: Aim: To describe prescription drug use in a nationwide prison population 
and compare it with contemporary drug use in other relevant populations as well as 
in a prison population 25 years ago. Detailed medication sheets from 37 prisons, 
covering 90% of the Norwegian prison population, were collected. All drugs were 
transcribed into the Anatomical Therapeutic Chemical classification system, and 
Defined Daily Doses/100 inmates were calculated. Data enabling relevant 
comparisons were gathered from reliable sources. Among the 2,617 inmates 
investigated, 48% used no medication. Sixteen percent used both psychotropic and 
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somatic drugs, 17% psychotropic drugs only, and 19% somatic drugs only. Strong 
correlations between drug use and gender, age, and prison characteristics were 
demonstrated. Psychotropic drug use was higher than in the general population but 
lower than in a psychiatric hospital unit. Somatic drug use was lower than in the 
general population, except non-steroid anti-inflammatory agents, antihistamines, 
and drugs to alleviate obstructive airway diseases. Psychotropic drug use, 
particularly antidepressant use, was higher than in prisons 25 years ago. High levels 
of use of all psychotropic and a number of somatic drugs were demonstrated in this 
nationwide prison population. Treatment studies are needed in order to ascertain 
whether the high levels of use of particularly psychotropic medications are indeed 
improving the mental health of prisoners. 
URL: http://www.informaworld.com/10.1080/17449200500156871  
 
Niveau, G. & Ritter, C. (2008). Route of administration of illicit drugs among remand prison 
entrants. European Addiction Research, 14(2), 92-99. 
 Abstract: Aims: To describe the self-reported routes of administration of illicit drugs 
among subjects entering a remand prison and the different drugs used by this 
population. Methods: A cross-sectional study, with a sample of 770 subjects, was 
conducted in Geneva (Switzerland). Participants were assessed with the semi-
structured interview from the Council of Europe Pompidou Group multi-city study. 
Results: 428 (55.6%) subjects admitted to having used illicit drugs during the 3 
months prior to entry. Amongst these illicit drug users, 54.7% took several drugs. 
Injectable drugs (heroin, cocaine or illicit benzodiazepines) were taken by 75.7% of 
drug users but the majority (84.1%) declared that they had not injected drugs 
during the 3 months prior to entering prison. 68 subjects (8.8% of the total sample) 
declared that they had injected drugs during the 3 months prior to entering prison, 
either alone or in association with other methods. Conclusion: By extrapolation it is 
possible to suggest that about 200 intravenous drug users entered the remand 
prison in Geneva in 1 year. This confirms the need for prison health services to 
implement a policy of treatment, prevention and education adapted to patterns of 
drug use in the local context. 
 URL: 
http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&ArtikelNr=11
3723&Ausgabe=234546&ProduktNr=224233&filename=113723.pdf 
 
Norden, P. (2004). Prison is not a healthy place. Paper presented at the Anex Harm 
Reduction Conference. 
Abstract: During the last decade, there has been a 50% expansion of the Australian 
prison population. This conference paper claims that much of this dramatic increase 
can be explained by the relationship between untreated mental health needs, 
subsequent illegal use of drugs as a form of self-medication, and the eventual 
intervention by instrumentalities of the criminal justice system. The author argues 
that the high proportion of the Victorian prison population who have been or continue 
to be injecting drug users and the high rate of Hepatitis C virus infection is one of the 
clearest indications that the criminal justice system is extending its boundaries. 
URL:http://www.jss.org.au/news/documents/AnexConferencePresentationPaperJuly2
004.doc  
 
Pereira, M. (1998). Medication of prisoners. Inside Out, 37, 11-13. 
Abstract: The excessive prescription of psychotropic drugs or anti-depressants for 
inmates is examined. A survey of male and female inmates at Adelaide Women's 
Prison and Yatala Labour Prison found that these drugs are regularly prescribed to 
help women cope with familial separation anxiety and to help both men and women 
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deal with various drug withdrawal. 
 
Peters, R. H., Strozier, A. L., Murrin, M. R., & Kearns, W. D. (1997). Treatment of 
substance-abusing jail inmates Examination of gender differences. Journal of 
Substance Abuse Treatment, 14(4), 339-349.  
Abstract: Females incarcerated for drug-related offenses represent one of the 
fastest growing populations within jails and prisons. The few studies of female 
offenders with substance abuse disorders depict a population with multiple 
psychosocial problems and treatment needs, and one that is characterized by 
frequent exposure to sexual abuse and other violence. The current study examined 
intake assessment results from a sample of 1,655 substance-involved jail inmates 
referred to a jail treatment program in Tampa, Florida, including 26% female and 
74% male inmates. The study was designed to identify gender differences in 
psychosocial characteristics and substance abuse treatment needs among jail 
inmates. Results indicate that female inmates more frequently experienced 
employment problems, had lower incomes, more frequently reported cocaine as the 
primary drug of choice, and were more likely to report depression, anxiety, suicidal 
behavior, and a history of physical and sexual abuse. Implications for developing 
specialized treatment approaches for female offenders are discussed, including use of 
integrated treatment strategies. 
URL: http://www.sciencedirect.com/science/article/B6T90-3RM0204-
4/2/a5d0d3aa7f61e23c04d4846a55f0c568 
  
Rounds-Bryant, J. L., Motivans, M. A., & Pelissier, B. M. M. (2004). Correlates of drug 
treatment outcomes for African American and white male federal prisoners: Results 
from the TRIAD study. The American Journal of Drug and Alcohol Abuse, 30(3), 495 
- 514.  
Abstract: The purpose of this study was to compare the effects of family 
background and preincarceration socioenvironmental variables on three-year post-
release drug use for African American and white prison-based drug treatment 
participants in order to explain the previously found disparities in rates of three-year 
post-release drug use between the two groups. There were two hypotheses: 1) for 
both groups, family background and preincarceration socioenvironmental variables 
would predict post-release drug use more strongly than sociodemographic 
characteristics and preincarceration behaviors, and 2) the predictors would be 
different for each group. The sample included 279 African American and 512 white 
male treatment participants who were supervised by a U.S. probation officer 
following incarceration. Event history analyses were used to model time to first drug 
use during post-release supervision. The results indicated that none of the family 
background factors or socioenvironmental variables predicted post-release drug use. 
The variables predictive of drug use for one or both racial groups were limited to 
sociodemographic characteristics and preincarceration behaviors such as age at 
release, prior commitments, and preincarceration employment. Yet, there were no 
significant between-group differences for these predictors. The authors concluded 
that future assessment of the effects of socioenvironmental variables on post-release 
drug use likely requires evaluation of the post-release social environment at the time 
of release. 
URL: http://www.informaworld.com/10.1081/ADA-200032265 
  
Simpson, M., & McNulty, J. (2008). Different needs: Women's drug use and treatment in the 
UK. International Journal of Drug Policy, 19(2), 169-176. 
Abstract: The experiences of female drug users are often very different from that of 
their male counterparts. Female, and especially pregnant, drug users suffer greater 
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social stigma than men, and often suffer a greater severity of addiction with physical 
and psychological reactions. This paper explores how women's experience of drug 
use differs from men, and the implication that this has for delivering drug treatment 
and drug services in the UK, including in the prison setting. It is argued that drug 
services in the UK need to be better tailored to meet the specific needs of women. 
 URL: http://info.library.unsw.edu.au/cgi-bin/local/access/ej-
access.cgi?url=http://dx.doi.org/10.1016/j.drugpo.2007.11.021?nosfx=y 
 
Strang, J., Gossop, M., Heuston, J., Green, J., Whiteley, C., & Maden, A. (2006). Persistence 
of drug use during imprisonment: relationship of drug type, recency of use and 
severity of dependence to use of heroin, cocaine and amphetamine in prison. 
Addiction, 101(8), 1125-1132.  
Abstract: Aim To investigate the persistence of use of heroin, cocaine and 
amphetamine drugs during imprisonment, and to identify factors associated with 
increased levels of persistence. Design The use of heroin, cocaine and amphetamine 
by current prison inmates has been examined and, in particular, the relationship 
between drug use within prison and the type of drug used prior to imprisonment, 
recency of use and severity of dependence. Setting and participants A randomly 
selected sample of 1009 adult male prisoners in 13 prisons in England and Wales 
during 1994/95; structured confidential interviews conducted by independent 
research staff. Enquiry about prior use of heroin, cocaine or amphetamine focused on 
three time-periods (ever, last year and last month pre-prison) and the use of these 
drugs during the first month of imprisonment. Findings A total of 557 (55%) of the 
1009 prisoners had used previously one of the three drugs selected for study: 58% 
had used heroin, 69% cocaine and 75% amphetamine. More than half (59%; 
327/557) had used these drugs in the month before the current imprisonment. Drug 
use in prisons was most likely to occur among those who had used in the month 
prior to imprisonment. The persistence of heroin use in prison occurred more 
frequently (70%) than use of cocaine (20%) or amphetamine (15%). Of those using 
heroin pre-imprisonment, 67% considered they were dependent, compared to 15% 
and 22%, respectively, for cocaine and amphetamine users. Conclusions Changes in 
the drug-taking behaviour of drug users after imprisonment vary according to the 
type of drug being taken. Prisoners were much more likely to continue to use heroin 
than either cocaine or amphetamines while in prison. Heroin was most likely to be 
used by those who had been using heroin during the immediate pre-imprisonment 
period, and particularly by the two-thirds of heroin users who considered themselves 
dependent. In view of the high prevalence of prior use of these drugs by individuals 
currently imprisoned, continuing attention is required to study of their behaviour and 
of the impact of interventions that may be introduced during or following their 
incarceration. 
URL: http://www.blackwell-synergy.com/doi/abs/10.1111/j.1360-
0443.2006.01475.x 
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There is a very large literature on risk behaviours in prisons (mainly HIV and Hepatitis). This 
section covers papers on risk behaviours, harm reduction and interventions for blood borne 
viruses. See also NSP listings. The first resource is an annotated bibliography on-line; 
followed by the WHO guidelines (remaining references are listed alphabetically). 
 
Jurgens, R. (2005). HIV/AIDS and HCV in Prisons: A Select Annotated Bibliography. 
[Electronic Version]. Retrieved 15th Feb 2008  
URL: http://www.hc-sc.gc.ca/ahc-asc/pubs/int-aids-sida/hiv-vih-aids-sida-prison-
carceral-7_e.html 
 
World Health Organisation. (1992). WHO Guidelines on HIV Infection and AIDS in Prisons. 
Geneva: World Health Organisation. 
URL: http://data.unaids.org/Publications/IRC-pub01/JC277-WHO-Guidel-
Prisons_en.pdf 
 
Banaszczyk, Brown, Falconer, Harvey, Hearne, Kaldor, et al. (1999). HIV prevalence at 
reception into Australian prisons, 1991-1997. Medical Journal of Australia, 171, 18-
21.  
Abstract: The extent and outcome of HIV antibody testing for prison entrants is 
measured. High rates of HIV antibody testing and low prevalence of HIV infection 
were assessed among people entering Australian prisons. HIV prevalence among 
prison entrants is low but the high incidence of Hepatitis C infection suggests 
continuing risk of HIV infection for prison inmates. 
 
Batey, R. G., Jones, T., & McAllister, C. (2008). Prisons and HCV: a review and a report on 
an experience in New South Wales Australia. International Journal of Prisoner Health, 
4(3), 156-163.  
Abstract: Prison populations in Western countries are characterised by a high 
hepatitis C prevalence. This reflects a high rate of imprisonment for drug related 
offences. Prison entrants who are HCV-negative face a significant risk of acquiring 
hepatitis C. Effective prevention strategies and successful treatment of a significant 
percentage of hepatitis C-positive inmates could reduce the risk of transmission in 
the prison context significantly. Several reports of treating hepatitis C in prisoners in 
major facilities have been published. We report our experience of establishing a liver 
clinic service in two regional prisons in New South Wales, Australia. Liver biopsy 
requirements to access treatment in Australia meant that only 46 of 196 reviewed 
patients were able to commence treatment in our 5-year experience. Treatment 
completion rate was 61% and end of treatment viral response was 57%. The 
removal of liver biopsy requirements in Australia in April 2006 has freed up access to 
treatment and our results encourage further effort to optimise the process of 
assessment and treatment in this high-risk population. 
URL: http://www.informaworld.com/10.1080/17449200802264712 
 
Bird, A. G., Gore, S. M., Hutchinson, S. J., Lewis, S. C., Cameron, S., & Burns, S. (1997). 
Harm reduction measures and injecting inside prison versus mandatory drugs 
testing: results of a cross sectional anonymous questionnaire survey. British Medical 
Journal, 315(7099), 21-24.  
Abstract: Objectives: (a) To determine both the frequency of injecting inside prison 
and use of sterilising tablets to clean needles in the previous four weeks; (b) to 
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assess the efficiency of random mandatory drugs testing at detecting prisoners who 
inject heroin inside prison; (c) to determine the percentage of prisoners who had 
been offered vaccination against hepatitis B. Design: Cross sectional willing 
anonymous salivary HIV surveillance linked to a self completion risk factor 
questionnaire. Setting: Lowmoss prison, Glasgow, and Aberdeen prison on 11 and 30 
October 1996. Subjects: 293 (94%) of all 312 inmates at Lowmoss and 146 (93%) 
of all 157 at Aberdeen, resulting in 286 and 143 valid questionnaires. Main outcome 
measures: Frequency of injecting inside prison in the previous four weeks by injector 
inmates who had been in prison for at least four weeks. Results: 116 (41%) 
Lowmoss and 53 (37%) Aberdeen prisoners had a history of injecting drug use but 
only 4% of inmates (17/395; 95% confidence interval 2% to 6%) had ever been 
offered vaccination against hepatitis B. 42 Lowmoss prisoners (estimated 207 
injections and 258 uses of sterilising tablets) and 31 Aberdeen prisoners (229 
injections, 221 uses) had injected inside prison in the previous four weeks. The 
prisons together held 112 injector inmates who had been in prison for more than 
four weeks, of whom 57 (51%; 42% to 60%) had injected in prison in the past four 
weeks; their estimated mean number of injections was 6.0 (SD 5.7). Prisoners 
injecting heroin six times in four weeks will test positive in random mandatory drugs 
testing on at most 18 days out of 28. Conclusions: Sterilising tablets and hepatitis B 
vaccination should be offered to all prisoners. Random mandatory drugs testing 
seriously underestimates injector inmates' harm reduction needs. Key messages Half 
of injector inmates of two Scottish prisons who had been in prison for more than four 
weeks had injected in the previous four weeks--an average of six times Injector 
inmates used sterilising tablets to clean injecting equipment as often as they injected 
Only 4% of inmates had ever been offered vaccination against hepatitis B 
Vaccination against hepatitis B and sterilising tablets are prisoners' rights Random 
mandatory drugs testing is likely to detect only one third to two thirds of heroin 
injectors in prison and so seriously underestimates injector inmates' drug reduction 
needs. 
URL: http://www.bmj.com/cgi/content/Abstract/315/7099/21 
  
Bloom, G. (1995). The community policy: prisons and blood borne communicable diseases. 
HIV/AIDS Legal Link, 6, 14-15. 
Abstract: The AIDS Council of NSW, the Gender Centre, the NSW Users and AIDS 
Association, and the Prisoners Action Group in New South Wales have joined forces 
to produce a policy on the prevention and treatment of blood borne diseases such as 
HIV and hepatitis in the prison system. The policy, called 'Prisons and blood borne 
communicable diseases - the community policy' is unique in reflecting the interests 
of a wide range of community based organisations which recognise the threat posed 
by such diseases to their constituencies. The policy covers legal reform, access to 
means of prevention, testing, access to treatments, positive prisoners and 
transgender prisoners. Its authors believe the climate for its implementation is 
favourable. 
 
Butler, T., Boonwaat, L., & Hailstone, S. (2005). National prison entrants' bloodborne virus 
survey report, 2004: prevalence of HIV, hepatitis C, hepatitis B, and risk behaviours 
among Australian prison entrants. Sydney: Centre for Health Research in Criminal 
Justice. 
Abstract: Prisoner populations are noted for engaging in high-risk behaviours, 
particularly injecting drug use, in both the community and prison setting. 
Consequently they are at an increased risk of exposure to bloodborne viruses such 
as Hepatitis B and C and HIV. Studies have also shown that the correctional 
environment is a high risk environment for bloodborne virus transmission. This study 
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is the first nationally coordinated survey of prisoners conducted in Australia, and 
included 612 of the 739 individuals entering prison from the community over a two 
week period in May 2004, in New South Wales, Queensland, Tasmania and Western 
Australia. Confidential questionnaires and serology requests were completed using a 
unique code for each inmate. The community Needle and Syringe Programs survey 
questionnaire was modified slightly for the correctional setting, and collected risk 
factor information on body piercing, tattooing, injecting drug use, sexual activity, 
and immunisation status. The results are comprehensively detailed. This survey 
demonstrates that further research into injecting drug use in prisons is required. 
Such data would allow custodial authorities to make informed decisions about the 
need for greater enforcement or better harm minimisation provisions in the custodial 
setting. 
URL: http://www.justicehealth.nsw.gov.au/pubs/bbv_survey.pdf 
  
Butler, T., Boonwaat, L., Hailstone, S., Falconer, T., Lems, P., Ginley, T., et al. (2007). The 
2004 Australian prison entrants' blood-borne virus and risk behaviour survey. 
Australian and New Zealand Journal of Public Health, 31, 44-50.  
Abstract: The objective of this study was to assess the prevalence of blood-borne 
viruses and associated risk factors among prison entrants at seven Australian prisons 
across four states. The survey was of a consecutive cross-sectional design, with 
voluntary confidential testing of all prison entrants for serological markers of human 
immunodeficiency virus (HIV), hepatitis C (HCV) and hepatitis B (HBV) over 14 
consecutive days in May 2004. Demographic data and data related to risks for blood-
borne virus transmission, such as sexual activity, body piercing, tattooing, and 
injecting drug use, were collected. The National prevalence for HIV was 1%, hepatitis 
B core antibody 20%, and hepatitis C antibody 34%. Fifty-nine per cent of 
participants had a history of injecting drug use. Among injecting drug users, the 
prevalence of HIV was 1%, hepatitis C antibody 56%, and hepatitis B core antibody 
27%. Forty-one per cent of those screened reported a previous incarceration. In the 
multivariate model, Queensland and Western Australian prison entrants were 
significantly less likely to test positive to HCV than those in New South Wales. 
Amphetamine was the most commonly injected drug in Queensland, Tasmania and 
WA. In NSW, heroin was the most common drug injected. In the multivariate 
analysis a history of injecting drug use, being aged 30 years or more, and a prior 
incarceration were positively associated with hepatitis C infection. For hepatitis B 
core antibody, age over 30 years and a history of injecting drug use were associated 
with an increased risk. The findings support the view that prisoner populations are 
vulnerable to blood-borne virus infection, particularly hepatitis B and C. Prisoner 
populations should be included in routine surveillance programs so as to provide a 
more representative picture of blood-borne virus epidemiology in Australia. 
URL: http://www.blackwell-synergy.com/doi/pdf/10.1111/j.1753-
6405.2007.00009.x 
 
Crofts, N., Cooper, G., Stewart, T., Kiely, P., Coghlan, P., Hearne, P., et al. (1997). 
Exposure to hepatitis A virus among blood donors, injecting drug users and prison 
entrants in Victoria. Journal of Viral Hepatitis, 4(5), 333-338.  
Abstract: To assess prevalence of exposure to hepatitis A virus (HAV) among 
injecting drug users (IDUs) and prison entrants in Victoria, and to compare this with 
prevalence of HAV among a reference population of blood donors, sera stored from 
two previous studies and from randomly selected blood donors were tested for total 
antibody to HAV. The first study was a longitudinal study of field-recruited IDUs from 
1990 to 1992 and the second was a study of all prison entrants in 1991–92 (both 
studies were carried out in Victoria); blood donors were from the Australian Red 
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Cross Blood Bank Victoria in 1995. Forty five per cent of 2175 prison entrants and 
51% of 293 IDUs were seropositive for HAV, compared with 30% of 2995 blood 
donors. When standardized for age against the blood donors, HAV seropositivity in 
IDUs was 44% and in prison entrants 60%. The strongest association of HAV 
seropositivity among the IDUs on multivariate analysis was a history of 
imprisonment. There are high rates of exposure to HAV among prison entrants, 
whether with a history of IDU or not, and among IDUs who have a prison history. 
The role of sharing contaminated injecting equipment in transmission of HAV seems 
to be less important than institutionalization per se. With adequate resourcing, both 
populations are appropriate targets for HAV vaccination, especially in a context of 
continuing decline of transmission of HAV in the general community. 
URL: http://www.blackwell-synergy.com/doi/abs/10.1046/j.1365-
2893.1997.00059.x 
  
Crofts, N., Dolan, K. A., & Webb-Pullman, J. (1996). An analysis of trends over time in 
social and behavioural factors related to the transmission of HIV among injecting 
drug users and prison inmates: evaluation of the National HIV/AIDS Strategy 1993-
94 to 1995-96. Canberra: Australian Government Publishing Service. 
Abstract: This review summarises research into risk taking behaviours for HIV 
infection among injecting drug users and prison inmates in Australia from 1985 to 
1994. The data presented are concerned with injecting drug use, cleaning and 
sharing of needles and syringes, use of bleach when cleaning needles and syringes, 
and tattooing among prisoners. 
 
Crofts, N., Hernberger, F., Thompson, S., & Wale, E. (1996). Risk behaviours for blood-
borne viruses in a Victorian prison. Australian and New Zealand Journal of 
Criminology, 29, 20-28.  
Abstract: The authors present the findings of a study of injecting drug use and 
tattooing practices in Pentridge Prison, Victoria, and the implications for the spread 
of blood-borne viruses, including hepatitis B and C, and HIV. They conclude that the 
risks of spreading infectious viruses is high. Urgent consideration of methods to 
decrease these risks is necessary, including assessment of the feasibility of 
controversial strategies such as needle and syringe exchange programs, and the 
provision of sterile tattooing equipment. 
 
del Castillo, L. S., Ruiz-Perez, I., de Labry-Lima, A.O., Soto-Blanco, J.M., Girela-Lopez, E., 
et al. (2008). Influence of antiretroviral treatment on quality of life in seropositive 
inmates. International Journal of STD & AIDS, 19(3), 172-177. 
 Abstract: The aim of the study is to evaluate the influence of antiretroviral 
treatment on health-related quality of life (HRQOL) of three groups of HIV-positive 
inmates: those who are taking antiretroviral treatment, those who are not on 
treatment as it has not yet been indicated, and those who refuse to take treatment 
even though it has been recommended. A cross-sectional study was conducted on 
585 HIV+ inmates in three prisons. The response variable was HRQOL. Independent 
variables were: sociodemographic variables, psychosocial and drug-related variables. 
Two multivariate linear regression models were constructed in order to determine the 
HRQOL, physical health score (PHS) and mental health score (MHS), for each of the 
three groups identified, using patients who refused treatment as the reference 
category. Patients who refused therapy had a lower MHS compared with patients in 
whom treatment was not indicated (P = 0.038). With regard to PHS, patients 
refusing therapy had a lower score than patients who were not indicated therapy (P 
= 0.005), and than patients receiving therapy (P = 0.010). 
URL: http://ijsa.rsmjournals.com/cgi/content/abstract/19/3/172 
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Dolan, K., & Larney, S. (2006). HIV in prison in Asia and the Pacific. Development Bulletin, 
69, 72-74.  
Abstract: Elevated levels of HIV infection and the over-representation of injecting 
drug users (IDUs) in prisons combined with HIV risk behaviour, create a crucial 
public health issue for prisons and the surrounding communities. Most research on 
these topics has occurred in developed countries; therefore the extent of the 
problem in Asia and the Pacific regions is largely unknown. This paper reviews data 
on imprisonment rates, the proportion of IDUs, and the prevalence and incidence of 
HIV in prison in Asia and the Pacific. It appears to be the first attempt to collate 
information for this area. 
 
Dolan, K., Wodak, A., & Hall, W. (1999). HIV risk behaviour and prevention in prison: a 
bleach programme for inmates in NSW. Drug and Alcohol Review, 18(2), 139 - 143.  
Abstract: One hundred and eighty-one inmates in AIDS education courses were 
surveyed about their risk behaviour and access to disinfectants for syringe cleaning 
in 1993. Overall, 40% of respondents reported HIV risk behaviour in prison. One-
quarter of respondents reported injecting, of whom three-quarters reported sharing 
syringes in prison. Most respondents who shared syringes reported cleaning them 
with disinfectants (96%), even though only one-third reported having easy access to 
disinfectants. One-sixth of respondents reported sharing tattooing equipment, of 
whom two-thirds reported using a disinfectant to clean the tattoo needle. Few 
respondents reported fellatio (8%) or anal intercourse (4%) in prison. Although 
some respondents faced difficulty in obtaining disinfectants, almost all respondents 
cleaned syringes with bleach when sharing. High levels of risk behaviour in prison 
might be reduced by methadone maintenance and condom programmes. A trial of 
strict one-for-one syringe exchange warrants consideration. 
URL: http://www.informaworld.com/10.1080/09595239996563 
  
Dolan, K. A. (1994). Monitoring HIV infection and risk behaviour among ex-prisoners in 
NSW. Paper presented at the National Drug and Alcohol Research Centre Annual 
Symposium. 
Abstract: An overview of HIV infection and transmission in prisons around the world 
and in Australia is presented. Dolan then describes a study in which ex-prisoners in 
NSW with a history of injecting drug use were interviewed. The study examines risk 
behaviours such as injecting, syringe sharing and sexual activity of drug injectors 
when they are in and out of prison. Dolan concludes by making recommendations to 
prevent the spread of HIV within the prison systems. 
URL:http://www.med.unsw.edu.au/NDARCWeb.nsf/resources/Mono_3/$file/Mono.21
.pdf 
 
Dolan, K. A. (1995). In and out of jail for the last ten years : risks behaviours and 
prevention in prison. Paper presented at the National Drug and Alcohol Research 
Centre Annual Symposium. 
Abstract: It has been suggested that incarcerating drug users is not an effective 
strategy. Now, more than ever, the repetitive incarceration of IDUs is a major 
concern with respect to HIV, hepatitis B and C. This paper examines the relevance of 
the National Drug Strategy to prisoners; studies risk behaviours; and considers HIV 
prevention in the prison setting and evidence of the effectiveness of such measures. 
Dolan suggests research priorities and recommends policy changes. 
URL:http://www.med.unsw.edu.au/NDARCWeb.nsf/resources/Mono_3/$file/Mono.27
.pdf 
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Dolan, K. A. (1996). HIV prevalence and transmission in prisons. Paper presented at the 
National Drug and Alcohol Research Centre Annual Symposium. 
Abstract: This paper examines HIV transmission in prisons and draws on evidence 
from community settings for comparison. While considerable research into HIV has 
been undertaken in community settings, very limited research has been undertaken 
into HIV risk behaviour and transmission in prison resulting in little progress in the 
prevention of HIV transmission among prisoners. This situation has serious health 
consequences for people who inject drugs because they are the group most at risk of 
imprisonment and then of infection while in prison. 
 
Dolan, K. A. (1997). AIDS, drugs and risk behaviour in prison : state of the art. 
International Journal of Drug Policy, 8, 5-17.  
Abstract: After considering the characteristics of prisoners and ethics of prison 
research, this article reviews the literature on the prevalence of HIV infection among 
prisoners; the proportion of prisoners who are drug injectors; and the risk 
behaviours in which prisoners engage such as drug injecting, tattooing and sexual 
activity. In order to improve understanding of the likelihood of HIV infection in 
prison, the evidence of HIV transmission in prison is also reviewed and the notion of 
mixing, or the extent of intermingling of inmates that is integral to prison systems, is 
considered. Dolan believes conditions in prison systems hinder detection of HIV 
transmission, and that efforts to prevent wider infection must include prisons. 
 
Dolan, K. A., Hall, W. D., & Wodak, A. D. (1994). Bleach availability and risk behaviours in 
prison in New South Wales. Sydney: National Drug and Alcohol Research Centre. 
Abstract: The aim of this study is to monitor the access of New South Wales 
prisoners to disinfectants for syringe decontamination and to investigate the 
prevalence of injecting drug use, syringe sharing, tattooing and sexual activity in 
prison. The findings indicate there are major deficiencies in existing measures to 
prevent the spread of HIV in prison. The authors offer a number of recommendations 
to reduce the problems. 
URL:http://notes.med.unsw.edu.au/NDARCWeb.nsf/resources/TR_27/$file/TR.022.p
df 
 
Dolan, K. A., & Wodak, A. D. (1999). HIV transmission in a prison system in an Australian 
State. Medical Journal of Australia, 171, 14-17.  
Abstract: In this study, interviews were conducted with 13 ex-prisoners who 
claimed to have been infected with HIV in prison. This and other data was assessed, 
with the conclusion that despite the difficulties with confirming HIV transmission in 
prison, of the group studied, there was a high probability that four acquired their HIV 
infection from shared injection equipment in prison. The conclusion is that HIV 
prevention strategies such as methadone maintenance treatment and syringe 
exchange schemes should be considered, in the interests of prisoner health. 
URL: https://www.mja.com.au/public/issues/171_1_050799/dolan/dolan.html 
 
Dolan, K. A., Wodak, A. D., & Hall, W. D. (1998). A bleach program for inmates in NSW: An 
HIV prevention strategy. Australian and New Zealand Journal of Public Health, 22(7), 
838-840.  
Abstract: Syringe cleaning guidelines for injecting drug users were revised in 1993. 
A study examines efforts by IDUs in New South Wales prisons to adopt the revised 
guidelines in 1994. Consecutive inmates (229) nearing release were visited and 
asked to call a toll free number for an interview once released. Respondents (102) 
did not differ from non-respondents (127). Many respondents (64%) reported ever 
injecting and many of these reported injecting (58%), sharing (48%) and syringe 
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cleaning (46%) when last in prison. A new methodology for prison research was 
found to be feasible in this study. 
URL:http://proquest.umi.com/pqdweb?did=40003946&Fmt=7&clientId=25620&RQT
=309&VName=PQD  
 
Douglas, R. M. (1991). AIDS in Australian prisons : what are the challenges? Paper 
presented at the National Conference on HIV and AIDS in Prisons.  
Abstract: After giving some background information about the first national 
HIV/AIDS and Prisons Conference, Douglas describes the communiqué which was 
issued by the participants. The communiqué dealt with: the influence of HIV/AIDS in 
prisons on the wider community; the realities of prison life; prison sexuality; drug 
use in prison; education; detection and management of HIV positive prisoners; ex 
offenders; occupational health and safety; collection of epidemiological information; 
and the legal obligations of prison authorities. 
URL: http://www.aic.gov.au/publications/proceedings/04/index.html#douglas 
  
Douglas, R. M., Gaughwin, M. D., & Wodak, A. D. (1991). Behind bars : risk behaviours for 
HIV transmission in prisons, a review. Paper presented at the National Conference on 
HIV and AIDS in Prisons. 
Abstract: Gaughwin focuses on: how to determine the extent of risk behaviours in 
prisons; the behaviour of HIV infected prisoners; evidence for prison environments 
facilitating risk behaviour; and the possible future of HIV infection in prisons. The 
appendices contain a number of statistical summaries compiled from international 
research. 
URL: http://www.aic.gov.au/publications/proceedings/04/index.html#gaughwin 
  
Dwyer, J. (1991). Minimising the spread of the Human Immunodeficiency Virus within the 
Australian prison system. Paper presented at the National Conference on HIV and 
AIDS in Prisons.  
Abstract: Dwyer argues that education and counselling are key components in 
minimising the spread of AIDS in prisons. He also comments on: dealing with sexual 
activity; problems associated with intravenous drug use; compulsory blood testing 
for HIV antibodies; and advance planning for release from jail. 
URL: http://www.aic.gov.au/publications/proceedings/04/index.html#dwyer 
  
Gaughwin, M. D., Gold, J., Miller, M., Ross, M., Shaw, J. M., & Wodak, A. D. (1991). Behind 
bars : HIV risk-taking behaviour of Sydney male drug injectors while in prison. Paper 
presented at the National Conference on HIV and AIDS in Prison. 
URL: http://www.aic.gov.au/publications/proceedings/04/index.html#wodak 
  
Gaughwin, M. Gerull, S. & Norberry, J. (1991). HIV/AIDS and prisons : proceedings of a 
conference held 19-21 November 1990. Paper presented at the 1st National 
Conference on HIV/AIDS and Prisons, Canberra. 
Abstract: The first national Conference on HIV/AIDS and Prisons was organised by 
the Australian Institute of Criminology and the National Centre for Epidemiology and 
Population Health. It examined many issues deriving from the relationship between 
health care in the prison setting and the management of prisons. Topics covered 
included overseas management of AIDS in prisons; risk minimisation strategies 
including education, health services, testing and segregation; and the problems of 
special groups within the prison population. Individual papers are separately 
indexed. 
URL: http://www.aic.gov.au/publications/proceedings/04/index.html 
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Hamilton, P. (1991). Managing a therapeutic community : K Division, a case study. Paper 
presented at the National Conference on HIV and AIDS in Prison.  
Abstract: HIV seropositive prisoners are located in Unit 5 of K Division in Pentridge 
Prison. Hamilton describes the operations of K Division in some detail. He attributes 
the successful management of seropositive prisoners to the introduction of a unit 
management regime as well as to a reverse integration policy. 
URL: http://www.aic.gov.au/publications/proceedings/04/index.html#hamilton 
  
Heale, P. (2003). Survey of harms in Victorian prisons. Melbourne, Vic: Turning Point 
Alcohol and Drug Centre. 
Abstract: While there is an acknowledgement that risk behaviours for blood borne 
viruses occur in prison, there is limited understanding of such behaviours. The aim of 
this project, which was based on interviews with 133 prisoners in five Victorian 
prisons, was to conduct an assessment of the harm related activities undertaken by 
prisoners in the Victorian prison system. The report of the project includes a review 
of relevant national and international literature, and presents findings from the 
prisoner interviews on the following areas of interest: work practices; sport / 
recreation; tattooing; piercing; sharing personal hygiene equipment; injecting drug 
use; unprotected sexual practices; other blood contact, mainly through fighting and 
self harm; serostatus with respect to hepatitis C and HIV / AIDS; and risk reduction 
strategies implemented by participants, as well as what they thought the prison 
could do in order to minimise the risks. The report concludes by making a number or 
recommendations designed to promote better infection control in prisons. 
URL: http://server-au.imrworldwide.com/cgi-bin/b?cg=downloads&ci=vic-
justice&tu=http://www.justice.vic.gov.au/wps/wcm/connect/DOJ+Internet/resources
/file/eb4fa60fc29d09f/Survey_of_Harms_in_Victorian_Prisons.pdf 
 
Hobbs, M., Krazlan, K., Ridout, S., Mai, Q., Knuiman, M., Chapman, R., et al. (2006). 
Mortality and morbidity in prisoners after release from prison in Western Australia 
1995-2003. Canberra: Australian Institute of Criminology. 
Abstract: Released prisoner are generally assumed to have poor health compared 
with members of the general population. Previous studies, including a recent study in 
Western Australia, have shown that released prisoners are at greater risk of death 
compared with the general population, particularly in the first few months after 
release. Other studies describing the health of prisoners during imprisonment have 
emphasised a high prevalence of mental disorders, addictive behaviours and 
infectious diseases including HIV-AIDS and hepatitis C, all of which are likely to 
affect health after release. There have, however, been few systematic studies of 
general health problems in released prisoners, due to the difficulty in identifying 
prisoners in routinely collected health statistics. In Western Australia this has 
become possible through the development of the Western Australian Data Linkage 
System that enables data from statistical health collections, including hospital 
admissions, mental health services and deaths, to be linked to other administrative 
records. The objectives of the present study were to: compare mortality in released 
prisoners with the general population and identify factors associated with increased 
risk of deaths after release from prison; and compare patterns of use of hospital and 
mental health services by released prisoners with the use of such services by the 
general population and identify factors associated with increased risk of use of 
services in released prisoners. Selected information relating to individual prisoners 
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